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In this study the non-syndromic ichthyoses were studied to evaluate any genes or biological 
processes common to them and to identify key genes and pathways pertaining to each 
ichthyosis individually. This group of monogenic diseases comprises of ichthyosis vulgaris 
(loss of FLG), X-linked ichthyosis (loss of STS) lamellar ichthyosis/congenital ichthyosiform 
erythroderma (due to mutations in ALOX12B, ICH, ABCA12) and harlequin ichthyosis (due to 
ABCA12). They all affect terminal differentiation and the cornified layer and manifest as scaly 
conditions along a spectrum ranging from mild (as in ichthyosis vulgaris) to having a major 
impact on quality of life (as in lamellar ichthyosis/congenital ichthyosiform erythroderma) to 
severe (as in harlequin ichthyosis). The aim of this study was to investigate the effect of 
ichthyosis gene knockdown (STS, FLG, ABCA12, TGM1, ICH and ALOX12B) using RNAi 
technology in primary neonatal keratinocytes. 3D	 in	 vitro	 cultures	 using	 primary	
keratinocytes	 for	 the	 ichthyosis	 of	 interest,	 from	 the	 same	 genetic	 background,	 were	
developed	 including	 a	 novel	 model	 (STS	 knockdown). All the	 ichthyosis	 gene	
knockdowns	in	this	study	affected	terminal	differentiation		(change	in	TGM1	expression)	
and	 loss	of	ABCA12	altered	early	differentiation	 in	addition	 to	 terminal	differentiation.	
RNA-Seq analysis was performed in primary keratinocytes transfected with siRNA. 62 genes 
were significantly down-regulated and 26 genes were significantly up regulated overlapping 
in all the ichthyoses models. Altered gene clusters were found for cell cycle, innate immune 
response, keratin filament/cytoskeleton and metabolism of lipids and lipoproteins. Functional 
studies showed an altered cytokine profile in unstimulated primary keratinocytes and 
following stimulation of TLR -2, -3, -5 in all the ichthyoses. The findings suggest that several 
overlapping genes involved in biological processes, including innate immunity, are altered in 
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Chapter 1: Introduction 
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1.1 An Overview Of The Skin 
The skin consists of three layers: subcutaneous fat, the dermis and an overlying epidermis.  
 
1.1.1 Subcutanous Fat/Hypodermis 
The tissue of the hypodermis is the innermost and thickest layer of the skin that protects vital 
structures, maintains body heat and acts as an energy reserve (Griffiths et al., 2016). The basic 
unit of the subcutaneous fat is the microlobule that is composed of collections of adipocytes-
cells specialised in accumulating and storing fat. Aggregations of primary microlobules form 
secondary lobules that are separated by connective tissue septa containing nerves, vessels, and 
lymphatics (Haake et. al. 2001). 
 
1.1.2 The Dermis 
Beneath the epidermis a vascularized dermis provides structural and nutritional support. Its 
thickness varies from less than 0.5 mm to more than 5 mm (Calonje et al.; 2012).  It is 
composed of two principle types of protein fibres: collagen and elastin. Collagen is the major 
extracellular matrix protein (comprising 80-85% of the dry weight of the dermis) and provides 
the skin with its tensile strength. 12 of the known twenty-nine collagens are expressed in the 
skin; the main interstitial dermal collagens are I and III  (Smith et al., 2006). Elastic fibres 
(~2-4% of the extracellular matrix) play a major role in skin elasticity and resilience (Kielty et 
al., 2002). The dermis also contains a number of non-collagenous glycoproteins including 
fibronectin, thrombospondin, laminin, vitronectin, and tenascin that interact with other matrix 
components via cell surface receptors called integrins and facilitate cell adhesion, migration, 
morphogenesis and differentiation (Griffiths et al., 2016). Between the dermal collagen and 
elastic tissue is the ground substance made up of proteoglycans and glycosaminoglycan 
macromolecules (Haake et. al. 2001). These contribute only 0.1-0.3% of the total dry weight 
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of the dermis but provide a vital role by maintaining hydration mostly due to the high water-
binding capacity of hyaluronic acid (Calonje et al.; 2012). In addition, the dermis 
accommodates epidermal-derived appendages (hair follicles and sweat glands), the cellular 
components of the dermis such as fibroblasts (most abundant cells in the dermis and are 
known to synthesize collagen, elastin, other matrix proteins and enzymes), macrophages and 
mast cells (Griffiths et al., 2016). It is well vascularised by a deep and superficial vascular 
plexus.  
 
1.1.3 The Epidermis 
The normal epidermis is a terminally differentiated, stratified, squamous epithelium. It is 
typically 0.05-0.1mm in thickness (Calonje et al., 2012). It has evolved to provide a physical 
and permeability barrier, which is essential for survival as an adaptation to terrestrial life in 
mammals. The epidermis is mainly composed of keratinocytes (95% of epidermal cells). 
Other cells in the epidermis are melanocytes (distribute packages of melanin pigment in 
melanosomes to surrounding keratinocytes to give skin its colour), Langerhans cells’ 
(antigen-presenting cells and play a key role in adaptive immune responses in the skin) and 
Merkel cells (serve as mechanosensory receptors in response to touch) (Griffiths et al., 2016).  
 
The keratinocyte moves progressively from the basal layer towards the skin surface, forming 
several well-defined layers during its transit (Freinkel et al., 2001). Thus on morphological 
grounds the epidermis can be divided into 4 distinct layers: stratum basale, stratum spinosum, 
stratum granulosum and stratum corneum.  
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1.1.3.1 Basal layer/Stratum Basale (SB): 
This is a continuous layer that is generally only 1 cell thick. The basal cells are small and 
cuboidal and have large, dark staining nuclei and ribosome rich cytoplasm. A small number of 
stem cells are also present in the basal layer, these cells undergo mitotic divisions which 
results in the continued production of keratinocytes necessary for epithelial homeostasis. 
Basal keratinocytes are attached to the underlying basement membrane by hemidesmosomes 
and to the surrounding cells via desmosomes and adherens junctions (Simpson et al., 2011; 
Walters and Roberts, 2002). The basal layer is typified by the expression of keratins 5 and 14 
(Candi et al., 2005). 
 
1.1.3.2 Stratified layer/Stratum Spinosum (SS): 
Triggered by poorly understood signals, certain basal keratinocytes migrate from the basal 
into the spinous layers, lose their mitotic activity, and begin to synthesize a new set of 
structural proteins and enzymes that are characteristic of cornification (the process by which 
epidermal cells progressively mature from basal cells with proliferative potential to non-
viable corneocytes is called keratinisation or cornification) (Candi et al., 2005; Simpson et al., 
2011). The spinous layer is characterised by the expression of differentiation-specific keratins 
1 and 10 (Fuchs et. al. 1980, Sun et. al. 1983).  Here tightly packed polyhedral shaped 
keratinocytes are held together by many desmosomes, which help to stabilize adjacent 
keratinocytes (Calonje et al.; 2012). The name of this layer is derived from the histological 
appearance of desmosomes that appear as narrow spikes or projections.  
 
1.1.3.3 Granular layer/Stratum Granulosum (SG): 
The granular layer can be identified by the presence of basophilic keratohyalin granules. The 
keratohyalin granules contain profilaggrin the precursor of the interfilamentous protein 
filaggrin. The cytoplasm of cells of the upper spinous and granular layer also contain 
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multifunctional, lysosome-like organelles, called lamellar bodies (LB). They discharge their 
lipid components into the intercellular space playing important roles in barrier function and 
intercellular cohesion within the SC (Candi et al., 2005; Kalinin et al., 2002; Walters and 
Roberts, 2002). In addition, they secrete a broad variety of lipid hydrolases, 
proteases/antiproteases, antimicrobial peptides, apolipoproteins and other proteins, in addition 
to lipids, into the extracellular spaces (Raymond et al., 2008). The movement of these 
organelles to the cell periphery in anticipation of secretion is dependant upon a set of 
colocalised motor and non-motor proteins (Raymond et al., 2008). In the stratum granulosum, 
keratinocytes are connected among each other by tight junctions (Simpson et al., 2011).  
 
 
1.1.3.4 Cornified layer /Stratum Corneum (SC) 
	
The outermost layer of the epidermis is the stratum corneum composed of mechanically 
tough, dead cornified cells (corneocytes), which develop as a result of terminal differentiation 
(Elias, 2010; Kalinin et al., 2002; Walters and Roberts, 2002) (Figure 1.1). These cells are 
anucleated and devoid of all organelles. Corneocytes in the cornified layer have a 
characteristic flattened shape. The shape of the keratinocytes is provided by a cytoskeleton 
made of keratin intermediate filaments, KIFs. Filaggrin aggregates the KIFs into tight 
bundles. This promotes the collapse of the cell into the flattened shape. The plasma membrane 
of the corneocytes is completely replaced and they are encapsulated within a highly 
specialized structure termed the cornified envelope (CE) formed by cross-linking of a series 
of structural proteins, involucrin, loricrin, trichohyalin and the small-proline-rich proteins, by 
specific epidermal transglutaminases that are synthesized in the high SS (Candi et al., 2005). 
A monomolecular layer of long-chain ceramides (ω-hydroxyceramides) is covalently bound 
to this protein layer, forming a cornified lipid envelope (CLE) on the surface of each 
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corneocyte. The cells in the CLE are surrounded by orderly intercellular lipids consisting of a 
mixture of ceramides, free fatty acids, cholesterol and its esters that are organised into 
repeating arrays of broad lamellar membranes that completely engorge the extracellular 
spaces (Candi et al., 2005). These lipids are processed/derived from precursor lipids 
(glucosylceramides, phospholipids and cholesterol), which were released from the lamellar 
bodies (LB) at the SG/SC interface, by concurrently released enzymes (Freinkel and Traczyk, 
1985).  The structural behaviour of the SC is analogized to a brick wall comprising of 
corneocytes, the “bricks”, provide the mechanical strength and are embedded in the "mortar" 
lipid lamellae, which represents the permeability barrier (Elias, 1983; Nemes and Steinert, 
1999). The composition of the intercellular lipids is important for an intact barrier function 
(Holleran et al., 2006; Menon et al., 2012). Corneocytes are connected to each other by 
corneodesmosomes, which derive from desmosomes through morphological changes in the 
transition zone between SG/SC (Candi et al., 2005; Proksch et al., 2003; Simpson et al., 
2011). Proteolysis of corneodesmosomes releases the bonds between corneocytes of the outer 
cornified layer, leading to desquamation (Elias, 2010; Walters and Roberts, 2002).  Under 
physiological conditions skin surface pH is between 5.0 and 5.5 (Schmid-Wendtner and 
Korting, 2006), the optimal pH for lipid processing by enzymes and also for limiting the 
colonization of pathogenic bacteria (Chan and Mauro, 2011; Holleran et al., 2006). One main 
difference of the intercellular lipid lamellae to other lipid matrices in the human body, is the 
absence of phospholipids in the stratum corneum (Walters and Roberts, 2002). The lamellar 
body-derived phospholipids are processed by secretory phospholipase to A2 (sPLA2) free fatty 
acids and glycerol. The latter has a strong water-binding capacity and, hence, contributes to 
SC hydration (Feingold, 2007).   
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Figure 1.1: Formation of the cornified envelope 
This is a complex process that involves the synthesis of cornified envelope proteins (envoplakin, 
periplakin, loricrin small proline-rich proteins (SPRs), involucrin and loricrin) and cross-linking of 
these proteins by transglutimases (TGs) to form the cornified envelope. The intercellular lipids (ω-OH-
ceramides, fatty acids and cholesterol) are extruded by the lamellar bodies into the extracellular space 
and are covalently attached to the cornified envelope to form the cornified lipid envelope. Adapted from 
(Candi et al., 2005).  
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1.2 Ichthyoses  
1.2.1 Classification of the Ichthyoses: disorders of cornification  
(DOC) 
In 2009, the first Ichthyosis Consensus Conference was held to establish a consensus for the 
nomenclature and classification of inherited ichthyoses, by which an international consensus 
for the classification of ichthyoses was achieved (Oji et al., 2010). This is a clinically-based 
classification in which DOC are referenced with their causative gene. Two principal groups 
are recognised: non-syndromic (limited to the skin without other organ involvement) and 
syndromic forms (skin and other organ involvement). There are several non-syndromic  
inherited ichthyoses as follows (Table 1): 
Inherited ichthyoses 
Part A: nonsyndromic forms 
Disease Mode of inheritance Gene(s) 
Common ichthyoses*   
  IV Autosomal semidominant FLG 
  RXLI Nonsyndromic 
presentation 
X-linked recessive STS 
ARCI   
  Major types   
    HI Autosomal recessive ABCA12 
    LI° Autosomal recessive TGM1/NIPAL4•/ALOX12B/ABCA12/loci on 
12p 11.2-q13 
    CIE Autosomal recessive ALOXE3/ALOX12B/ABCA12/CYP4F22/NIPA
L4•/TGM1/loci on 12p11.2-q13 
  Minor variants   
    SHCB Autosomal recessive TGM1, ALOX12B, ALOXE3 
    Acral SHCB Autosomal recessive TGM1 
    BSI Autosomal recessive TGM1 
Keratinopathic ichthyosis (KPI)   
  Major types   
    EI¯ Autosomal dominant KRT1/KRT10 
    SEI Autosomal dominant KRT2 
  Minor variants   
    AEI¯ Autosomal dominant KRT1/KRT10 
    ICM Autosomal dominant KRT1 
    AREI Autosomal recessive KRT10 
    Epidermolytic nevi’’ Somatic recessive KRT1/KRT10 
Other forms   
  LK Autosomal dominant LOR 
  EKV>> Autosomal dominant GJB3/GJB4 
  PSD Autosomal recessive Locus unknown 
  CRIE Autosomal dominant (isolated 
cases) 
Locus unknown 
  KLICK Autosomal recessive POMP 
AEI, Annular epidermolytic ichthyosis; ARCI, autosomal recessive congenital ichthyosis; AREI, autosomal epidermolytic ichthyosis; BSI, bathing 
suit ichthyosis; CIE, congenital ichthyosiform erythroderma; CRIE, congenital reticular ichthyosiform erythroderma; EI, epidermolytic ichthyosis, 
EKV, erythrokeratodermia variabilis; HI, harlequin ichthyosis; ICM, ichthyosis Curth-Macklin; IV, ichthyosis vulgaris; KLICK, keratosis linearis-
ichthyosis congenital-keratoderma; LI, lamellar ichthyosis; LK, loricrin keratoderma; PSD, peeling skin disease; RXLI, recessive X-linked 
ichthyosis; SEI, superficial epidermolytic ichthyosis; SHCB, self-healing collodion baby. 
*Often delayed onset (in RXLI mild scaling and erythroderma may be present already at birth). 
°Few cases of autosomal dominant LI described in literature (locus unknown). 
•Also known as ICHTHYIN gene. 
¯KRT1 mutations are often associated with palmoplantar involvement. 
’’May indicate gonadal mosaicism, which can cause generalized EI in offspring generation. 
>>Whether progressive symmetric erythrokeratodermia represents distinct mendelian disorders of cornification form is debated. 
Table 1: Clinicogenetic classification of inherited non-syndromic ichthyoses. 
The phenotype is limited to the skin without other organ involvement. Taken from (Oji et al., 2010). 
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This study focuses on the monogenic non-syndromic ichthyosis, due to mutations in STS, 
FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B which constitute a subgroup within the 
greater group of DOC.  
 
1.2.2 The non-syndromic monogenic ichthyoses:  
Defects in SC lead to a clinically and etiologically heterogenous group of disorders ranging 
from mild (as in ichthyosis vulgaris MIM 146700) to having a major impact on quality of life 
(X-linked ichthyosis MIM 308100, lamellar ichthyosis MIM 242300/congenital 
ichthyosiform erythroderma MIM 242100) to severe cases that can be life-threatening 
(harlequin ichthyosis MIM 242500). The last 10 years have seen considerable advances in our 
understanding of the genetic basis of the ichthyoses (Oji et al., 2010) (Figure 1.2). 
 
The pathogenesis of various ichthyoses can be thought to be associated with at least one of 
components of the epidermal skin barrier (sections 1.4 and 1.5). The known causative 
molecules underlying ichthyosis include ABCA12, lipoxygenase-3, 12R-lipoxygenase, 
ichthyin and steroid sulfatase, are thought to be related to the intercellular lipid layers. 
Transglutaminase1 plays a role in cornified cell envelope formation.  Filaggrin is essential for 






































































































































































































































































































































































































































































































































































































1.3 Common Ichthyoses 
1.3.1 ICHTHYOSIS VULGARIS (IV) (MIM 308100) 
Ichthyosis vulgaris represents the most common disorder of cornification. Its prevalence 
appears to vary with geographical region ranging from 1 in 100 in British school children 
(Wells, 1966) to 1:1000 and 2000 in Japan and Mexico (Cuevas-Covarrubias et al., 1999). 
Varying clinical criteria for the diagnosis and/or geographical variation in the mutation 
frequency and seasonal variability (improves in the summer months) are thought to account 
for the discrepant prevalence rates. 
 
The phenotype is rarely evident before 3–6 months after birth, but usually manifests during 
childhood and becomes more severe with age. Individuals display mild generalized fine 
scaling most pronounced on the extensor surfaces of extremities with characteristic flexural 
sparing. Hyperlinearity of palms and soles (linear grooves perpendicular to the thenar and 
hypothenar eminence) is common as is the association with keratosis pilaris and atopic 
dermatitis (AD) (Sandilands et al., 2007).   
 
Atopic dermatitis is a chronic relapsing inflammatory skin disease presenting as pruritic, dry, 
scaly skin with excoriations as well as cutaneous infections and is associated with asthma 
and/or alleric rhinitis (McGrath and Uitto, 2008, Sidbury et al., 2014, Spergel, 2010).  It 
occurs most commonly during infancy/childhood but can also affect adults (Griffiths et al., 
2016).  
 
1.3.1.1 FLG: Gene 
In 2006, loss of function mutations in the FLG gene, located in the epidermal differentiation 
complex (a region that also harbours genes for several other proteins that are expressed during 
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terminal differentiation several of which become cross-linked enzymatically into the CE) on 
chromosome 1q21, resulting in a lack of functional filaggrin were identified in IV patients 
from Scottish, Irish and European-American populations (Smith et al., 2006).  In addition to 
causing IV, a monogenic genodermatosis,  mutations in the FLG gene is the major genetic 
predisposing factor for AD, which is a complex trait, resulting from the interaction of multiple 
genetic and environmental risk factors (McLean, 2016). 
 
FLG comprises three exons, the initiation codon for translation being located in exon 2, and 
the bulk of the profilaggrin protein is encoded by exon 3 (Presland et al., 1992). In addition to 
the two common premature termination causing mutations, p.R501X and c.2282del4 in exon 
3, that were initially identified, several other rare or family-specific loss-of-function mutations 
within FLG exon 3 have been discovered in populations of white European ancestry. Asian 
populations have been shown to have their own mutation spectra, following detailed study of 
the Japanese (Osawa et al., Nomura et al., 2009) and Han Chinese (Zhang et al., 2011) and 
Singaporean Chinese populations (Chen et al., 2011). All mutations are either nonsense or 
frame-shift mutations in the protein encoding exon. 	
	
The prevalent filaggrin mutations are loss-of-function alleles leading to complete or almost 
complete loss of filaggrin expression (Sandilands et al., 2007, Palmer et al., 2006). There is a 
dose effect in that heterozygous patients display a mild or no phenotype, while homozygous 
and compound heterozygous FLG genotypes exhibit the full ichthyosis vulgaris phenotype. 
The same FLG mutations have been linked to atopic dermatitis (Palmer et al., 2006, 
Sandilands et al., 2007) but these are predominantly found in the heterozygous configuration.  
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1.3.1.2 Pro-Filaggrin and Filaggrin Protein 
The initial product of FLG translation is Profilaggrin, a 400-kDa protein (Figure 1.3). It is 
composed of a short N-terminal domain, followed by the 10 to 12 repeats of nearly identical 
filaggrin that makes up most of the profilaggrin molecule (typically, there are 10 highly 
homologous and only slightly genetically distinct filaggrin units, although the number of 
filaggrin repeat units is variable and genetically determined). This means different individuals 
have 10, 11 or 12 filaggrin repeat units (copy number variants) in total plus a C-terminal 
domain (Gan et al., 1990).  An incremental reduction in the risk of atopic dermatitis with each 
additional unit of copy number has been noted (Brown et al., 2012) and even a modest 10-
20% increase in epidermal filaggrin expression is predicted to be therapeutic for eczema or 
protective against developing eczema (Brown and McLean, 2012).  
 
Upon terminal differentiation, profilaggrin is proteolytically cleaved into filaggrin peptides of 
approximately 37 kDa and the N-terminal domain containing an S100-like calcium-binding 
domain. The N-terminal domain translocates to the nucleus where it possibly plays a role in 
the enucleation of keratinocytes in the outer stratum corneum (Sandilands et al., 2009).  The 
S100-like calcium binding domain (Markova et al., 1993) may play a role in the regulation of 
calcium-dependent events during terminal epidermal differentiation (Presland et al., 1992) or 
conversely, calcium may be involved in the control of profilaggrin processing (Presland et al., 
1992, Sandilands et al., 2009). Filaggrin has keratin binding properties. The precise function 




Figure 1.3: Schematic representation of Pro-FLG showing loss of function mutations in the FLG gene 
detected in individuals with IV and eczema.  
Profilaggrin is composed of a short N-terminal domain (contains a S100 calcium-binding domain), followed by 
the 10 nearly identical filaggrin that makes up most of the profilaggrin molecule plus a C-terminal domain. 
There are polymorphic variations in the number of filaggrin repeats: some individuals have duplication of the 8th 
or 10th domain or both. The mutations shown in green are common in individuals of European ancestry while 
those in dark green are common in Oriental populations. The other mutations are rare. Taken from (McGrath and 
Uitto, 2008).  
 
 
1.3.1.3 Paucity/loss of keratohyalin granules due to loss-of-function 
mutations  
In the absence of functional protein, as in IV, a reduced or absent granular layer due to 
paucity of keratohyalin granules and reduced cellular profilaggrin content (profilaggrin is the 
major component of the keratohyalin granules seen in the SG) is observed (Fleckman and 
Brumbaugh, 2002). Ultrastructurally, the residual keratohyalin granules are poorly formed 
(“crumbly”) (Anton-Lamprecht and Hofbauer, 1972) or absent (Fleckman and Brumbaugh, 
2002). Absence of the granular layer is independent of body site and season of the year, but 
correlates with severity of the disease (Fleckman and Brumbaugh, 2002), and mutation status. 
Patients with one mutation (heterozygous) display a reduced granular layer whereas patients 
with two FLG mutations (homozygous or compound heterozygous) in most instances show a 
virtually complete lack of a granular layer (Smith et al., 2006, Gruber et al., 2007, Nomura et 
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al., 2007). However in rare cases even patients with two mutations show residual granular 
cells (Gruber et al., 2007). This persistence of keratohyalin granules appears to depend on the 
location of the mutation within the gene i.e. more proximal mutations show complete absence 
of profilaggrin in homozygotes (Smith et al., 2006), whereas more distal mutations show 
residual, yet greatly reduced, truncated profilaggrin species that are not processed to FLG 
monomers (Sandilands et al., 2007).  
 
1.3.1.4 Filaggrin: Role in structural integrity of SC 
Filaggrin, also known as filament-aggregating protein, aggregates the keratin cytoskeleton, 
facilitating the collapse and flattening of cells in the outermost stratum corneum to produce 
flattened anuclear squames (Manabe et al., 1991).  Although, this process of cell flattening is 
seen in the absence of processed filaggrin, on an ultrastructural level disorganized keratin 
filaments are noted (Gruber et al., 2011). Additionally, impaired lamellar body loading and 
abnormal architecture of the lamellar bilayer is observed (Gruber et al. 2012). One possible 
explanation for this may be that filaggrin is a histidine-rich protein (Lynley and Dale, 1983) 
and histidine is metabolized to trans-urocanic acid (trans-UCA); pyrrolidone-5-carboxylic 
acid (PCA) is the other main breakdown product of filaggrin and together these organic acids 
help to maintain the pH gradient of the epidermis as evidenced by a higher surface pH in FLG 
null mutation carriers (Jungersted et al., 2010).  An acidic pH within the stratum corneum is 
also important for the functional activity of enzymes involved in ceramide metabolism (Fluhr 
et al., 2010).  Another observation is reduction in corneodesmosome density and tight 
junction protein expression observed in the skin from ichthyosis vulgaris patients (Gruber et 
al., 2011). It is unclear as to how these observations may be attributable to filaggrin 
deficiency and the mechanisms by which profilaggrin and filaggrin, as intercellular proteins 
contribute to what appears to be a paracellular barrier defect (Gruber et al., 2011) 
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(Scharschmidt et al., 2009) remain to be defined.  
 
1.3.1.5 Filaggrin: Role in SC hydration  
FLG is proteolysed into its constituent amino acids and other small molecules, the so-called 
‘natural moisturising factor’ which contributes to epidermal hydration and barrier function 
(Presland et al., 2000, Scott et al., 1982, Nachat et al., 2005). FLG null mutations are 
associated with lower levels of hygroscopic amino acids in the SC and there is a concominant 
increase in transepidermal water loss (Kezic et al., 2008).  
 
1.3.1.6 Filaggrin: In Vitro knockdown models  
Several in vitro models for filaggrin knockdown and IV have been reported; these models 
were generated either using siRNA transfected primary keratinocytes grown at air-liquid 
interface on collagen I (containing fibroblasts) gels and were cultured for 7 (Mildner et al., 
2010) and 14 days (Kuchler et al., 2011, Vavrova et al., 2014) or by shRNA interference of 
primary keratinocytes grown on a polycarbonate filter  cultivated for 10 days (Pendaries et al., 
2014). Loss of FLG was demonstrated by qPCR, immunofluorescence in all three models and 
additionally by western blotting by Mildner et al. and Pendaries et al (Mildner et al., 2010, 
Pendaries et al., 2014). The model generated by Mildner et al. did not demonstrate changes in 
keratinocyte differentiation and SC morphology but this was in contrast to the other models 
where alteration in both was noted and this difference was attributed to the longer cultivation 
time (Kuchler et al., 2011). No difference in intercellular lipid lamellae or total lipid content 
in the FLG knockdown compared to normal construct was found on day 7 (Mildner et al., 
2010, Vavrova et al., 2014) but disordered intercellular lipid lamellae accompanied by an 
almost 2-fold increase in FFA was found on day 14 of cultivation (Vavrova et al., 2014). All 
the in vitro models showed reduced levels of FLG degradation products, urocanic and/or 
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pyrrolidone carboxylic acid compared to a normal skin model, which is in agreement with in 
vivo findings (Kezic et al., 2008, O'Regan et al., 2010). The skin barrier function was assessed 
by assessing SC permeability using a dye penetration assay, Lucifer yellow, by Mildner et al. 
and Pendaries et al (Mildner et al., 2010, Pendaries et al., 2014). In both studies increased 
permeability was noted; the dye penetrated into the SC and diffused further down to the SB or 
polycarbonate filter in the FLG-deficient skin model whilst in the control it was retained 
within the SC. This finding was supported by Kuchler et al. who reported higher permeability 
towards lipophilic testerone but no significant increase in permeability to hydrophilic caffeine 
in the FLG knockdown compare to control was noted. In contrast another FLG knock-down 
model using shRNA transfected NTERTs (on a collagen I scaffold cultivated for 14 days) 
showed no changes in SC permeability for lipophilic butyl p-aminobenzoic acid. In addition 
there was no effect in SC lipid organisation and composition in the NTERT model in keeping 
with Mildner et al. (van Drongelen et al., 2013). 
 
1.3.2 RECESSIVE X-LINKED ICHTHYOSIS (RXLI) (MIM 
308100) 
RXLI is a keratinization disorder and affects roughly 1:2000 to 1:6000 males (Shwayder, 
1999) who inherit an X chromosome bearing a mutated steroid sulfatase gene (STS) from their 
asymptomatic carrier mother (Shapiro et al., 1978, Koppe et al., 1978). In 75% of cases 
scaling is evident within the first week of life but 6% develop scaling after the age of 1 year 
(D. A. Burns, 2010). The disorder sometimes presents with fine peeling of the entire 
integument at the age of 1-3 weeks and shows fine scaling in early life. The scaling increases 
throughout childhood and is polygonal, thick and dark. It is prominent on the posterior and 
lateral neck, upper, lateral abdominal wall, outer thighs, the lower legs and preauricular facial 
skin. Extensor surfaces of the upper arms are commonly affected but in contrast to IV, 
flexures are involved (Hernandez-Martin et al., 1999). Palms and soles are spared. Extra-
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cutaneous organ involvement as a result of contiguous gene syndrome has been described.  A 
family history of prolonged labour and consequently perinatal complications may be reported 
(Hernandez-Martin et al., 1999).  
 
1.3.2.1 STS: Gene 
STS is located on Xp22.3 and has 10 exons spread over 146 kilo base pairs encoding a 62 kDa 
polypeptide (Sugawara et al., 2006). STS gene deficiencies are heterogeneous and in addition 
to the more common deletions (80-90% of RXLI) there are several described point mutations; 
most are missense mutations but non-sense mutations and one splice site mutation has also 
been reported (Gonzalez-Huerta et al., 2006,	 Liao et al., 2007).  Although the genotypic 
deficiencies are heterogeneous, they all lead to loss of STS enzyme activity.  
 
1.3.2.2 Steroid sulfatase (SSase): Protein 
The STS gene encodes steroid sulfatase, a membrane-bound microsomal enzyme that is 
ubiquitously expressed and hydrolyzes estrone sulfate, dehydroepiandrosterone sulfate, and 
cholesterol sulfate, CSO4, (Alperin and Shapiro, 1997).  In epidermis, SSase activity is low in 
the basal and spinous layers, whereas enzyme levels peak in the SG (10–20 times higher) and 
persist into the SC.  In the SG, SSase is concentrated in lamellar granules and then secreted 
into the intercellular spaces of the SC, along with other lamellar granule-derived lipid 
hydrolases (Elias et al., 2004) where steroid sulfatase catalyzes the desulfation of CSO4 
generating cholesterol for the barrier (Shapiro et al., 1978, Kubilus et al., 1979).  In RXLI, 
due to absence of the enzyme steroid sulfatase cholesterol sulfate accumulates in the SC (up 
to 10- to 20-fold increase) [(Williams and Elias, 1981)].  
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1.3.2.3 Sulfatases: The superfamily 
Sulfatases belong to a conserved family of enzymes that are involved in the regulation of cell 
metabolism and in cell signaling (Mueller et al., 2015).  They are hydrolytic enzymes that 
desulfate esters contained in hormones, proteins, and complex macromolecules. Each 
sulfatase has its own substrate specificity (Buono and Cosma, 2010). To date, 17 distinct 
genes that can code for sulfatases in humans have been identified, which have been further 
divided on the basis of their subcellular localization and their pH-dependent activities. The 
protein structures are characterized by four domains: A, B and C, highly conserved domains, 
participate in the formation of N-terminal region with the B domain including the active site 
while the D domain includes the less conserved C-terminal region. A highly conserved 
cysteine in their active site is post-translationally converted into formylglycine by the 
formylglycine-generating enzyme encoded by SUMF1  (sulfatase modifying factor 1) in all 
sulfatases leading to protein activation. Disorders due to gene mutations of sulfatases include 
those resulting from improper catabolism of substrates (ARSA gene mutations cause 
metachromatic leukodystrophy, which is characterized by extensive neuron demyelination in 
the nervous system due to improper catabolism of the sulfatide, cerebroside-3S, which is one 
of the major structural components of the myelin sheath) or accumulation of non-catabolised 
substrates (Louis and Fluharty, 1991; Buono and Cosma, 2010). Mutations in the genes 
encoding for lysosomal sulfatases such as ARSB results in a group of lysosomal storage 
disorders, mucopolysaccharidoses, that arise following accumulation of non-catabolized 
substrates which severely impair lysosomal function, resulting in defects in protein, 
glycoconjugate, lipid, nucleic acid, and phosphate metabolism) (Neufeld EFM, 1999). 
 
1.3.2.4 SSase: Role in Permeability Barrier Function 
Ultrastructural images of SC in RXLI show frequent but focal disruption of intercellular lipids 
(Rehfeld et al., 1988, Zettersten et al., 1998) due to excess CSO4, and to some extent, 
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decreased cholesterol (reduced by ~50%) [(Elias et al., 2004)]. 
 
1.3.2.5 SSase: Role in desquamation 
In normal epidermis, the progressive decline in cholesterol sulfate (~5% of total lipid in the 
SG, declining to ~1% in the outer SC [(Long et al., 1985, Ranasinghe et al., 1986, Elias et al., 
1998)] permits corneodesmosome degradation leading to intact desquamation (Elias et al., 
2004) and regulation of permeability barrier homeostasis. Loss of SSase in RXLI leads to 
persistence of corneodesmosomes.  Two key serine proteases, kallikrein (KLK) KLK7 
[stratum corneum chymotryptic enzyme (SCCE)] and KLK5 [stratum corneum tryptic 
enzyme (SCTE)] are thought to mediate desquamation by degrading corneodesmosomes. 
CSO4, is a known serine protease inhibitor and accumulation of CSO4, possibly retards 
desquamation by inhibiting serine proteases in the SC (Williams, 1991, Elias et al., 2004).  
 
1.3.2.6 SSase: Regulation of differentiation by cholesterol sulfate  
CSO4 is known to stimulate epidermal differentiation by at least two mechanisms; It activates 
the η isoform of protein kinase C (Denning et al., 1995), which in turn stimulates the 
phosphorylation of differentiation-linked proteins (Elias et al., 2004).  CSO4 is a 
transcriptional regulator of TGM1 and involucrin expression, operating through an activator 
protein-1, AP-1, binding site in the promoter region (Hanley et al., 2001).  
1.4 The Autosomal Recessive Congenital Ichthyoses 
(ARCI) 
ARCIs is an umbrella term for the lamellar ichthyosis (LI)/Nonbullous congenital 
ichthyosiform erythroderma (NCIE) spectrum patients and Harlequin Ichthyosis (Oji et al., 
2010). They all share in common an autosomal recessive mode of inheritance and disease 
presentation at birth, most often with a collodion membrane.  
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1.4.1 HARLEQUIN ICHTHYOSIS (HI) (MIM 242500):  
HI is the most devastating congenital ichthyosis. Affected newborns are encased in an 
“armour” of thick scale plates separated by deep fissures. There is bilateral ectropion and 
eclabium. The nose and ears are flattened and appear rudimentary. Digital contractures and 
autoamputation of digits due to constricting skin bands have been reported. Infants are often 
born prematurely, and some are stillborn. As the skin barrier is severely compromised, 
neonates are more prone to sepsis, dehydration, and impaired thermoregulation. Additionally, 
the constricting scales can impair respiration and/or feeding leading to perinatal mortality. In 
neonates who survive the perinatal period, the plate-like encasement is shed, and the 
phenotype shifts to a severe ichthyosiform erythroderma (Williams and Elias, 1993, Akiyama, 
1999). The compensatory mechanisms for ABCA12 leading to the milder phenotype are not 
known. In 2005, mutations in ABCA12 on chromosome 2q33-5 were reported to underlie HI 
(Kelsell et al., 2005, Akiyama et al., 2005) 
 
1.4.1.1 ABCA12: Other Genotype/Phenotype correlations 
Several genotype ⁄ phenotype correlations with ABCA12 mutations, other than HI, have also 
been reported; in 2003 it was reported that combinations of missense mutations (resulting in 
only one amino acid alteration) underlie the LI phenotype, (Lefevre et al., 2003). Clinically, 
no distinct characteristic features are known for this type of LI (Parmentier et al., 1999, 
Parmentier et al., 1996, Lefevre et al., 2003). In addition, two cases of NBCIE were reported 
to have ABCA12 missense mutations (Natsuga et al., 2007, Nawaz et al., 2012, Sakai et al., 
2009).  
 
1.4.1.2 ABCA12: Gene 
Thus far the mutations reported in HI are homozygous or compound heterozygous nonsense 
substitutions, whole exon deletions and insertions or splice site mutations predicted to cause a 
	 37	
truncated protein affecting important nucleotide-binding fold domains and/or transmembrane 
domains resulting in severe loss of ABCA12 function (although a compound heterozygous 
mutation with a missense and a premature stop codon has been reported) whereas the 
ABCA12 mutations in LI/NCIE reported to date have solely been missense mutations. 
(Akiyama et al., 2005, Kelsell et al., 2005, Akiyama et al., 2006a, Akiyama et al., 2006b, 
Thomas et al., 2006, Akiyama et al., 2007b, Akiyama et al., 2007a, Rajpar et al., 2006). Both 
lamellar ichthyosis and NCIE have a much milder phenotype than HI. ABCA12 mutations in 
LI have been found exclusively in the first nucleotide-binding fold and in NCIE in the 
extracellular domain and the nucleotide-binding fold (Rajpopat et al., 2011, Nawaz et al., 
2012). Thus, the severity of the disease is thought to be affected by the nature of the ABCA12 
mutation and its location within the protein and mortality is associated with homozygous 
mutations. Additionally certain mutations are more prevalent in certain populations due to 
founder effect such as c7322delC in exon 49 in 80% of Pakistani HI patients (Thomas et al., 
2008). 
1.4.1.3 ABCA12: Protein 
ABCA12 is found in 2 isoforms-ABCA12-L (NM_173076) and the shorter ABCA12-S 
(NM_173076). The former has a calculated molecular weight of 293 kDa and the latter 257 
kDa. The full-length expressed protein contains a signal peptide at the N terminus, two 
transmembrane domains (TMD) and two nucleotide binding folds (NBF) (Figure 1.4). The 
NBFs bind ATP and the energy released in this process is used to transport lipids across the 
membrane. In normal skin, ABCA12 is expressed throughout the epidermis with abundant 
expression in the spinous and granular layers (Sakai et al., 2007) and abnormal LGs are the 
most obvious characteristic findings in HI lesional epidermis. It serves as a putative 




Figure 1.4: Structure of ABCA12 protein:	
ABCA12 is a transmembrane protein. It contains a signal peptide at the N terminus, two transmembrane domains 
(in red) and two nucleotide binding folds. The nucleotide binding folds bind ATP and the energy released in this 
process is used to transport lipids across the membrane (Akiyama, 2014).	
 
1.4.1.4 ABCA: The transporter superfamily 
ABCA12 is a member of a large superfamily of the ATP-binding cassette (ABC) transporters. 
ABCs are a large group of proteins which bind and hydrolyze ATP to transport various 
molecules across a limiting membrane or into a vesicle (Borst and Elferink, 2002). To date, 
48 ABC genes have been identified, which have been further divided into seven subfamilies 
organized from A to G, based on the amino acid sequence and the organization of ATP 
nucleotide binding folds (Akiyama et al., 2005, Borst and Elferink, 2002, Allikmets et al., 
1996, Dean et al., 2001). These proteins contain two transmembrane sequences and two ATP 
binding domains, which undergo conformational changes that facilitate first the binding and 
then the dissociation of attached lipids (Hollenstein et al., 2007). The transmembrane domains 
typically contain from six to eleven membrane-spanning alpha-helices and it is this region of 

































functional transporters that all mediate lipid transport (Jiang et al., 2008), (Peelman et al., 
2003) with the exception of one pseudogene (ABCA11). ABCA transporters function as 
components of highly specialized cellular lipid-transporting organelles in major physiological 
systems, in which defects cause severe inherited diseases in the cardiovascular, visual, and 
respiratory systems. Gene mutations in ABCA1 leads to Tangier disease where patients have 
a greatly reduced ability to transport cholesterol out of their cells, leading to a deficiency of 
high density lipoproteins in the blood stream and the accumulation of cholesterol in many 
tissues (Jetten et al., 1989, Jetten et al., 1987). ABCA3 regulates pulmonary surfactant 
transport/secretion by LB in type II alveolar cells (Yamano et al., 2001, Mulugeta et al., 2002) 
and pulmonary surfactant deficiency in newborns has been linked to ABCA3 deficiency 
(Strott and Higashi, 2003).  
 
1.4.1.5 ABCA12: Role in lipid delivery and permeability barrier formation 
In normal skin, ABCA12 localises to the LB and Golgi apparatus colocalising with 
glucosylceramide (Sakai et al., 2007). LB are found in the spinous and granular layers and are 
contiguous with the trans-Golgi network and fusion of LB with the surface of granular cells is 
observed (Ishida-Yamamoto et al., 2004). These observations imply that ABCA12 serves as a 
transporter for glucosylceramides from the Golgi apparatus into epidermal LB.  The LB fuse 
with the plasma membrane at the apical surface of the granular keratinocytes secreting 
glucosylceramides into the extracellular space where they are hydrolysed to ceramides.  They 
contribute both to lamellar extracellular lipids and to form the CLE (Sakai et al., 2007, 
Akiyama, 2006). In HI, loss of function mutations in ABCA12 results in several 
morphological defects in skin. Compared to normal skin, electron microscopy of HI skin has 
shown absent, abnormally shaped, or reduced number of LB with absence of intercellular 
lamellae (Dale et al., 1990, Milner et al., 1992, Akiyama et al., 1994, Akiyama et al., 1998). 
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In HI keratinocytes an aberrant distribution of glucosylceramide immunofluorescent staining 
is noted, demonstrating defective glucosylceramide transport, but this phenotype is 
recoverable by in vitro ABCA12 corrective gene transfer (Akiyama et al., 2005). Furthermore, 
unlike in normal skin where there are polar and nonpolar lipids in HI skin the majority of the 
lipids are polar suggesting an absence of nonpolar lipids such as ceramides (Thomas et al., 
2009). Mutations in ABCA12 cause defective lipid accumulation into LB (Akiyama et al., 
2005, Yamanaka et al., 2007), resulting in malformation of the intercellular lipid layers of the 
stratum corneum (Akiyama et al., 2005) leading to a profound barrier abnormality 
(Moskowitz et al., 2004).  Despite these findings the nature and scope of ABCA12’s 
involvement in lipid homeostasis remains unclear. 
 
1.4.1.6 ABCA12: Role in protease delivery and corneodesmosome retention  
Harlequin ichthyosis is characterized by striking hyperkeratosis. Although this is driven, at 
least in part, by the high transepidermal water loss (Moskowitz et al., 2004) due to the 
profound barrier abnormality, it is possible that this is also due to a desquamation 
abnormality, but by an indirect mechanism, since corneodesmosomes are found to persist in 
the outer SC. An array of LB-derived proteases is required for degradation of 
corneodesmosomes and normal desquamation (Brattsand et al., 2005, Caubet et al., 2004, 
Horikoshi et al., 1999). Lipid delivery to LB is required for the subsequent or concurrent 
importation of these proteases into these organelles (Jobard et al., 2002). Colocalisation of 
proteases Cathepsin D and KLK5 with ABCA12 in normal keratinocytes and reduction of 
both in HI skin and a HI organotypic model has been noted (Thomas et al., 2009). Thus a 
failure of lipid delivery may also impair the delivery of these proteins into LB and 
consequently to the SC thereby resulting in corneodesmosome retention, explaining (along 
with the intense hyperplastic response to the barrier abnormality) the extreme hyperkeratosis 
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in neonates with HI. However the mechanism by which this happens in HI is unknown. 
 
1.4.1.7 ABCA12: Role in late epidermal differentiation 
Expression of markers of late epidermal differentiation such as filaggrin, TGM1, K10 are 
highly dysregulated in HI skin leading to premature epidermal differentiation suggesting that 
ABCA12 may have a key role in keratinocyte differentiation (Thomas et al., 2009, Smyth et 
al., 2008).  
 
1.4.1.8 ABCA12: Gene Regulation 
Nuclear hormone receptors peroxisome proliferators-activated receptor, PPAR (gamma and - 
beta/delta) and liver X receptor, LXR (to a lesser extent than PPAR) upregulate ABCA12 
expression in cultured human keratinocytes and improve epidermal permeability barrier 
homeostasis by stimulating keratinocyte differentiation, lipid synthesis, and increasing LB 
formation/secretion (Jiang et al., 2008).  
 
1.4.2 LAMELLAR ICHTHYOSIS (LI)/NONBULLOUS 
CONGENITAL ICHTHYOSIFORM ERYTHRODERMA 
(NCIE) 
The LI/NCIE	group is clinically and genetically heterogeneous with LI phenotype at one end 
of the spectrum and NCIE at the other with many intermediate, overlapping phenotypes 
(Williams, 1992b, Williams, 1992a). Clinical phenotypes can change over time and in 
response to treatment e.g. retinoid-treated LI can turn into NCIE.  Histological features in this 
patient group are non-specific but include a compensatory thickening of the SC and epidermal 
hyperplasia. Mutations in 8 genes have been identified that cause the observed phenotype 
including TGM1, ABCA12, Ichthyin (also known as NIPAL4) CYP4F22 and the lipoxygenase 
genes ALOX12B and ALOXE3, LIPN, CERS3 (Radner	et	al.,	2013), PNPLA1 (Grall et al., 
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2012). However, there is poor genotype-phenotype correlation.  For example the LI 
phenotype is frequently, but not exclusively, caused by TGM1 deficiency. The same TGM1 
mutation can cause both LI and NCIE phenotypes, and the LI phenotype can result from 
mutations other than TGM1 (Lawlor, 1988, Lefevre et al., 2004, Lesueur et al., 2007, 
Dahlqvist et al., 2007). Additionally, other variants/subtypes can be distinguished clinically: 
bathing suit ichthyosis attributed to TGM1 mutations and the self-resolving collodion baby 
associated with TGM1, ALOXE3 and ALOX12B mutations.	
 
1.4.2.1 Lamellar Ichthyosis (LI) (MIM 242500)  
The incidence of LI is estimated at 1:200000 (Eckl et al., 2005) but is more common in 
certain regions [(1:90,000 in Norway and 1:122,000 in Galicia in NW Spain due to a founder 
effect (Rodriguez-Pazos et al., 2011)]. Affected individuals are often (90%) (Burns et al., 
2010) born with a parchment-like collodion membrane that is replaced in the first weeks of 
life by coarse, dark, plate-like scales (Williams and Elias, 1985). Due to the impaired skin 
barrier they are endangered by dehydration, sepsis and thermodysregulation (Huber et al, 
1995). Eclabium and/or ectropion, with incomplete closure of the eye-lids, leading to 
conjunctivitis and keratitis, scarring alopecia, palmoplantar hyperkeratosis, hypoplasia of 
auricular and nasal cartilage, severe heat intolerance due to hypohidrosis may be noted 
(Griffiths et al. 2016).  
 
1.4.2.2 Nonbullous Congenital Ichthyosiform Erythroderma (NCIE) (MIM 
242100) 
In nonbullous congenital ichthyosiform erythroderma, after desquamation of the collodion 
membrane in the first weeks of life, erythroderma develops with fine white-gray semiadherent 
scales which become large and plate-like on the lower limbs. Erythroderma often improves 
during childhood. Sites of predilection for scales are the face, arms and trunk. In up to about 
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70 % of patients, palmoplantar hyperkeratosis is present (Burns et al., 2010). Further frequent 
characteristics are ectropion, eclabium, mild nail dystrophy and heat intolerance (Burns et al., 
2010). 
 
1.4.2.3 Transglutaminase-1 (TGM1) 
Of the many genes implicated in ARCI a variety of loss-of-function mutations in TGM1 
(Huber et al., 1995, Russell et al., 1995, Laiho et al., 1997, Akiyama et al., 2001), are most 
common accounting for over a third of this group (Fischer, 2009).  The most typical 
phenotype of TGM1-linked ARCI is that of (classic) lamellar ichthyosis but TGM1 mutations 
are reported to underlie NCIE phenotype (Laiho et al., 1997, Akiyama et al., 2001).  
 
1.4.2.3.1 TGM1: Other genotype-phenotype correlations 
Other than the phenotypes mentioned above TGM1 mutations are also responsible for self-
healing collodion baby (Vahlquist et al., 2010), limited lamellar ichthyosis and bathing suit 
ichthyosis (Oji et al., 2006).  In self-healing collodion baby, the collodion membrane heals 
with no or only very mild ichthyosis, and bathing suit ichthyosis, characterized by pronounced 
scaling in the bathing suit areas but sparing of the extremities and the central face (Vahlquist 
et al., 2010, Oji et al., 2006). Bathing suit ichthyosis is thought to be a temperature-sensitive 
phenotype where the enzyme activity decreases at temperatures >33°C (Trindade et al., 2010). 
In this very rare condition there appear to be areas of normal looking skin and areas of skin 
with abnormal plate-like scaling. The amount of normal skin may vary at any one time. 
 
1.4.2.3.2 TGM1: Gene 
The TGM1 gene localizes to chromosome 14 and contains 15 exons. To date, over 115 
different mutations have been identified in this gene in 234 individuals from diverse 
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racial/and ethnic backgrounds (Herman et al., 2009).  Most reported mutations are missense 
followed by nonsense, deletion and insertion (Herman et al., 2009). The most severe cases of 
LI are caused by nonsense and missense mutations resulting in loss of functional protein 
(Russell et al., 1995). The c.877-2A>G is the most commonly reported TGM1 mutation and it 
had been shown that this mutation is common among North American and Norwegian 
patients due to a founder effect (Herman et al., 2009).  
 
1.4.2.3.3 TGM1: Protein 
TGM1 is mainly expressed on the upper spinous and granular layers of the stratified 
epidermis (Huber et al., 1995). It is a 92 kDa membrane-bound, calcium-dependent enzyme 
that is involved in CE assembly (by catalysing the N-y-glutamyl lysine) by cross-linking of 
precursor proteins such as involucrin, small proline-rich proteins and loricrin (Steinert and 
Marekov, 1995). Additionally it plays a role in covalently linking ω-hydroxyceramide, a 
constituent of the CLE, by ester bonds to CE proteins, most abundantly to involucrin (Candi 
et al., 2005).  
 
1.4.2.3.4 Transglutaminases (TGs): The superfamily 
Transglutaminases are encoded by a family of structurally and functionally related genes. 
Nine TG genes have been identified, eight of which encode active enzymes (Esposito and 
Caputo, 2005). A four-sequential domain arrangement is highly conserved in TG isoforms 
(Esposito and Caputo, 2005). The enzymes catalyze transamidation of glutamine resides a 
reaction associated with a wide variety of physiological processes including blood clotting, 
keratinization and fertilization (Huber et al., 1995).  It consists of an N-terminal, a catalytic 
and two C-terminal ß-barrel domains. The epidermis harbours four of the nine TG isoforms 
(TG1, TG2, TG3 and TG5). TG2 is only detected in the basal layers and it is not involved in 
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cornification. TG1, TG3 and TG5 are expressed in the upper layers (Esposito and Caputo, 
2005). These play consecutive and complementary roles in the formation of CE (Esposito and 
Caputo, 2005) on the intracellular surface of the plasma membrane of keratinocytes 
undergoing terminal differentiation. Although TGM3 and TGM5 are involved in the assembly 
of the CE, TGM1 is the major subtype involved (Yamanishi et al., 1992, Kim et al., 1992); 
TG 3–/– mice display no obvious defect in skin development nor in barrier function 
suggesting that epidermal loss of TG3 can be compensated for by other family members (John 
et al., 2012) and mutations in TGM5 lead to another type of ichthyosis, acral peeling skin 
syndrome MIM 609796. The fact that TGM1–/– mice die soon after birth with impaired skin 
barrier is the strongest validation of the importance of TG1 for cornified-envelope formation 
(Kuramoto et al., 2002).  
 
1.4.2.3.5 TGM1: Role in Barrier function 
Although TGM1 plays a role in CE formation, the barrier defect is paracellular as seen by 
lanthanum tracer studies (Elias et al., 2002). Ultrastructural studies reveal that the CEs are 
focally attenuated at all levels of the SC and abnormalities in extracellular lipid structures are 
evident and these correspond to regions where the cornified envelope is attenuated (Hohl et 
al., 1993, Paige et al., 1994, Elias et al., 2002). Furthermore, alterations in the lipid fatty acid 
synthesis pathway, following microarray analysis, in a rat epithelial organotypic model have 
been reported (O'Shaughnessy et al., 2010). Thus, mutations in TGM1 secondarily cause 
defects in the intercellular lipid layers in the SC, leading to defective barrier function and to 
the ichthyotic phenotype seen in LI patients (Elias et al., 2002) and in transglutaminase 1 
knockout mice (Kuramoto et al., 2002).  Ex vivo gene replacement of TGM1, followed by 
transplantation to SCID mice, successfully corrects the ARCI phenotype, including the barrier 




1.4.2.3.6 TGM1 expression  
TGM1 is expressed on cell borders in the granular layer of healthy skin. In patients with 
ALOX12B, ALOXE3 and NIPAL4 mutations, the expression of TGM1 is altered and extends into 
the stratum corneum and in several layers of the viable epidermis (Li et al., 2012). TGM1 and 
eLOX-3 are found to colocalize mainly in the granular layer of healthy control skin and this 
colocalization is markedly increased in patients with ALOX12B and ALOXE3 mutations (Li et al., 
2012). Additionally, loss of TGM1 is reported to cause changes in epithelial differentiation 
markers (increase in keratins 1, loricrin and downregulation of involucrin) in a rat epidermal 
keratinocyte organotypic model (O'Shaughnessy et al., 2010).  
 
1.4.2.4 ALOX12B/ALOXE3   
In 2002, mutations in two lipoxygenase genes, ALOXE3 and ALOX12B, on chromosome 
17p13, coding lipoxygenase-3 and 12(R)-lipoxygenase, respectively, were reported to 
underlie LI/NCIE (Jobard et al., 2002). They represent the second most common cause of 
ARCI after TGM1 (~15% of ARCI patients) (Eckl et al., 2009, Fischer, 2009). Most reported 
mutations are missense but deletions, insertions, splice site mutations leading to frameshift 
and mutations resulting in premature termination codons in both genes have been reported. 
Although ALOX12B mutations are distributed throughout the gene, two significant hotspots 
for mutations in ALOXE3 were found in one study of 250 patients (Eckl et al., 2009). All 
mutations are loss of function mutations, either impairing enzyme activity or ablating protein 
synthesis thus confirming the crucial role of the LOX in barrier formation (Eckl et al., 2009) 
as evidenced by 12R-LOX and eLOX-R deficient mice that display a postnatal lethal 
phenotype due to severely impaired barrier function (Epp et al., 2007, Moran et al., 2007, 
Krieg et al., 2013).   
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1.4.2.4.1 LOX: Lipoxygenases family  
Lipoxygenases (LOX) represent a widely distributed family of non-heme, iron-containing 
dioxygenases that insert molecular oxygen into polyunsaturated fatty acids producing highly 
active metabolites that play important roles in cell signaling or modification of membrane 
structures (Brash, 1999). Within the mammalian LOX family, a distinct subclass of 
epidermal-type LOX has been found to be preferentially synthesized in the skin and few other 
epithelial tissues (Brash et al., 1997, Boeglin et al., 1998). The genes for the human epidermal 
LOX, 15-LOX-2, 12R-LOX, and eLOX-3, map closely together on human chromosome 
17p13.1 (Krieg et al., 2001). Their differentiation-dependent expression pattern in the 
epidermis suggests a common physiological role in epidermal differentiation. The epidermal 
12R-LOX and eLOX-3 differ from all other mammalian LOX in their unique structural and 
enzymatic features (Boeglin et al., 1998, Krieg et al., 1999) as both proteins contain an extra 
domain located at the surface of the catalytic subunit. 12R-LOX represents the only 
mammalian LOX that forms products with R chirality (i.e. spatial arrangement of molecules 
with R chirality are mirror images of molecules with S chirality), and, unlike all other LOX, 
eLOX-3 does not exhibit dioxygenase activity but acts as a hydroperoxide isomerase (Yu et 
al., 2003).  
 
1.4.2.4.2 LOX:12R-LOX/eLOX-3  
Both 12R-LOX and eLOX-3 are localized to the stratum granulosum. Because the same 
phenotype is caused by mutation of either gene, the encoded proteins 12R -lipoxygenase (12R 
-LOX) and epidermal lipoxygenase-3 (eLOX3) are proposed to function in the same pathway 
of skin barrier formation.  It is thought that both enzymes act in sequence: 12R-LOX to 
convert fatty acid substrates to R-hydroperoxides and eLOX3 in turn converts the 12R-LOX 
product into a specific epoxyalcohol derivative.  
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1.4.2.4.3 Lipoxygenase-3 and 12(R)-lipoxygenase: Role in terminal 
differentiation 
With arachidonic acid as a substrate, the 12R-LOX/eLOX-3 pathway results in the production 
of specific R-epoxyalcohol metabolites which are known to function as signaling molecules 





















Figure 1.5: Postulated role of 12R-LOX and eLOX-3 in the same metabolic pathway.  
12R-LOX converts fatty acid substrates to 12R-hydroperoxyeico-	 satetraenoic	 acid	 (12R-
HPETE)	and eLOX3 converts the 12R-LOX product into the	corresponding	hepoxilin-	 like	
epoxyalcohol,	 8R-hydroxy-11R,12R-epoxyeicosatrienoic	 acid.	 Ichthyin is thought to the 

















1.4.2.4.4 LOX: Structural role in skin barrier formation (CLE)-defective 
ceramide processing  
Here, linoleate-containing EOS ceramide is the substrate. It is catalysed by 12R-LOX/eLOX-
3 to an oxidized linoleate moiety which is hydrolysed further resulting in a free hydroxyl on 
the ceramides for coupling to the cross-linked proteins of the CE and forming the CLE (Krieg 
et al., 2013, Zheng et al., 2011). Thus, it has been proposed that the LOX pathway may play a 
role in ceramide processing and consequently in the formation of the CLE (Zheng et al., 
2011).   
 
1.4.2.5 Ichthyin 
1.4.2.5.1 LI/NCIE phenotypes due to Ichthyin mutations 
In patients with Ichthyin mutations LI/NCIE phenotypes have been noted, with a slightly 




Figure 1.6: Involvement of 12R-LOX and eLOX-3 in ceramide processing.  
The linoleate moiety of linoeoyl-ω-hydroxy-ceramide (EOS) is successively oxidised by 12R-LOX 
and e-LOX-3.  This LOX induced oxidation facilitates further hydrolysis to ω-hydroxyacyl-
sphingosine (ω-OH-OS) and ω-OH-very long chain fatty acid (ω-OH-VLC-FA). The resulting ω-OH 
derivatives are esterified by transglutaminase 1 (TGase 1) to glutamines in the cross-linked proteins of 
the cornified envelope (CE). Protein-bound OS ceramides and VLC-FA form the corneocyte-bound 
lipid envelope (CLE).  
Adapted from (Krieg et al., 2014) 
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wide, even among members of the same family, (Wajid et al., 2010) ranging from NCIE to LI 
to a mixture of both. Palmoplantar keratoderma is present in most cases. Some patients are 
born with a collodion membrane (Lefevre et al., 2004, Dahlqvist et al., 2007).  Other features 
such as hypohidrosis, itching, joint contractures, clubbing and ectropion have also been 
reported.  
 
1.4.2.5.2 Ichthyin: Gene 
Ichthyin, also known as NIPAL4, defects were reported to be associated with ARCI in 2004. 
(Lefevre et al., 2004). The gene is localized on chromosome 5q33 and has 6 exons. 
Homozygous mutations reported include 6 missense mutations (most commonc.527C ->A), 2 
splice site mutations and 1 nonsense mutation (Wajid et al., 2010).  
 
1.4.2.5.3 Ichthyin: Protein 
The protein belongs to a new family of proteins and is predicted to have several 
transmembrane domains. Ichthyin-like proteins are localized in the plasma membrane, and 
share homologies to both magnesium transporters and G-protein coupled receptors (Lefevre et 
al., 2004).  In normal skin, Ichthyin is expressed in the viable part of epidermis with highest 
expression in the SG with localization to the cell borders in a honeycomb pattern (Li et al., 
2013, Wajid et al.,	 2010).  On electron microscopy it localises to keratin throughout the 
viable epidermis and desmoplakin (Dahlqvist et al., 2012). (Interestingly, patients with 
mutations in keratin 1 and desmoplakin have palmoplantar keratoderma, a feature observed in 
this ichthyotic phenotype). 
 
In patients with Ichthyin mutations no loss of Ichthyin protein has been observed (Dahlqvist 
et al., 2012) but relocation to the cytoplasm as well as weak expression of the protein in the 
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stratum corneum has been detected (Li et al., 2013). Ultrastructurally, aggregation of mutant 
ichthyin protein is seen (Dahlqvist et al., 2012). These findings suggest altered or loss of 
functional protein in mutant Ichthyin. 
 
1.4.2.5.4 Ichthyin: Role in lipid metabolism  
The function of Ichthyin is unknown. It has been proposed to function both as a receptor for 
metabolites produced by the 12R-LOX and eLOX-3 lipoxygenases in the hepoxilin pathway 
(Lefevre et al., 2004) and as a magnesium transporter (Goytain et al., 2008) with a possible 
role in lipid metabolism; In support of this, structural changes in the SG (empty or partially 
filled vacuolar and vesicular structures, which are thought to represent defective LB and 
perinuclear elongated membranes) due to ichthyin deficiency have been seen on electron 
microscopy (Dahlqvist et al., 2007) and abnormal lipid accumulation within cells (but not in 
the intercellular space) is seen in the SG and SC on Nile Red lipid analysis (Dahlqvist et al., 
2012, Wajid et al., 2010). Further support for the role of Ichthyin in lipid metabolism comes 
from another finding; Ichthyin is found to colocalize with FATP4 protein in the SG.  The 
putative function of FATP4 is that of acyl-CoA synthetase with some predilection for long 
and very-long FFA (Lenz et al., 2011). It is thought to be essential for lipid deposition in the 
cornified layer and lack of fatty acid transport protein, FATP4, leads to a syndromic 
ichthyosis in the neonatal period called Ichthyosis Prematurity Syndrome. Down-regulation of 
Ichthyin results in the up-regulation of FATP4 expression possibly reflecting a compensatory 
feedback mechanism (Li et al., 2013). FATP4 is known to be a magnesium-dependent 
enzyme and it may be possible that it requires ichthyin for Mg2+ recruitment (Li et al., 2013).  
 
1.4.2.5.5 Ichthyin: Putative receptor for products of the lipoxygenase pathway 
The expression of Ichthyin is upregulated in ALOX12B-/-, ALOXE3-/- and TGM1-/- mutations. 
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In turn, along with altered localization of ichthyin, ALOX12B, ALOXE3 are upregulated with 
increased colocalisation in ICHTHYIN-/- (Li et al., 2012, Li et al., 2013) suggesting abnormal 
enzyme turnover due to a chain of events in which these ARCI genes may be involved.  
 
However, the exact mechanisms of how Ichthyin mutations can cause an ichthyotic phenotype 
and interact with other ichthyosis genes, in particular ALOX12B and ALOXE3 along a 




The monogenic non-syndromic ichthyoses (ichthyosis vulgaris, X-linked ichthyosis, 
congenital ichthyosiform erythroderma, lamellar ichthyosis, harlequin ichthyosis) cause a 
similar clinical phenotype of varying severity that affects terminal differentiation in skin with 
compromise of the cornified envelope due to genetic defects arising from different underlying 
gene mutations located on separate chromosomes. 
 
The null hypothesis states that despite the common phenotype the individual ichthyosis do not 





1. Development of in-vitro 2D (and where possible 3-D) models of the ichthyoses.  
2. RNA-Seq on generated models from the same genetic background with knockdown of 
relevant ichthyosis genes using primary human keratinocytes from neonatal foreskin. 

















Chapter 2: Materials and Methods 
	 55	
2.1 Ethics  
This study was conducted according to the Declaration of Helsinki Principles and was 
approved by the East London and City Health Authority Research Ethics Committee and	
cooperating	centres	(Ethics	reference:	08/H1102/73). 
	
2.2 Cell culture  
2.2.1 Primary Keratinocyte culture  
Primary human keratinocytes were derived from neonatal foreskins and purchased from 
Invitrogen (Cat. No. C-001-5C). 
2.2.1.1 Isolation of primary keratinocytes from neonatal foreskin 
Foreskin was obtained following circumcision from neonatal Caucasian males. The skin was 
delivered post-operatively in transport medium [DMEM Dulbecco’s Modified Eagles medium 
(E4) containing 10% (v/v) foetal bovine serum (FBS), 1% (v/v) L-glutamine (200 mM), 1% 
(v/v) penicillin-streptomycin (P/S)] and processed the same day or the following day after 
overnight storage at 4°C. Skin was placed on a sterile Petri dish containing Versene (EDTA). 
Excess dermis and subcutaneous fat were removed. The skin pieces were washed with 
Versene and cut into small 1-2mm fragments. The fragments were placed in 1x trypsin in a 15 
ml tube and incubated at 37°C, 10% CO2 for 2 hours. At 30-minute intervals and at the end of 
the incubation the tube was shaken vigorously. The cell suspension was transferred into a 
sterile tube and resuspended in an equal volume of DMEM:Ham’s F12 (3:1) growth medium  
supplemented with 10% (v/v) (FBS), 1% (v/v) L-glutamine (200 mM), 1% (v/v) P/S  and 1x 








Table 2.1: RM+ supplement 
 
RMplus supplement 
0.4 µg/ml hydrocortisone 
0.5 µg/ml insulin 
10 ng/ml epidermal growth factor 
0.1 nM cholera toxin 
5 µg/ml transferrin 
20 pM Liothyronine 
 
The cell suspension was filtered through a sterile gauze into another Falcon tube and 
centrifuged (1200 rpm, 5 min, RT). The cell pellet was resuspended in keratinocyte growth 
media containing 2.5 µg/ml amphotericin, the cells counted in a haemocytometer, and plated 
at densities of 2x106cells/T75 flask on a feeder-layer of 3T3 (2x106cells/flask) mouse 
fibroblasts that that had previously been growth arrested by lethal irradiation-6000Gy 
(Rheinwald and Green, 1975). Cells were grown at 37°C, 10% CO2 and media were changed 
2-3 times/week. Old feeders were removed by incubating cells in Versene for 5 min at 37°C, 
and new growth arrested 3T3 cells were added every 2-3 days to maintain optimal 3T3 
density. Primary keratinocytes are seen to grow in colonies. 
 
2.2.1.2 Subcultivation of keratinocytes 
The 3T3 feeders were removed by incubating cells in Versene for 5 min and the cells were 
incubated with 0.02% trypsin-EDTA at 37°C until cells were seen to be rounded and detached 
over a period of 5-7 minutes. Trypsin was neutralised with an equal volume of serum 
containing media. Cells were then centrifuged (1200 rpm, 5 min, RT) and frozen, subcultured 
for amplification, or seeded for experiments.  
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2.2.1.3 Subculture with 3T3-mouse fibroblast feeders  
For cultivation of primary keratinocytes on a feeder-layer of irradiated 3T3 fibroblasts 
(Rheinwald and Green, 1975), 3T3 fibroblasts were seeded into T75 flasks at 2x106 cells/flask 
and grown in DMEM Dulbecco’s Modified Eagles medium (E4) containing 10% FBS 
overnight at 37°C, 10% CO2. The following day, primary keratinocytes were resuspended in 
keratinocyte growth media, and seeded at approximately 1.5-2 million cells per T75 flask 
containing the growth- arrested 3T3 fibroblasts. Cells were grown at 37°C, 10% CO2 and 
media were changed every 2-3 days. Old feeders were removed by incubating cells in Versene 
for 5 min, and new growth arrested 3T3 cells were added every 2-3 days. When the primary 
keratinocytes were 70-80% confluent, feeders were removed, and keratinocytes were frozen, 
subcultured for amplification, or seeded for experiments. 
 
2.2.1.4 Subculture in serum-free conditions  
Primary human keratinocytes derived from neonatal foreskins, nHEK, either isolated as above 
or purchased from Invitrogen, were expanded and cultured according to the company’s 
instructions. Briefly, cells were thawed and seeded into a T75 flask pre-coated with rat-tail 
collagen type I (2mg/ml, Firstlink), containing 14 ml of pre-warmed serum-free growth media 
(EpiLife Medium with growth supplement, HKGS (S-001-5), Invitrogen). Cells were 
incubated at 37°C, 5% CO2. Once the cells were 70-80% confluent, they were passaged. Old 
culture medium was removed, were washed once in Phosphate buffered saline (PBS), and 
then subcultured by incubation with pre-warmed 0.02% trypsin-EDTA at 37°C in stages (1-
2min) over a period of 5-7 minutes. Trypsin was neutralised with an equal volume of growth 
medium containing serum. Cells were then centrifuged (1200 rpm, 5 min, RT), and 
resuspended in serum free media. Cell counts were obtained using a haemocytometer, and 
cells were then resuspended and subsequently seeded at 5x103 cells/cm2 in collagen I coated 
	 58	
flasks for further amplification, or at variable densities for experiments. Cells were frozen for 
long-term storage as above.  
 
2.2.1.5 Cryopreservation of cells  
To maintain cell stocks for experiments, cells were cryopreserved. For this, following 
trypsinisation, cells were resuspended at a density of 1-2x106 cells/ml in freezing media 
containing 10% Dimethyl Sulfoxide (DMSO), and 90% complete growth medium, cooled in a 
Mr. Frosty™ Freezing Container (ThermoFisher Scientific)  at -80°C o/n and then stored in 
liquid nitrogen.  
 
2.2.1.6 Thawing Cells 
Ampoules of cryopreserved cells were thawed rapidly by incubation in a water bath at 37°C. 
The ampoule was swabbed with 70% ethanol before opening. The cells were diluted in media 
containing 10% FBS, then pelleted by centrifugation (as above) and resuspended and plated 
as required. 
 
2.2.2 Primary fibroblasts 
Primary human fibroblasts were isolated from the separated dermis of neonatal foreskins by 
overnight incubation in collagenase D (1 mg/ml) (Roche) in DMEM supplemented with 10% 
FBS, 1% L-glutamine (200 mM) and 1% P/S (Fibroblast growth medium) at 37°C. Cells were 
collected by centrifugation and expanded until the second passage, at this point stocks of 
fibroblasts were cryopreserved and stored in liquid nitrogen. For routine culture primary 
fibroblasts were plated into T175 flasks at a density of 6,000 cells per cm2 in fibroblast growth 
media and growth until 70-80% confluent. Subculturing was performed as described above in 
fibroblast growth media. 
	 59	
 
2.2.3 Immortalised keratinocyte (nTERT) culture  
The immortalised cell line, nTERT, expressing the catalytic subunit of telomerase (nTERT) 
combined with deletion or mutation of p16INK4a, was obtained from cryopreserved 
departmental stocks (Rheinwald et al., 2002). The cell line was grown in keratinocyte growth 
media, and incubated at 37°C, 10% CO2. Media were changed every 2-3 days until the cells 
were confluent. Cells were passaged and split 1:5 or counted and seeded depending on 
experimental requirements. For cryopreservation 1x106 cells were resuspended in FBS 
containing 10% dimethyl sulfoxide (DMSO) as a cryoprotectant. Freezing was performed at a 
rate of -1°C/min to a temperature of -80°C. At this stage the tubes were transferred to -180°C 
liquid vapour phase cryostore.  
 
2.2.4 RNAi for terminal differention genes in nHEKs 
For transient transfection, custom made siRNAs (Invitrogen, UK) sequence-specific to the 
genes of interest were transfected into nHEKs.  
Table 2.2: siRNA sequences  
 
Gene siRNA used siRNA sequence 
STS 2 CCUCAGAACAGCACAUCCAUCUGGA 
FLG 1 ACAGAAAGCACAGUCAUCAUGAUAA 
ABCA12 1 GACCGAACUUCUUUGUGAAUCUGAA 
TGM1 3 CGGGAGGACAUCACCUACCUCUAUA 
ICHTHYIN 3 CAAGAACGUCCUUGUGGACAAUAUA 
ALOX12B 2 CCAUAAGCAGCUGCUGAACCACUUU 
Control non-targeting primer sequences were not made available by Invitrogen. 
 
Transfection was performed according to the HiPerFect transfection protocol (Quigen, UK) 
and optimised for a 6-well plate format. nHEKs were plated at a density of 1.5x105 per well 
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and incubated in  Epilife media (Cascade Biologics, UK) in a 6-well plate, and incubated at 
37°C/5% CO2. After 24 h, nHEKs of 50–60% confluency using HiPerFect were transfected 
with a siRNAs for STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B (table 2.2) and the 
non-targeting control.  For transfection, siRNA duplexes (5-25nM)  and 15 µl of HiPerFect 
transfection reagent were diluted with 95 µl Epilife media, vortexed and incubated at room 
temperature (RT) for 10 min. After incubation the volume was made up to 2 ml in Epilife 
growth media and pipetted onto primary keratinocytes and incubated overnight at 37°C/5% 
CO2. The following day transfection media was replaced with Epilife growth media.  Cells 
transfected with non-targeting siRNAs, (Invitrogen, UK) at the same final concentration were 
used as negative controls.  
 
 2.2.5 Calcium shift assay 
nHEKs were transfected as described previously. After 12 h, the cells were shifted to high 
calcium (1.3 mM) Epilife media and incubated for 24 h. Calcium was added to Epilife media 
as CaCl2 (Sigma-Aldrich, UK), and the media filter-sterilised using a vacuum-driven filtration 
system (Millipore, UK). Cells incubated in low calcium media for 24 h were kept as a control. 
Cells were harvested in RLT Plus Buffer or QIAzole lysis reagent (Qiagen) for RNA analysis 
and 1x Triton-lysis buffer for Western Blotting. 
 
2.2.6 Organotypic cultures on de-epidermalised dermis (DED) 
Sterilised glycerol-preserved skin (Euro Skin Bank, Beverwijk, The Netherlands) was washed 
three times in PBS and incubated in PBS containing antibiotic mix (600 U/ml penicillin-G, 
600 µg/ml streptomycin sulphate, and 2.5 µg/ml amphotericin) for 10 days at 37°C. After 
incubation the epidermis was scraped off the dermis using the blunt side of a scalpel, and cut 
into 1.5 cm2-squares. Each square of DED was placed into a well of a 6-well plate with the 
	 61	
reticular side facing up onto which a stainless steel ring was placed. 5x105-primary human 
fibroblasts in 500 µl fibroblast growth media (DMEM supplemented with 10% FBS, 1% L-
glutamine (200 mM) and 1% P/S) were seeded into each ring. Fibroblasts were cultured on 
the DED for 2 weeks with media changes every 2 days. Then, the DED was flipped over so 
that the papillary side was facing up, which allowed the seeding of 5x105 keratinocytes in 500 
µl Epilife growth media into rings placed on the papillary side of the DED. After 48 hours the 
cultures were raised to the air-liquid interface on stainless steel grids in a 6-well plate. 
Keratinocyte growth media containing 50 µg/ml ascorbic acid (vitamin C) was added and 
refreashed every 2 days. After 10 days the cultures were harvested and bisected, with one half 
being fixed in 4% PFA and paraffin embedded and the other half was snap frozen in liquid 
nitrogen, cryo-embedded in Bright Cry-M-Bed (Jencons), and stored at -80°C. 
 
2.3 RNA methods  
2.3.1 Extraction of RNA using the RNeasy Plus Mini kit  
Total RNA was extracted from primary keratinocytes using RNeasy Plus Mini Kit (Qiagen, 
West Sussex, UK) according to the manufacturer’s instructions.  Briefly, cells were harvested 
by adding 350 µL of lysing Buffer RLT Plus (containing β-Mercaptoethanol; 10 µl for 1 ml of 
RLT buffer). The lysates were homogenised by centrifugation for 2 minutes at maximum 
speed in a QIAshredder spin column (Qiagen) and placed in a collection tube. The 
homogenised lysate was transferred to a genomic (g) DNA eliminator spin column (Qiagen) 
and centrifuged for 60 s at 10,000 rpm to remove gDNA. One volume of  (600 µl) of 70% 
ethanol was added to the flow-through and mixed well. The sample was then applied to an 
RNeasy spin column and centrifuged for 30 seconds at 10,000 rpm and the flow-through 
discarded. The column was washed with RW1 buffer (700 µl) followed by two washes with 
RPE buffer (500 µl). After a final centrifugation for 1 minute at 14,000 rpm for 1 min, the 
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RNeasy column was then transferred to a new 1.5 ml collection tube and RNA eluted by 
adding 25 µl of RNase free water and centrifuging. A second elution step with a further 25 µl 
was performed before quantifying the RNA. Purified RNA was stored at –80°C in RNase-free 
water.  
 
2.3.1.2 Spectrophotometric quantification of RNA 
RNA concentration was determined by measuring the absorbance at 260 nm with a 
spectrophotometer after RNA extraction (Nanodrop, ND-1000 Spectrophotometer) and 
samples were stored at -80°C. 
 
 
2.3.2 Complementary DNA (cDNA) synthesis using Superscript 
VILO cDNA Synthesis Kit 
cDNA was synthesised from total RNA using the Superscript VILO cDNA synthesis kit 
(Invitrogen, Paisley, UK) according to manufacturer’s instructions. Briefly, 2 µg of total RNA 
was added to a mixture containing 1X SuperScript enzyme mix (containing, SuperScript III 
RT, RNaseOUT recombinant ribonuclease inhibitor, and a property helper protein), 1X VILO 
reaction mix (containing, random primers, MgCl2, and dNTPs), and DEPC-treated water to a 
final volume of 20 µl. The mixture was placed in the DNA Engine Tetrad 2 Peltier Thermo 
Cycler (MJ Research, CA) and incubated at 25°C for 10 minutes, and then at 42°C for 60 
minutes. To terminate the reaction the sample was heated to 85°C for 5 minutes. cDNA was 
stored at  20°C. cDNA was quantified using the NanoDrop and then stored at -20°C.  
 
2.3.3 Polymerase chain reaction  




Primer3	 program	 and	were	 checked	with	 the	mRNA	 sequence	 of	 interest.	 In	 the	 case	
that	multiple	isoforms	exist	for	the	same	gene,	all	isoforms	were	aligned	together	using	
the	ClustalW	alignment	tool	and	primers	were	designed	to	overlap	a	region	common	to	
all	 the	 isoform	sequences	(Larkin	et	al.,	2007).	To	check	 the	specificity	of	 the	primers,	
both	forward	and	reverse	primer	sequences	were	input	into	the	NCBI	Nucleotide	BLAST	




qPCR	was	 performed	with	 200	 ng	 of	 cDNA	 using	 The	 ReddyMix®	 PCR	Mastermix	 kit	
(Fisher	 Scientific,	 Leicestershire,	 UK).	 cDNA	was	mixed	with	 ReddyMix®	 (12.5	 μl),	 25	
mM	 MgCl2	 (1	 μl),	 1	 μM	 primer	 template	 (2	 μl).	 The	 mix	 was	 adjusted	 to	 a	 reaction	
volume	of	20	μl	with	RNase	free	water.	For	genes	that	have	lower	expression,	the	cDNA	
and/or	primer	concentration	was	increased.	For	a	negative	control,	a	reaction	mix	was	
made	 with	 cDNA	 substituted	 with	 an	 equal	 volume	 of	 H2O.	 PCR	 reactions	 were	
performed	using	the	PTC-240	DNA	Engine	Tetrad	2	Peltier	Thermal	Cycler	(MJ	Research,	
USA)	with	 the	 following	 cycle	 sequence:	 initiation	 at	 95°C	 for	 5	minutes,	 45	 cycles	 of	









repeatedly	boiled	until	 the	agarose	 crystals	were	 fully	dissolved.	The	agarose	 solution	
was	 cooled	 for	 1	 minute	 with	 cold	 tap	 water	 before	 GelRed	 was	 added	 at	 1	 μl/ml	
(Biotium,	CA,	USA).	The	solution	was	then	poured	into	a	gel	castor	with	a	comb	and	left	




2.3.4 Quantitative polymerase chain reaction (qPCR) 
qPCR was performed with 200 ng of cDNA using the Rotor-Gene SYBR green PCR kit 
(Qiagen, West Sussex, UK). cDNA was mixed with SYBR mix (12.5 µl), 25 mM MgCl2 (1 
µl), 1 µM primer template-forward and reverse (2 µl). The mix was adjusted to a reaction 
volume of 20 µl with RNase free water.  For primer sequences refer to Table 2.3. The qPCR 
reaction was carried out using Rotor-Gene Q (Qiagen, West Sussex, UK) with the following 
cycle sequence: initiation at 95°C for 5 minutes, 35 cycles of denaturation at 95°C for 5 
seconds, annealing at 60°C for 5 seconds, and extension at 60°C for 10 seconds. A house-
keeping gene was used as an endogenous control and gene expression was normalised to the 
house-keeping gene (details in section 3). Technical triplicates were used for each sample. 
Water (no template, cDNA excluded) was included as a negative control. Data analysis was 
performed using Microsoft Excel 2008. The relative mRNA expression values were 
calculated using the x=2-ΔΔCt formula where x represents the induction value and Ct represents 
the average threshold cycle of the triplicate samples. ΔCt refers to the difference between the 
Ct values of the gene of interest and the housekeeping reference gene. ΔΔ Ct represents the 




Table 2.3 Primer sequences used for qPCR  
 
 























ALOX 12B F-CCTCCTGGAGCACAGAAAAG 
R-TGAGGAAGGAGTAGCGGAGA 
 
2.3.5 Next Generation Sequencing (RNA-Seq) Experiment  
Tranfection was performed as described in section 2.2.4 for the genes of interest (STS, FLG, 
ABCA12, TGM1, ICHTHYIN ALOX12B) and three negative controls (non-targeting siRNA, 
mock and untreated). For mock conditions, 2 ml of culture media with transfection reagent 
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were added per well and for untreated cells 2 ml of culture media were added per well and 
incubated at 37°C/5% CO2. For untreated cells 2 ml of culture media were added per well and 
incubated at 37°C/5% CO2. 12 h post-transfection, a calcium switch assay was performed as 
described in section 2.2.5. RNA was extracted 3 days post-calcium switching as described in 
section 2.3.1. RNA	 concentration	was	 determined	 as	 described	 in	 section	 2.3.1.2.	RNA 
(from triplicated biological replicates) was sent to GSK (RD Molecular Discovery Research, 
GlaxoSmithKline, Collegeville, PA, USA) for sequencing.  The laboratory at GSK confirmed 
that all samples had an RNA Integrity Number of >8.  Dr Harpreet Saini (Dr Anton Enright 
group) carried out analysis of the sequenced reads at European Bioinformatics Institute (EBI), 
Cambridge (described in section 5.0) and differentially expressed gene (DEG) lists were 
provided. The DEGs were analysed further using DAVID, REACTOME and GeneMANIA 
(chapter 5).  Heatmaps were generated using ggplot2 by Dr Harpreet Saini at EBI (chapter 6). 
	
	
2.3.5.1 Extraction of RNA using the miRNeasy Mini Kit and MaXtract 
High Density gel tube 
RNA was extracted from primary keratinocytes using miRNeasy Mini Kit and MaXtract High 
Density gel tubes (Qiagen, West Sussex, UK). MaXtract High Density gel tubes enables 
improved recovery of nucleic acids and ensures ease of handling when working with standard 
organic extraction mixtures. It acts as a barrier between the organic and aqueous phases, 
allowing the nucleic acid-containing phase to be easily removed by decanting or pipetting. 
Compared to traditional organic extraction methods, use of MaXtract High Density gel can 
result in the recovery of 20–30% more nucleic acid. Cells were harvested by washing in PBS, 
lysed in 700 µL of QIAzol Lysis Reagent and the lysate was transferred into a prespun (13000 
rpm for 30s) MaXtract High Density gel tube (Qiagen). 140 µl chloroform was added to the 
tube containing the homogenate and the tube was shaken vigorously for 15 s. The tube was 
left at RT for 15 s and then centrifuged at 4°C at 13000 rpm to separate the phases. After 
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centrifugation, the sample separated into 3 phases: an upper, colourless, aqueous phase 
containing RNA; a white interphase (MaXtract High Density gel); and a lower, red, organic 
phase containing protein. The upper, aqueous phase was decanted into a fresh tube with 525 
µl of 100% ethanol and mixed thoroughly by pipetting up and down several times. The 
sample was washed as described previously (section 2.3.1). Each RNA sample was eluted 
with 50 µl of nuclease-free water and divided into a 2µg aliquot for RNA-Seq and the 




2.4 Protein analysis  
2.4.1 Western Blotting 
2.4.1.1 Antibodies  
The antibodies used for this project together with their dilutions for Western blotting are listed 
as follows: 
Table 2.4 Antibodies used for Western Blotting 
 
 




STS R Abcam, 
ab83668  
1:250 
TGM1 M B.C1 1:1000 
 
ICHTHYIN R Ichthyin (P-12) 
sc-133280 
1:250 
GAPDH R Abcam, 
ab9485  
1:5000 
The secondary antibodies (goat anti-rabbit #P0448, goat anti-mouse #P0447) for Western blotting were 
purchased from Dako, UK and used at 1:5000 dilution.  
2.4.1.2 Total cell lysate preparation  
Cell extracts were prepared from keratinocytes that were 80% confluent in a 6 well plate. At 
the appropriate time points, media were removed from the cells, cells were washed with PBS 
and lysed for approximately 30 min on ice in a  1XTriton lysis buffer (20mM Tris pH 7.4, 137 
mM NaCl, 2 mM EDTA pH 7.4, 1 % Triton X-100 and 10 % glycerol) containing a complete 
protease inhibitor cocktail 2 mM N-ethylmaleimide (NEM), 1 mM phenylmethylsulfonyl 
fluoride (PMSF), and 10 mM EDTA (Roche, UK) and collected using a cell scraper. Lysates 




For quantification of protein concentration 20 µl of the lysate was put into a 1.5 ml tube for 
quantification using the Bio-Rad DC Protein Assay kit (Bio-Rad, MA, USA). 2 µl of Solution 
S and 98 µl of Solution A were added to the tube and mixed. 800 µl of Solution B was added 
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to each tube and mixed at which point, the mix changed colour. A high protein concentration 
creates stronger blue colour intensity. A set of diluted standards was used to generate a 
standard curve. Using a spectrophotometer, the protein absorbance (AU) measured at a 
wavelength of 655 nm. A standard curve was generated using the AU measurements obtained 
from known concentrations of bovine serum albumen (BSA, Sigma, Poole, UK).  
 
2.4.1.3 SDS-PAGE electrophoresis in Laemmli system  
Equal protein amounts were separated by SDS-PAGE with 10% polyacrylamide resolving 
gels using electrophoresis apparatus from Hoefer Inc., USA. Samples were diluted in 5x 
sample buffer (6% (w/v) SDS, 180 mM Tris-HCl pH 6.8, 15% (w/v) β-mercaptoethanol, 60% 
(v/v) glycerol, and 6% (w/v) bromophenol blue), boiled for 5 minutes at 95°C and loaded 
onto the polyacrylamide gel. Samples were boiled with the sample buffer for 2 min at 80°C, 
spun down and then loaded into wells created in the 5% stacking gel. 7 µl of Precision Plus 
Protein Kaleidoscope Standards (Biorad, UK) were loaded in a separate lane to visualize 
progress and to evaluate the molecular weight of separated proteins. Electrophoresis was 
performed in 1x running buffer (25 mM Tris-HCl pH 8.3, 0.2 M glycine, 0.1% (w/v) SDS) at 
90 V until samples reached the resolving gel, then at 120 V for approximately 90 min to 
separate the proteins. Proteins were electrotransferred from the polyacrylamide gel onto 
Amersham Hybond-C Extra (GE Healthcare, UK) nitrocellulose membrane in transfer buffer 
(25mM Tris-HCl pH 8.3, 0.2 M glycine, 0.01% (w/v) SDS, 20% (v/v) methanol) at a 70 V 
current for approximately 120 min at 4°C. Transfer quality was assessed in Ponceau S 
(Sigma-Aldrich MO, USA) solution for 5 minutes followed by de-staining in ddH20. 
 
Membranes were blocked in 5% milk (Marvel) in TBST (20 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 0.1% Tween-20) for 1 hour at RT to block non-specific antibody binding to the 
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membrane. Membranes were incubated with primary antibody (Table 2.4) at the appropriate 
dilution in 5% milk o/n (4°C) with gentle agitation. After washing three times with TBST, the 
membranes were incubated with horseradish peroxidase-conjugated secondary antibody 
(1/5000 in 5% milk in TBST) for 1 hour at RT. After membranes were washed again (as 
described above) and incubated in ECL plus Mix Solution (GE Healthcare, UK), and exposed 
to chemiluminescence sensitive film (GE Healthcare, UK) and developed. 
 
2.4.2 Haematoxylin and Eosin (H&E) staining  of  DEDs 
Haematoxylin and Eosin (H&E) staining of paraformaldehyde (PFA) fixed paraffin embedded 
and cryo-embedded organotypic culture sections was undertaken.  Sections (5 µm-thick) of 
4% PFA-fixed and paraffin-embedded organotypic cultures were cut. Sections were de-
paraffinised in two changes of xylene for 5 and 3 minutes and hydrated in descending grades 
of ethanol (100% twice, 90% and 30%) for 3 minutes each. Sections were washed in distilled 
water for 5 minutes. Nuclei were stained with Haematoxylin for 5-8 minutes, washed in 
running tap water, differentiated by immersing briefly in 1% acid alcohol, and rinsed in water. 
The cytoplasm was stained with Eosin for 5 minutes. Sections were then dehydrated by 
ascending grades of ethanol followed by xylene (inverse of described above). Sections were 
mounted with DePex mounting medium (Fisher Scientific). 
 
2.4.3 Immunohistochemistry 
Cryosections (5 µm-thick) of frozen samples mounted in optimal cutting temperature, ,OCT, 
(Tissue-Tek®, NL) were cut in a cryostat, placed on a Poly-lysine plus coated slide and stored 
at -80°C. For H&E staining, sections were air-dried at room temperature for 30 minutes and 




Specimens were mounted in paraffin and sectioned at 5 µm. Haematoxylin and eosin staining 
was performed first, then sections were deparaffinized, quenched with 3% hydrogen peroxide 
to block endogenous peroxidases, and antigen retrieval was achieved by boiling in a 
microwave in antigen unmasking solution (10 mM citrate buffer pH=6.0), for 10 minutes. 
Sections were blocked with 2.5% normal horse serum, and probed with primary antibodies 
either overnight at 4°C, or for one hour at RT. Peroxidase conjugated secondary antibodies 
were then applied, and DAB substrate kits were used for peroxidase detection (Vector 
Laboratories). 
 
2.4.4 Immunofluorescence (IF) staining of PFA-fixed paraffin 
embedded and cryo-embedded sections 
The PFA-fixed paraffin embedded sections were cut, de-paraffinised and hydrated as 
described above (Section 2.4.4.1). Antigen retrieval was performed by heating sections in 10 
mM citrate buffer (pH 6.0) in a water bath set to 95°C for 10 minutes. Sections were washed 
in distilled water for 5 minutes and PBS for 5 minutes before proceeding to IF staining 
protocol. Cryoembedded sections of 5 µm were cut on a cryostat microtome 
(Thermoscientific cryotome FSE) and placed on electrostatically charged slides (Superfrost 
plus, BDH). Frozen sections were dried and either fixed in 4% PFA at room temperature for 
10 minutes or fixed in 1:1 methanol: acetone for 10 min before proceeding to the IF staining 
protocol. 
 
Slides were washed three times for 5 minutes in phosphate-buffered saline (PBS).  Non-
specific binding was blocked with PBS containing 0.3% Bovine Serum Albumin (BSA) for 
20 min at RT and washed as previously.  The sections were incubated with primary antibody 
diluted in PBS containing 1% BSA (Table 2.5), overnight at 4°C.  The sections were washed 
	 72	
again and the secondary antibody, Alexa Fluor 568-red or 488-green, goat anti-rabbit or goat 
anti-mouse was applied at a dilution of 1:800 in the same dilutant at room temperature for 40 
min. The samples were light protected thereafter. Sections were washed twice in PBS before 
counterstaining with 4',6-Diamidino-2-phenylindole (DAPI, 1:20,000 in PBS) nuclear stain 
for 5 min at room temperature. After a further washing step, sections were mounted with 
ImmuMount mounting medium (Thermo-Fisher Scientific).  
	
Table 2.5 Antibodies used in Immunohistochemistry and Immunofluorescence. 
R= rabbit, M= mouse 
 




STS R Abcam, 
ab83668  
1:50 
TGM1 M B.C1 1:1000 
 
ICHTHYIN R Ichthyin (P-12) 
sc-133280 
1:800 
GAPDH R Abcam, 
ab9485  
1:5000 
Keratin 10  M 
 
CRUK 
(LHK10)   
1:1000 





























2.5 Functional Protein analysis 
2.5.1 Stimulation of siRNA transfected keratinocytes with ligands 
Transfection was performed as described in section 2.2.4 for the genes of interest (STS, FLG, 
ABCA12, TGM1, ICHTHYIN and ALOX12B) and negative control, non-targeting siRNA (C). 
12 h post-transfection, a calcium switch assay was performed as described in section 2.2.5. 24 
h following calcium switching, keratinocytes were stimulated with peptidoglycan (PGN) from 
Staphylococcus aureus (10 ug/ml), Poly I:C (10 ug/ml) and flagellin (Salmonella 
Typhimurium 1 ug/ml) (in duplicate for each condition). Culture supernatants were recovered 
at 12 and 24 hours thereafter for cytokine measurement. Total RNA was extracted 24 hours 
following addition of ligands as described in section 2.3.1. 
 
2.5.2 BD™ CBA Human Inflammatory Cytokines Kit  
The  (Cat No. D8000C) was used to quantitatively measure interleukin-8 (IL-8), interleukin-
1β  (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor (TNF), and 
interleukin-12p70 (IL-12p70) protein levels in a single sample using flow cytometry.  
 
Six bead populations with distinct fluorescence intensities had been coated with capture 
antibodies specific for IL-8, IL-1β, IL-6, IL-10, TNF, and IL-12p70 proteins i.e. each capture 
bead in the kit had been conjugated with a specific antibody. The six bead populations were 
mixed together to form the bead array. A single set of diluted standards was used to generate a 
standard curve for each analyte. The inflammatory cytokine capture beads were mixed with 
the recombinant standards or samples, containing recognized analytes, and incubated them 
with the detection reagent, phycoerythrin (PE)-conjugated detection antibodies which 
provides a fluorescent signal in proportion to the amount of bound analyte, to form sandwich 
complexes (capture bead + analyte + detection reagent). Flow cytometry was used to measure 
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these complexes. The intensity of PE fluorescence of each sandwich complex correlated with 
the concentration of that cytokine. FCAP Array™ software was used to generate results in 
graphical and tabular format. 
 
2.6 Replicates and Statistical analysis 
Technical triplicates were used for all qPCR experiments. Biological triplicates were used for 
the RNASeq experiment and western blots. Biological duplicates were used for cytokine 
analysis using the BD™ CBA Human Inflammatory Cytokines Kit. Ten measurements from 
each organotypic were taken at random from different positions using the measuring tool with 
Image J. Statistical analysis was performed using an paired two-tailed t-test using Prism v7.od 
(GraphPad software Inc. Ca, USA). Cell count quantification was done using cell profiler 



















Chapter 3: RNAi for Terminal 








RNA interference (RNAi) is the process of mRNA degradation that is induced by double-
stranded RNA in a sequence specific manner. This process was first discovered to occur 
endogenously in plants (Napoli	 et	 al.,	 1990)	 and subsequently in the nematode 
Caenorhabditis elegans (Tabara	 et	 al.,	 1999),	 humans (Elbashir et al., 2001a) and other 
mammalian cells (Hammond et al., 2000). The mechanism of RNAi exists to protect the host 
from molecular invaders such as viruses and transposons. Double stranded RNA (dsRNA) 
entering a cell will be targeted for immediate destruction via this pathway. Using RNAi as a 
molecular tool allows the investigator to study the function of one gene at a time, as the 
process of gene knockdown is usually very specific (Moazed, 2009). 	
 
RNAi is a two-step process. The first step involves the cleavage of long dsRNA into 21 to 23 
bp siRNA with dinucleotide 3’ overhangs by the enzyme Dicer (Zamore et al., 2000). Dicer is 
a type III endoribonuclease and is a ubiquitous member of the proteome. In the second step, 
one strand of siRNA (the guide strand) is assembled into an RNA-inducing silencing complex 
(RISC) that cleaves the target mRNA leading to down regulation of the protein encoded by 
that gene (Elbashir et al., 2001b). The siRNA is thought to provide target specificity of RISC 
through base pairing of the guide strand with the target mRNA. Assessing the phenotype of a 
cell after suppressing expression of a specific gene by siRNA transfection has become a 
powerful tool in laboratory research. 
 
3.1.1 Aim 
The aim of this chapter was to establish an in vitro disease model for the non-syndromic 
ichthyoses by knockdown of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B in 
normal keratinocytes from neonatal skin. Transient	 knock-down	 of	 the	 Ichthyosis	 genes	
was	achieved	by	using	siRNAs	in	normal	human	keratinocytes.	This will enable analysis 
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of the effect of knockdown in keratinocytes with the same genetic background.  
 
3.2 Results 
3.2.1 Transfection of primary keratinocytes with siRNA to 
knockdown ichthyosis genes: STS, FLG, ABCA12, TGM1, 
ICHTHYIN and ALOX12B 
3.2.1.1 Optimisation of the siRNA-transfection conditions 
Low transfection efficiency will result in a lower level of silencing, and the transfection 
efficiency may vary between cells and cell lines and should be optimised for each cell line. 
Therefore, prior to transfecting the siRNA sequence-specific to the ichthyosis genes into the 
normal human keratinocytes  (nHEKs), the transfection efficiency was optimised by 
determining the volume of lipid-based HiPerFect transfection reagent (Qiagen) having least 
impact on cell viability and the highest efficiency of siRNA delivery.  
 
Three different volumes (according to the range suggested by the manufacturer) of the 
transfection reagent (12, 15 and 18 µl) were tested on nHEKs. Cells were plated in a 6-well 
plate and incubated with the transfection solution containing the respective amount of 
HiPerFect, according to the manufacturer’s instructions. Cell number and morphology were 
analysed under bright-field microscopy twenty-four hours post-incubation. Further cell count 
quantification was done using cell profiler (http://cellprofiler.org). A significant reduction 
(p=0.004) was found between 12µl and 18µl but no significant difference in cell count was 











Figure 3.1: The effect of HiPerFect transfection reagent quantity on nHEKs viability.  
Representative photomicrographs of nHEKs 24 h after incubation with different volumes of HiPerFect 
transfection reagent diluted in 2 ml of medium: 12 µl (HiPerFect-12 µl) or 15 µl (HiPerFect-15 µl) or 18 µl 
(HiPerFect-18 µl). Pictures were taken under brightfield microscopy. Scale bars represent 50 µm. Cell count 
quantification for different volumes of HiPerFect transfection reagent using Cell Profiler. Significant difference 
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Then, it was determined which of the following volumes 12, 15 or 18 µl of transfection 
reagent, provided the highest siRNA-delivery efficiency into these cells at 24 or 48 hours. For 
that, a siRNA control fluorescently labelled with the fluorophore Cy3", siGLO" siRNA, was 
used. The uptake of siGLO" siRNAs can be visualised with the appropriate filters on a 
microscope. Analysis of transfected cells under fluorescence microscopy showed that all 
volumes of transfection reagent were effective in delivering the siRNA molecules into the 
cells. Cells transfected with 15 µl of HiPerFect reagent at 24 hours, showed increased 
fluorescence compared to 12 or 18µl viability, thereby suggesting that transfection of these 


















3.2.1.2 Cell density at transfection 
The optimal cell confluency for transfection should be determined for every new cell type to 
be transfected and kept constant in future experiments. This is achieved by counting cells 
before seeding and by keeping the interval between seeding and transfection constant. This 
ensures that the cell density is not too high and that the cells are in optimal physiological 
condition at transfection. For transfection a 50-60% cell density at the time of transfection is 




Figure 3.2: The effect of HiPerFect transfection reagent quantity on siRNA delivery 
into nHEKs.  
Representative photomicrographs of nHEKs transfected with the siGLO" siRNA (siRNAs 
fluorescently labelled with the fluorophore Cy3" for easy detection) and different volumes 
of HiPerFect transfection reagent diluted in 2 ml of medium: 12 µl (HiPerFect-12 µl), 15 
µl (HiPerFect-15 µl) and 18 µl (HiPerFect-18 µl) Twenty four and fourty-eight hours after, 
cells were analysed under brightfield (top panel) and fluorescence (bottom panel) 
microscopy (n=3). The presence of fluorescently labelled-siRNAs (white) inside the cells 
can be detected with fluorescence microscopy. Scale bars represent 50 µm. 
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counts, 100,000, 200,000 and 300,000, according to the manufacturer’s instructions. Cell 
density was determined the following day.  
 
Collagen is the most widely used extracellular matrix protein and has been shown to be 
involved in cell attachment and differentiation. Type I collagen can be used as a thin film to 
promote cell attachment and/or proliferation in vitro. To evaluate if collagen I affected nHEK 
cell proliferation and differentiation, cells were seeded, as above, on collagen uncoated and 
coated six well plates. Higher cell proliferation and epithelioid morphology was observed 
with collagen-coated plates. 50-60% cell density for transfection was observed with a cell 


























Figure 3.3: Optimistion of cell density at transfection for nHEKs.  
Representative photomicrographs of nHEKs 16 hours after seeding 100,000, 200,000 and 300,000 
cells/w ll in a six-well plate uncoated and coated with rat tail Collagen I.  Photomicrographs were taken 
under brightfield microscopy (n=2). Scale bars represent 100 µm.	
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3.2.1.3 RNAi knock-down expression of ichthyosis genes of interest 
Three custom made Stealth siRNAs  (25bp each) targeting different regions in the mRNA for 
the gene of interest and a high and low GC negative control, designated CH and CL 
respectively, were obtained from Invitrogen.  The siRNA was transfected into nHEKs of 50–
60% confluency using HiPerFect. siRNAs were used at a concentration of 25nM each. The 
degree of gene expression down-regulation was determined at mRNA level two days post-
transfection using quantitative, real-time PCR (qPCR). For that, RNA was extracted, total 
cDNA synthesised and used for qPCR with specific primers for each gene of interest. Relative 
quantitation of gene expression was calculated using the Comparative CT method. Expression 
of each gene of interest was normalized to expression of the housekeeping gene, GUSB. Each 
siRNA sequence for each gene of interest down-regulated gene expression at the mRNA 
level. The most effective siRNA sequence for each gene was used in subsequent experiments. 
Since the GC content of siRNA used for subsequent experiments was between 36-52% a low 























































































































































































Figure 3.4: qPCR showing downregulation of Ichthyosis genes. 
Each siRNA sequence targeting the gene of interest lead to significant down-regulation of gene 
expression. qPCR analysis of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B expression in 
nHEKS two days post transfection with three different siRNA  sequences targeting each gene of 
interest. Two different non-targeting controls, CL and CH, were used. Values derived from qPCR 
for siC were set at 1 (fold induction) and the relative expression levels of cells transfected with the 
experimental siRNA (n=3).   Error bars represent mean ± standard deviation.   
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3.2.1.4 Optimal siRNA concentration to minimize off-target effects in RNAi 
experiments 
Studies have indicated that transfection of siRNA can result in off-target effects, in which 
siRNAs affect the expression of non-homologous or partially homologous gene targets. The 
mechanisms of off-target effects are not fully understood. They may be caused by siRNA 
targeting mRNA with close homology to the target mRNA, by siRNAs functioning like 
miRNAs, or by a cellular response to siRNA toxicity. Off-target effects, which may produce 
misleading results in RNAi experiments, can be largely avoided by using low siRNA 
concentrations. To evaluate the lowest concentration of siRNA for each gene of interest that 
will allow gene silencing without compromising knockdown efficiency nHEK cells were 
transfected with 5 nM, 10 nM and 25 nM of siRNA. Low GC non-targeting siRNA, siC, was 
used as a negative control. Gene expression was determined at the mRNA level, 2 days after 


















































































































Figure 3.5: qPCR analysis of nHEK cells transfected with different concentrations of siRNA targeting the 
gene of interest.  
nHEK cells were transfected with three different concentrations, 5 nM, 10 nM and  25 nM, of siRNA targeting 
STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B . Nonsilencing siRNA, siC, was also transfected. 2 days 
later, cells were harvested for qPCR. Values derived from qPCR for siC were set at 1 (fold induction) and the 




3.2.2 Reference gene selection for qPCR in siRNA transfected 
primary keratinocytes  
For qPCR to yield meaningful results, it is necessary to normalise expression of the gene of 
interest to a stably expressed endogenous control. Housekeeping genes are genes coding 
proteins responsible for maintaining basic functions of cells. They are thought to be relatively 
constitutively expressed and therefore are candidates for internal control genes in qPCR. 
However, evidence shows that these and other housekeeping genes are not as resistant to 
internal and external environmental changes as previously thought and that mRNA expression 
of housekeeping genes may show alterations depending on applied experimental conditions 
(Balogh et al., 2008).  
 
The current study involved establishing expression profiles for 6 putative housekeeping genes 
(GAPDH, B2M, RPLOPO, TBP, YWHAZ and GUSB) with different functions in cellular 
maintenance to study gene expression of STS, FLG, ABCA12, TGM1, ICHTHYIN, and 
ALOX12B in neonatal human epidermal keratinocytes, nHEKs, following gene silencing 
using 3 different primer siRNA sequences targeting each gene of interest, as previously 
described.  
 
The stability of gene expression for candidate HKGs was analyzed using the geNorm analysis 
program. Genes with different cellular functions were chosen because selecting genes that 
share identical biochemical pathways could bias analyses (Bär et al., 2009). The geNorm 
algorithm expresses the internal control gene-stability measurement as M. Genes with the 
lowest M-values exhibit the most stable expression and are thought to be more reliable for 
normalization (Allen et al., 2008). Genes with a M-value under 0.5 are considered acceptable 
for valid HKG (Minner and Poumay, 2009). This analysis revealed that the cutoff M-value of 
GUSB was below 0.5 thus supporting the choice of GUSB as HKGs in experiments to study 
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differentiation of keratinocytes by real-time qPCR.  
 
		
To further confirm the stability of HKGs qPCR analysis was undertaken using three different 
HKGs-GAPDH, YWHAZ and GUSB. GUSB and YWHAZ were chosen because they had the 

















Figure 3.6: Genorm Analysis of HKGs.  
Average expression stability values, M. M-values under 0.5 are considered acceptable for valid HKG 
(Minner and Poumay, 2009). GUSB was the only gene with an M value below 0.5. Following transfection 
with siRNA gene expression of the ichthyosis genes was analysed; Total RNA was extracted, reverse 















































































































Figure 3.7: STS knockdown assessment following normalization with 3 different HKGs. 
STS expression is consistent directionally with quantitative changes observed in siSTS-1 compared to controls, siCH 
and siCL, following normalization with GAPDH (least stable HKG) when compared to GUSB and YWHAZ (n=3).  



































































































Figure 3.8: ABCA12 knockdown assessment following normalization with 3 different HKGs. 
ABCA12 expression is consistent directionally and quantitatively following normalization with all three HKGs  






































































































Figure 3.9: TGM1 knockdown assessment following normalization with 3 different HKGs. 
TGM1 expression is consistent directionally and quantitatively following normalization with all three HKGs 






































































































Figure 3.10: ICH knockdown assessment following normalization with 3 different HKGs. 
ICH expression is consistent directionally with some quantitative changes observed with GAPDH (least stable 
HKG) when compared to GUSB and YWHAZ, following normalization with all three HKGs (n=3).  Error bars 




In order to understand what impact reference gene selection might have on expression data of 
the genes of interest, the expression of siRNA transfected nHEKs was measured and 
normalized versus the most stable reference genes (GUSB and YWHAZ) and least stable 
reference gene (GAPDH) calculated by geNorm analysis. For all genes of interest all three 
HKGs showed directionally similar results i.e. reduced expression compared to control.  Some 






















































siCL	 siALOX12B-1	 siALOX12B-2	 siALOX12B-3	
GAPDH	
Figure 3.11: ALOX12B knockdown assessment following normalization with 3 different HKGs. 
ALOX12B expression is consistent directionally with some quantitative changes observed, following normalization 




3.2.3 Establishing an experimental system for epithelial 
differentiation in monolayers 
Mammalian epidermis displays a characteristic calcium gradient, in the non-linear gradient in 
human skin with a low concentration in the basal layer, the lowest concentration being in the 
supra-basal / early spinosum layers and with a marked increase in the late spinosum, granular 
and corneum layers (Leinonen et al., 2009). Calcium has been shown to be a major factor in 
controlling keratinocyte differentiation (Hennings et. al., 1980).  In vitro, nHEKs can be 
selectively cultured and grown optimally in monolayers in media having a calcium 
concentration <0.1mM with protein markers characteristic of basal cells. Calcium addition 
(1.2mM or above) to cultures leads to inhibition of cell proliferation followed by induction of 
terminal differentiation characterized by a series of coordinated morphological changes such 
as formation of adherens junctions and desmosomes coupled with the increased expression of 
terminal differentiation markers such as involucrin (Micallef et al., 2009). Although in vitro 
results cannot be directly extrapolated to the in vivo situation (e.g. due to the impact of the 
dermis on the epidermis) much has been learned about calcium-regulated differentiation from 
in vitro studies, that is applicable to the in vivo epidermis (Bikle et. al., 2012). 
 
3.2.3.1 Morphological changes shown in normal human keratinocytes 
cultured in high calcium media 
nHEKs were plated at a density of 1.5x105 and calcium switched as described in	 section	
2.2.4.  After 12 h, the cells were shifted to high calcium (1.3 mM) Epilife media and 
incubated for 24 h	(section	2.2.5). Cells incubated in low calcium media for 24 h were kept 
as a control. Cell morphology was observed with brightfield microscopy. 24 hr post calcium 
switch, morphological changes such as cell-cell adhesion and stratification were noted in HC 











STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B expression are induced by calcium 
switch from LC to HC media in nHEKs. For all qPCR experiments, results are shown 
comparing mRNA expression on days 1, 3, 5 and 7 following calcium switch to gene 
expression in cells grown in LC media indicated as baseline. The expression of all genes 
except FLG was elevated 24 h post calcium switching and was maintained for 7 days for STS, 
ICHTHYIN, FLG AND ALOX12B but not for TGM1 and ABCA12. However gene expression 
was upregulated during days 3 and 5 for all genes of interest. All genes had sufficient baseline 
expression in LC on day 1 to serve as controls. Further gene expression knock-down 










Figure 3.12: Morphological changes in normal human keratinocytes due to different calcium 
ion concentrations. 
Morphological changes in nHEKs cultured in low calcium (LC) and high calcium (HC) medium for 







3.2.3.2 Comparison of expression of STS, FLG, ABCA12, TGM1, 
ICHTHYIN and ALOX12B in low and high Ca media following transfection 
with siRNA 2 days post-transfection 
nHEKs were plated at a density of 1.5x105 per well in incubated in low calcium (0.06 mM) 
Epilife (Cascade Biologics, UK) medium a 6-well plate, and incubated at 37°C/5% CO2. 
After 24 h, nHEKs were transfected with siRNAs for STS, FLG, ABCA12, TGM1, ICHTHYIN 
and ALOX12B and the non-targeting control, as described previously. After 12 h, the cells 
were shifted to high calcium (1.3 mM) Epilife media and incubated for 24 h. Additionally, 
transfected cells for each gene were incubated in low calcium media for 24 h and kept as a 



















































































































Figure 3.13: qPCR of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B gene 
expression over 7 days in nHEKs cultured in high Ca media compared to low Ca media. 
Analysis by qPCR of the STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B mRNA expression in 
nHEKs in low (0.06 mM) set at fold induction 1 to serve as baseline or high (1.3 mM) extracellular 
calcium concentrations during 7 days. For each gene, mRNA levels were normalized with a house 














































































































Figure 3.14: qPCR showing optimal suppression with siRNA targeting all genes of interest in low 
and high Ca media 2 days post-transfection. 
Transfection with siRNA targeting STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B respectively in low 
and high Ca media 2 days post-transfection. Optimal suppression with siRNA targeting all genes of interest 





3.2.3.3 Time-course analysis of STS, FLG, ABCA12, TGM1, ICHTHYIN and 
ALOX12B down-regulation 
	
The degree of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B down-regulation in 
nHEKs after transfection with the siRNA targeting the gene of interest and after induction of 
differentiation by calcium switching as described was assessed for 8 days. Cells were 
harvested at day 2 and 8 post-transfection and STS, FLG, ABCA12, TGM1, ICHTHYIN and 
ALOX12B expression analysed by qPCR. There was significant down-regulation of 
expression of all genes on day 2 but this was maintained significantly for STS, FLG, ABCA12 
only by day 8 (Figure 3.16) suggesting that this is a good monolayer model for all 6 

















































































































Figure 3.15: qPCR showing expression of  STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B in 
nHEKs  posttransfectiona over a period of 8 days following calcium switch. 
Time course of mRNA expression of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B at day 2 (D2), and 
8 (D8) after siRNAs transfection into nHEKs following calcium switch 1 day post-transfection (n=3).  Error bars 





3.2.3.4 Optimal knock-down of STS, FLG, ABCA12, TGM1, ICHTHYIN and 
ALOX12B 4 days post transfection in differentiated nHEKs 
The degree of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B down-regulation in 
nHEKs 4 days post transfection (mRNA expression of all genes was upregulated Figure 3.13) 
was assessed in differentiated cells using three negative controls (non-targeting, mock and 
untreated) as described in section 2.3.5. For non-targeting control cells were transfected with 
non-targeting siRNA, for mock cells were cultured in media with transfection reagent and for 
untreated cells were cultured in culture media only. Cells were harvested in QIAzole lysis 
reagent and RNA extracted using miRNeasy Mini kit (Qiagen) from triplicated biological 
replicates. cDNA was made as previously and gene expression assessed by qPCR. Knock-
down of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B compared to each control 
used was noted (figure 3.17).  RNA was sent to GSK for sequencing (section 2.3.5). 
Figure 3.16: qPCR showing expression of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B in 
nHEKs cultured in high calcium medium 4 days post transfection. 
Analysis of siRNA mediated silencing in of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B in nHEKs 
cultured in high calcium medium 4 days post transfection using three different controls, non-targeting, mock and 





3.2.4 Optimal knock-down of STS, TGM1 and ICHTHYIN in 
HEKs 4 days post transfection in differentiated nHEKs leads to 
loss of protein confirmed by western blotting 
Significant knock-down of STS, TGM1 and ICHTHYIN in HEKs 4 days post transfection in 
differentiated cells (differentiation induced the day following transfection as previously 







Figure 3.17: Western blot analysis showing siRNA-mediated silencing of STS, Ichthyin and TGM1.  
Representative Western blots of 3 biological repeats. Separate blots for knockdown and HKG shown because 















































3.3 Discussion  
In this chapter in vitro disease models for the non-syndromic ichthyoses by knockdown of 
STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B in normal keratinocytes derived from 
neonatal foreskin were developed. Primary keratinocytes were selected as a model because 
they are more physiologically relevant to keratinocytes in vivo than a cell line (Pan et al., 
2009).  However, as they have a limited passage capability siRNA was used to induce a 
transient knockdown (rather than stable knockdown where intracellular expression of siRNAs 
is induced).	This enabled analysis of the effect of knockdown in keratinocytes with the same 
genetic background.  
 
The efficiency of transfection was optimised for the primary keratinocytes as low transfection 
efficiency usually results in lower levels of gene knock-down.  This happens because mRNA 
expression from untransfected cells will contribute to the total observed mRNA level. Optimal 
transfection reagent volume (HiPerFect-15 µl) with highest efficiency of siRNA delivery with 
least impact on cell viability and optimal cell plating density (150,000 cells/well on collagen I 
coated plate) were determined. Three custom made siRNAs targeting different regions in the 
mRNA for the gene of interest. Demonstration of the siRNAs’	 specificity by providing the 
appropriate controls is crucial (Hüttenhofer et al., 2003). Two different non-targeting controls, 
a high and low GC negative control, designated CH and CL respectively, were used. Each 
siRNA sequence for each gene of interest down-regulated gene expression at the mRNA level 
detected 2 days after transfection. The most effective siRNA sequence for each gene was used 
in subsequent experiments. Since the GC content of siRNA used for subsequent experiments 
was between 36-52% a low GC negative control was used as advised by the manufacturer. 
For RNAi to be a useful tool in gene knock-down experiments, it is critical that siRNA-
mediated silencing is specific i.e. limited to the specific knock-down of the target gene. 
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Down-regulation of unintended gene targets, i.e. off-target effects, is a result of non-specific 
silencing and can be a consequence of siRNA methods. Sequence independent off-target 
effects can result from high siRNA concentration introduction as this can displace 
endogenous miRNAs from RISC (Khan et al., 2009). The lowest concentration of siRNA (5-
25nM) for each gene of interest that would allow gene silencing without compromising 
knockdown efficiency nHEK cells was evaluated. 
 
For qPCR to yield meaningful results, it is necessary to normalise expression of the gene of 
interest to a stably expressed endogenous control (Bustin et. al.; 2005, Huggett et.al.; 2005). 
The stability of gene expression for 6 candidate HKGs (GAPDH, B2M, RPLOPO, TBP, 
YWHAZ and GUSB) was analyzed using Genorm analysis and further by qPCR for the 2 most 
stable genes GUSB and YWHAZ and the commonly used GAPDH. The overall findings 
supported the choice of GUSB as HKG to study gene suppression in siRNA transfected 
nHEKs by qPCR and hence it was used as HKG for this project. 
 
The ichthyosis genes play a role in terminal differentiation and the genes of interest in this 
study are expressed late in differentiation.  Induction of genes in monolayer cultures was 
achieved by switching low calcium media to high calcium media. Gene expression was 
upregulated during days 3 and 5. All genes had sufficient baseline expression in LC on day 1 
to serve as controls. In one study, a 3 day calcium switch lead to induction of TGM1 but, in 
contrast to our study, not in FLG and induction of FLG in vitro was attributed to increased 
cell confluency (Borowiec et al., 2013). These differences may be explained by different cell 
culture conditions (serum and cell confluency). Use of a negative control (cells cultured in 
low calcium media) in this study confirms that gene induction was due to calcium switching 
in this project. It has been suggested that calcium switch is a potent model for inducing 
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calcium- dependent genes but not for studying differentiation of in vitro keratinocytes 
(Borowiec et al., 2013).  In this study, induction of all genes of interest was noted at 
transcriptome level following calcium switch. Confirmation of gene induction at protein level 
to allow for post-translational modifications would allow further validation of this model. To 
assess whether the experimental conditions in this project serves as an appropriate model for 
keratinocyte differentiation other genes involved in differentiation e.g. genes involved in 
induction of the ER stress response (Sugiura et al., 2009) can be assessed at transcriptome 
and/or protein level. 
 
Following calcium switch optimal suppression with siRNA targeting all genes of interest was 
achieved on day 3 (confirmed using three different controls). The silencing potential of the 
siRNAs targeting the ichthyosis genes was maintained for 8 days for STS, FLG, ABCA12 but 
not for the other genes. Knockdown was confirmed at protein level for STS, TGM1 and 
ICHTHYIN by Western blotting on day 3. Further gene expression knock-down experiments 
using this model were performed at this time point.  
 
In summary, a model to study transient knockdown of genes expressed in late differentiation 
in monolayer cultures was developed. By optimizing transfection conditions (including 
calcium switching) and by using the appropriate controls a highly reproducible protocol for 
consistent, efficient and specific knock-down in STS, FLG, ABCA12, TGM1, ICHTHYIN and 
ALOX12B nHEKs was established at transcriptome level and confirmed at protein level for 
STS, TGM1 and ICHTHYIN by Western blotting. This paves the way for further experiments 
where the specific effect of STS, FLG, ABCA12, TGM1, ICHTHYIN and ALOX12B loss on 
nHEKs can be determined. 
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3.4 Further work 
The limitation of siRNA as a method for protein knockdown is that the knockdown is 
transient; therefore it is desirable to generate a stable knockdown so that long-term 
experiments can be carried out. For example, although the effects of siRNAs are sustained for 
longer in organotypic skin model than in monolayers (Mildner et.al.; 2006) longer lasting 
experiments could be performed. For this a keratinocyte cell line such as N/TERT-1 would be 
appropriate because it was shown that normal keratinocyte differentiation was maintained 
after immortalisation (Dickson et al., 2000). To produce a stable induction of RNAi, 
endogenous expression of short-hairpin RNAs (shRNAs) by expression plasmids or viral 
vectors is commonly used (Paddison et al., 2002, Stegmeier et al., 2005). shRNAs are 
processed by Dicer to produce siRNAs. Upon binding to the cell the viral genome is 
transported into the cytoplasm where it undergoes reverse transcription into DNA. The DNA 
is then integrated into the host genome, allowing the shRNA to be constitutively expressed. 



























Chapter 4: Characterisation of 3D 
Organotypic Cultures of Keratinocytes 
Following Knockdown of Ichthyosis Genes 
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4.1 Introduction 
Organotypic culture is a form of three-dimensional tissue culture where cultured cells are used 
to reconstruct a tissue or organ in vitro the objective being to allow the cells to exhibit as 
many properties of the original organ as possible. Three-dimensional organotypics (3D 
organotypics) are superior to monolayers of keratinocytes because they preserve the 
physiological 3D architecture of the skin, with cell proliferation occurring in the basal layers 
and cell differentiation towards the surface. Gene silencing by means of RNA interference 
(RNAi) is a powerful tool for gene function analyses in vitro. The combination of RNA 
interference technology and human organotypic skin cultures is an efficient method to study 
gene functions in epidermal development (Mildner et al., 2006,	Kuchler et al., 2011, Vavrova 
et al., 2014, (O'Shaughnessy et al., 2010).  
 
The skin consists of a stratified cellular epidermis composed mainly of keratinocytes and an 
underlying dermis composed predominantly of fibroblasts in a collagen-rich stroma. Full 
thickness skin models contain both epidermal and dermal compartments. The best in vitro 
model that best mimics normal skin are organotypic cultures of keratinocytes on a fibroblast 
populated scaffold where a SC is formed indicating terminal differentiation and complete 
barrier formation. Terminal differentiation of keratinocytes can be induced by culturing 
keratinocytes at an air/liquid interface resulting in a multilayer stratified tissue modelling 
normal skin. The keratinocytes used for epidermis formation can vary in that either 
keratinocyte cell lines or primary keratinocytes can be used. In addition, there are a number of 
possible dermal materials/scaffolds that can be used for organotypic cultures of skin such as 
de-epidermalised dermis, type I collagen gels (Boelsma et al., 1999), and collagen and 
Matrigel mixtures (Sobral et al., 2007). 	
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In vitro skin models (using siRNA in primary keratinocytes using dermal scaffolds) provide a 
way of mimicking monogenic skin disorders. This is advantageous in that it allows the gene 
specific effects to be evaluated without other possibly contributing factors. However it does 
not mimic in vivo skin and lacks other epidermal cells-melanocytes, Langerhans cells, Merkel 
cells. Additionally the amount and composition of SC lipids in in vitro models varies from 
that of skin (Vavrova et al., 2014). Furthermore, the dermal scaffolds do not represent the 
vascularized dermis, including circulating immune cells, and appendageal structures such as 
hair follicles and sweat glands. Additionally, the underlying subcutaneous layer is not 
represented.  
 
For this study, fibroblasts were cultured in de-epidermalised dermis for two weeks prior to 
seeding primary keratinocytes. Primary keratinocytes were grown at the air/liquid interface 
for 10 days.  
	
Figure 4.1: Organotypic culture of primary keratinocytes on fibroblast populated de-epidermalised 





















4.1.1 Development of skin models to study the ichthyoses in vitro 
In recent decades a number of murine models have been developed for the ichthyoses. The 
flaky-tail mouse, which lacks processed murine filaggrin because of a frameshift mutation in 
the gene encoding profilaggrin, has impaired barrier function (Presland et al., 2000, Fallon et 
al., 2009).  However this mouse model has another recessive hair mutation, matted and it was 
found that the latter gene, rather than filaggrin, causes development of spontaneous 
development of AD with increased IgE levels (Sasaki et al., 2014, Sasaki et al., 2013). 
Subsequently, the FLG-/- mouse model was generated. These mice have dry skin, enhanced 
percutaneous allergen priming but do not develop spontaneous dermatitis under specific 
pathogen-free conditions (Kawasaki et al., 2012). Thus, it has been suggested that the flaky 
tail mouse is not a true model of filaggrin deficiency and all of the previous work on these 
models needs to be re-evaluated (Moniaga et al., 2010, Moniaga and Kabashima, 2011, 
Oyoshi et al., 2009, Scharschmidt et al., 2009, Moniaga et al., 2013). 
 
Skin from the 12R-LOX mice transplanted onto wild-type nude mice develops an 
ichthyosiform phenotype (de Juanes et al., 2009).  Mice knockouts for ABCA12 have been 
described as having a post-natal lethal phenotype with skin resembling that of newborn HI 
skin (Smyth et al., 2008, Yanagi et al., 2008). The expression of ABCA12 in normal foetal 
skin development and the grafting of HI keratinocytes on immunodeficient mice have also 
been described (Yamanaka et al., 2007).  Mice knockouts for TGM1 do not recapitulate the 
human skin phenotype and die within the first hours of life (Matsuki et al., 1998). A TGM1 
deficient skin-humanized mouse model for LI has been reported  (Aufenvenne et al., 2012). 
 
In vivo models of the skin such as murine animals provide a 3D model however interspecies 
transferability of the results and ethical issues remain a problem. Reconstructed human 
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epidermis serve as effective models for the study of skin disorders. In vitro human FLG 
(Mildner et al., 2010), ALOX12B, ALOXE3, TGM1, ICH/NIPAL4, ABCA12 (Thomas et al., 
2009, Eckl et al., 2011) models using siRNA in primary human keratinocytes and a rat in vitro 
model (O'Shaughnessy et al., 2010) have been described.  These have not been fully 
characterized. No 3D in vitro models for STS or ichthyin are known.  
 
Skin models to study the ichthyoses were developed using siRNA transfected primary 
keratinocytes and harvested 10 days post transfection. 
 
4.1.2 Aim 
The aim of this chapter was to study the role of the ichthyosis genes (FLG, STS, TGM1, 
ALOX12B, NIPAL4, and ABCA12) in epidermal differentiation and maturation of the 
epidermal barrier by establishing (and characterizing) full-thickness human skin models for 
the common ichthyosis and the autosomal recessive congenital ichthyosis. Organotypic 
cultures were generated using primary keratinocytes with knockdown of FLG, STS, TGM1, 
ALOX12B, ICH, and ABCA12 using siRNA. The effect on epidermal differentiation was 
investigated in these cultures compared to control. 
 
4.2 Results 
4.2.1 Haematoxylin and Eosin staining of ichthyoses organotypic 
culture following ichthyosis protein knock-down using de-
epidermalised dermis 
Organotypic cultures on a fibroblast populated de-epidermalised dermis were generated with 
primary keratinocytes with knockdown of the ichthyosis genes:  STS, FLG, TGM1, ALOX12B, 
ICH, and ABCA12 (siSTS, siFLG, siABCA12, siTGM1, siALOX12B, siICH). A non-
targeting siRNA was used as a control (siC). Figure 4.2 shows H&E staining of siSTS, siFLG, 
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siABCA12, siTGM1, siALOX12B, siICH and siC organotypic cultures. A multi-layered fully 
differentiated epidermis was observed in all cultures. The stratum corneum was present 
confirming that the keratinocytes have successfully undergone terminal differentiation. The 
nucleated epidermis of the ichthyosis gene knock-downs were thicker (i.e. more acanthotic) as 
well as the SC (i.e. compact hyperkeratosis) compared to the control suggesting that the 










Figure 4.2: Organotypic cultures of primary keratinocytes following ichthyosis gene knockdown.  
(a) Haematoxylin and eosin staining of 3D	 organotypic cultures on a fibroblast populated de-epidermalised 
dermis were generated with primary keratinocytes with knockdown of the ichthyosis genes:  STS (siSTS), FLG 
(siFLG), TGM1 (siTGM1), ALOX12B (siALOX12B), ICH (siICH), and ABCA12 (siABCA12). Non-targeting 
siRNA was used as a control (siC). Sections were stained with haematoxylin, which stains the cell nucleus 
purple, and eosin, which stains the cytoplasm pink. Scale bars represent 200µm (b) Graphs showing epidermal 








































































































4.2.2 Ichthyosis protein expression in primary keratinocyte 
organotypic cultures 
Due to the transient nature of siRNA knockdown it was important to confirm knockdown was 
still present in organotypic cultures of primary keratinocytes. There was efficient knockdown 
of FLG as measured by IF staining (Figure 4.3) and of TGM1, ICH and ABCA12 as 












Figure 4.3: IF staining of Filaggrin (red) in siC, siFLG organotypic cultures and skin sections.  
IF staining of Filaggrin (red) in siC, siFLG organotypic culture and skin sections. DAPI (blue) was used as a 
nuclear stain. Scale bars represent 100µm in siC and siFLG and 200 µm in Untreated Skin panels.  
 
In normal skin filaggrin staining was observed in the SG and SC, as expected.  In siC 
organotypics, filaggrin expression was observed in the upper layer of the epidermis. However, 












Figure 4.4: IHC staining of TGM1 in siC, siTGM organotypic cultures and skin sections using DAB.   
IHC staining of TGM1 in siC, siTGM organotypic cultures and skin sections. DAPI was used as a nuclear stain. 
Scale bars represent 100µm in siC and siTGM1 and 200 µm in Untreated Skin panels.  
.  
 
The TGM1 protein is expressed primarily in the SC in normal skin. In siC it is expressed 
throughout the entire epidermis but primarily in the SC, SG and upper SS. In the TGM1 
knockdown TGM1 expression is limited to the SC only. 	
siC siFLG Untreated Skin 











Figure 4.5: IHC staining of Ichthyin in siC, siICH organotypic cultures and skin sections using DAB.   
IHC staining of Ichthyin in IHC staining of Ichthyin in siC, siICH organotypic cultures and skin sections.  DAPI 
was used as a nuclear stain. Scale bars represent 200 µm. 
 
Expression of Ichthyin was examined by IHC. Ichthyin is expressed throughout the viable and 
non-viable epidermis in normal skin and siC. In the ICH knockdown reduced expression is 
















Figure 4.6: IHC staining of ABCA12 in siC, siABCA12 organotypic cultures and skin sections using DAB.   
IHC staining of ABCA12 in siC, siABCA12 organotypic cultures and skin sections.  DAPI was used as a nuclear 
stain. Scale bars represent 200 µm.  
 
IHC demonstrated ABCA12 was expressed throughout the epidermis with apparent increased 
expression in the upper epidermis. This could be an edge artefact, but is in keeping with 
staining pattern in normal skin (Thomas et al., 2009).  In the ABCA12 knockdown reduced 
staining is noted throughout the epidermis. 
 
4.2.3 Further characterisation of organotypic cultures 4.2.3.1 
Characterization of FLG organotypic culture 
To further characterize FLG 3D model loricrin (LOR) and keratin10 (K10)-late and early 
differentiation markers respectively-were used. Furthermore, IF staining was done using 
siC Untreated Skin siICH 
siC siABCA12 
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keratin14 (K14) to evaluate changes in the SB. LOR was expressed in the SC in normal skin 
and siC. There was loss of expression of LOR following FLG silencing. K10 is expressed in 
the suprabasal layers of the epidermis and a typical staining pattern is shown in siC and 
normal skin sections. There is reduced expression of K10 in siFLG. K14 expression is most 
evident in the basal layer as seen in normal skin. There is increased expression of K14 in siC 
and siFLG and it is seen in the suprabasal layers compared to normal skin.  Suprabasal K14 
has been noted previously in 3D epidermal models (Lamb and Ambler, 2013). 
 
Figure 4.7: IF staining of the epidermal differentiation marker LOR, K10 and K14 in siC, siFLG and 
normal skin.  
IF staining of LOR (green) and K14 (red) and K10 (red) in siC, siFLG and skin. DAPI (blue) was used as a 
nuclear stain. Scale bars represent 100µm.   
siC siFLG
siC siFLG Untreated Skin
Untreated Skin





4.2.3.2 Characterization of ABCA12 knockdown organotypic culture 
	
Figure 4.8: IF staining of filaggrin and K10 in siC, siABCA12 and skin sections.  
IF staining of the terminal differentiation marker FLG (green) and early differentiation marker K10 (red) in siC, 
siABCA12 and normal skin. DAPI (blue) was used as a nuclear stain.  Scale bars represent 100µm. 
	
To	further	characterize	the	siABCA12	organotypic	culture	filaggrin	a	 late	differentiation 
marker and K10 expression were evaluated. There was expression of filaggrin in the SG in 
siC and siFLG but also in the SS in the latter lending support to premature termination 
differentiation in an ABCA12 knockdown (immortalized cell) model (Thomas et al., 2009). 
Early differentiation marker K10 is expressed in the suprabasal layers of the epidermis as seen 
in siC and normal skin sections.  K10 expression is limited to the upper spinous layer in 
siABCA12. 
 
4.2.4 Epidermal differentiation of ichthyoses organotypic cultures 
The localization TGM1 in normal skin was assessed by IHC (fig.4.4) and was primarily in the 
SC. On comparison to siC TGM1 expression was altered in the remaining ichthyoses 
knockdowns suggesting dysregulation of terminal differentiation (Figure 4.9); there was 
reduced expression of TGM1 in TGM1 knockdown as expected but also in the STS and ICH 
knockdowns. In siFLG, siALOX12B and siABCA12 there was increased expression in the 






suggesting premature terminal differentiation in these disease models. This was most striking 


























































Figure 4.9: IF staining of the epidermal differentiation marker TGM1 in siC, siSTS, siFLG, siABCA12, 
siTGM1, siALOX12B and siICH organotypic cultures.  
IF staining of TGM1 (green) in siC, siSTS, siFLG, siABCA12, siTGM1, siICH and siALOX12B organotypic 







In this study, in vitro human skin models were generated for the common ichthyoses and the 
autosomal recessive congenital ichthyoses. Organotypic cultures were generated using 
primary keratinocytes with knockdown of FLG, STS, TGM1, ALOX12B, ICH/NIPAL4, and 
ABCA12 using siRNA on a de-epidermalised dermis. Full thickness epidermis was generated 
for each organotypic culture and loss of protein assessed (where possible) by IHC or IF. 
Further characterization by staining with differentiation markers was undertaken to assess the 
effect of knockdown on epidermal differentiation. 
 
Novel ichthyosis in vitro disease models for STS and ICH knockdowns were developed.  H&E 
staining in the STS knockdown demonstrated a fully differentiated epidermal compartment 
with all viable layers and SC. The SC appeared more compact and thicker (compact 
hyperkeratosis) and the viable layers slightly thicker (slight acanthosis) than that of control as 
noted in vivo (Calonje et al.; 2012). Immunofluorescent staining did not reveal any changes 
compared to control or normal skin. For the ICH knockdown compact hyperkeratosis, nuclei 
in the SC (parakeratosis) and acanthosis were noted on H&E staining.  ICH mutations lead to 
LI/NCIE phenotypes and several of the observed histological features in the generated model 
have been noted in affected patients; hyperkeratosis, moderate acanthosis and parakeratosis in 
NCIE phenotype and orthohyperkeratosis, moderate acanthosis, normal or reduced granular 
layer and mild irregular undulation of the epidermal surface (papillomatosis) are seen in 
lamellar phenotype (Fischer et al., 2007).  The loss of the target protein following knockdown 
was further demonstrated by IHC analysis of diseased skin compared to normal skin 
equivalent. However, the staining pattern noted throughout the epidermis may not be 
representative of Ichthyin expression but may be non-specific due to the polyclonal antibody 
used; polyclonal antibodies target multiple epitopes of the same antigen and are less specific 
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than monoclonal antibodies that recognize one epitope of an antigen only. IHC with another 
antibody would verify these findings.  
 
In addition to the novel models generated, in vitro cultures were established for the remaining 
ichthyoses using primary keratinocytes (neonatal) from the same genetic background i.e. same 
donor. In the FLG knockdown H&E staining demonstrated, a fully differentiated epidermal 
compartment with all viable layers and SC. Morphology of the SC did not appear to be 
compromised. The impact of FLG knock down on filaggrin protein expression in the skin 
construct was verified by IF.  Immunofluorescence labeling of filaggrin in the granular layers 
of control organotypic and normal skin was seen. Notable reduction of fluorescence staining 
intensity in FLG knock down in comparison to normal control was noted most likely due to 
loss of keratohyalin granules in the granular layer. Further characterization revealed loss of 
LOR and reduced expression of TGM1 confirming that it affects terminal differentiation and 
leads to disturbed maturation of the epidermis in contrast to previous studies (Mildner et al., 
2010). These differences are most likely due to the shorter cultivation period of seven days; it 
is thought that the influence of filaggrin deficiency on epidermal maturation does not become 
visible until cultivation periods exceed one week in duration (Kuchler et al., 2011). No 
changes were noted on IF staining with K14 (expressed in the basal layer) confirming that it 
does not impact on the SB as shown in previous studies (Mildner et al., 2010). IHC of three-
dimensional organotypic cultures expressing siRNA to ALOX12B showed reduced expression 
of ALOX12B throughout the epidermis compared to complete loss of ALOX12B protein noted 
by IF in another reported model reflecting the differences in technique used-IHC being more 
sensitive than IF (Eckl et al., 2011).  TGM1 knockdown displayed compact hyperkeratosis 
and acanthosis. IF and IHC staining showed a reduction in TGM1 staining in the viable 
epidermis compared to C and skin. This is in keeping with another TGM1 in vitro model 
	 120	
using primary keratinocytes (Eckl et al., 2011). A HI model using primary keratinocytes was 
generated in this study; This bears out several features related to epidermal differentiation 
noted in HI skin; hyperkeratosis and acanthosis were noted. Furthermore nuclei were seen in 
the SC (parakeratosis) and there was irregular undulation of the epidermal surface 
(papillomatosis). Protein knockdown was confirmed by IHC. Terminal differentiation was 
altered in the HI model with increased expression of both TGM1 and filaggrin in the viable 
epidermis compared to control suggesting premature terminal differentiation as noted 
previously in HI skin (Thomas et al., 2009); filaggrin expression was in keeping with HI skin 
and involved the upper spinous layers adding further support to the previously reported error 
in filaggrin processing in HI skin (Thomas et al., 2009). TGM1 expression was limited to the 
suprabasal layers rather than the entire epidermis as seen in HI skin and NEB1 organotypic 
model in another study (Thomas et al., 2009). This may be because of the different antibodies 
used in the two studies. In addition, there was a reduction of K10 expression implying altered 
early differentiation in HI.  
 
Assessment of terminal differentiation of all disease models (from the same genetic 
background) generated in this study was undertaken to evaluate comparative changes in 
terminal differentiation by IF staining of TGM1. All the ichthyosis knockdowns impact on 
TGM1 expression suggesting dysregulation of terminal differentiation. Transglutaminase 1 
(TGM1) is an enzyme involved in the cross-linking of the components of the CE proteins 
(Candi et al., 2005). The CE functions as a platform for cross-linking organized lipid layers-
which is essential for the barrier function of the skin (Lorand and Graham, 2003). 
Additionally, TGM1 contributes to the formation of the CLE by attachment of long-chain 
omega-hydroxyceramides to involucrin (Nemes et al., 1999). Thus, interactions between 
TGM1 and ALOX12B (involved in lipoxygenase pathway) and ICH (putative receptor for the 
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end products of this pathway) may be explained by perturbations in omega ceramide synthesis 
that compromises CLE formation and TGM1 expression. How these changes come about 
mechanistically in the remaining ichthyoses is unclear. This could result from impairment of 
barrier function leading to compensatory changes as observed in other barrier diseases, AD 
and psoriasis, where upregulation of TGM1 has been observed (de Koning et al., 2012).  
 
In summary, all the ichthyosis knockdowns in this study impact on TGM1 and changes in 
ABCA12 alter early differentiation in addition to terminal differentiation. In addition, in this 
study 3D in vitro cultures using primary keratinocytes for the ichthyosis of interest, from the 
same genetic background, were developed including a novel models (STS and ICH 
knockdown) in order to study the individual ichthyosis and make comparative assessments 
and evaluate impact on epidermal biology.  
 
4.4 Future work 
Further characterization of the ichthyosis models (other than for FLG knockdown) to assess 
changes in SB and SS can be undertaken by IF staining with K14 and K10 respectively (for 
ABCA12 knockdown further K14 IF staining).  
 
The ichthyoses are disorders of cornification and impair the skin barrier. To investigate 
functional barrier assessment a penetration assay using Lucifer yellow can be applied on fully 
differentiated organotypic skin cultures for the disease models and control. Lucifer yellow can 
be added on top of the organotypic cultures and its penetration measured, which is indicative 
of a functional SC (Mansbridge and Knapp, 1993). The cultures can be harvested 2 hours post 
application for permeation studies.  
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As lipid composition is crucial for epidermal barrier function alterations in the composition of 
total lipids by Nile Red analysis of lipids can be performed to compare the lipid profile 
between the knockdowns and control. Nile Red fluoresces green in the presence of nonpolar 
lipids (such as ceramides) and red in the presence of polar lipids (such as phospholipids and 
sphingomyelin) (Thomas et al., 2008). Furthermore lipids extracted from 3D organotypics 
(control and knockdowns) can be investigated using mass spectroscopy. 
 
Organotypic cultures of skin are a model for the in vivo environment; therefore it is important 
to confirm that the phenotype observed due to ichthyosis knockdown is biologically relevant. 
Ichthyosis patient samples could be used to see if the above in vitro findings are also seen in 
vivo. 
 
RNAi, leads to gene-specific silencing but can also lead to off-target effects. Rescue 
experiments remain the gold standard control to confirm the specificity, and hence the validity 
of RNAi data (Hüttenhofer et al., 2003).  There are two main methods used (Cullen, 2006); if 
the siRNA used was designed to bind to a sequence in the mRNA open reading frame, then 
this resistance can be achieved by mutation of the mRNA, without changing the encoded 
protein, by taking advantage of the redundancy of the genetic code. Alternatively, the siRNA 
can be designed to target the 3′ untranslated region (UTR) of the mRNA, and rescue of 
expression can then be achieved by expressing a form of the mRNA lacking its normal 3′ 
UTR. Another acceptable approach is to show that two or three distinct siRNAs targeted to 
different regions of the mRNA exert the same phenotypic effect (Hüttenhofer et al., 2003).   
 
Stable knock-down models can be used to investigate the role of the icthyosis genes in 
epidermal differentiation and barrier function by using primary keratinocytes with stable 
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knockdown. This can be achieved by lentiviral shRNA infection. Clustered regularly 
interspaced short palindromic repeats (CRISPR)/Cas9 system (CRISPR-CAS9) can be also be 
used for performing targeted editing to alter or knockout gene expression of the ichthyosis 
genes.  This system requires a Cas nuclease and a single guide RNA (sgRNA) against the 
target sequence to function as a site-specific nuclease.  
 
In this project, transcriptome analysis was undertaken on a 2D models. A more robust 
approach would be evaluation of the transcriptome using the epidermal component of the 
























Chapter 5: RNA-Seq analysis of 




RNA sequencing (RNA-Seq) is a powerful method for transcriptome analyses. The 
transcriptome is the complete set of transcripts in a cell, and their quantity, for a specific 
developmental stage or physiological condition. Understanding the transcriptome is essential 
for interpreting the functional elements of the genome and revealing the molecular 
constituents of cells and tissues, and also for understanding development and disease (Wang 
et al., 2009). Various technologies have been developed to deduce and quantify the 
transcriptome.  The automated Sanger method is considered as a ‘first-generation’ technology 
and the newer methods, which include RNA-Seq (this supersedes the automated Sanger 
method), are referred to as next-generation sequencing (NGS) (Metzker, M.L., 2010). RNA-
Seq generates huge amounts of data, which poses a challenge both for data storage and 
analysis, and consequently often necessitates the use of powerful computing facilities and 
efficient algorithms (Trapnell., 2012).  
 
In this project, RNA (from triplicated biological replicates) was sent to GSK for sequencing. 
Analysis of the sequenced reads was performed in collaboration with the Enright group at 
European Bioinformatics Institute, Hinxton (http://www.ebi.ac.uk/research/enright) and 
differentially expressed gene (DEG) lists were provided. The DEGs were analysed further 
using DAVID, KEGG, REACTOME and GeneMANIA.  
 
RNA was converted to a library of cDNA fragments and adaptors attached to one or both 
ends. Following amplification each molecule was sequenced in a high-throughput manner 
using the Illumina platform to obtain sequences from both ends i.e. pair-end sequencing (the 
alternative is single-end sequencing where sequences are from one end) with read length of 
50bp (the reads are typically 30–400 bp). The reads were not strand specific.  
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RNA sequencing data was analysed   using the pipeline as shown in Figure 5.1: 
 
 
Figure 5.1: Summary of workflow. 
Software used in the workflow and the main functions of each tool. All tools used are fully documented on the 
web and actively maintained by a team of developers.  
 
KRAKEN  (http://www.ebi.ac.uk/research/enright/software/kraken) pipeline, used for quality 
control, developed in the Enright lab was used to process the RNA-Seq data. It consists of 3 
tools: Reaper, Tally and Minion. Reaper is a program for demultiplexing, trimming adapter 
sequences and filtering sequencing data. First, the Reaper command was used to trim the 3’ 
adaptor sequences. The 3’ adaptors were stripped using the criteria: 14-nt alignment stretch 
with no more than 2 mismatches and no gaps. Low complexity sequences were then removed 
with a dust score cut-off of 20. Complexity scores range from 0 to 100. Higher scores imply 
lower complexity. Then, Tally was used to reduce identical reads to a single entry while 
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keeping the depth values. A file with unique reads and their corresponding counts was 
generated for each sample. 
 
The final processed unique paired-end reads were aligned to the reference human genome 
(GRCh37/hg19) with Tophat v2.0.4. TopHat2 aligns RNA-Seq reads to the genomes using the 
short read aligner BOWTIE, and then analyzes the mapping results to identify splice junctions 
between exons. 
 
For transcript quantification, the number of reads mapped to transcripts 
(Homo_sapiens.GRCh37.74.gtf from Ensembl) were obtained from Tophat2 aligned sam files 
using the HTSeq-count command from the HTSeq library 
(http://wwwhuber.embl.de/users/anders/HTSeq/doc/). HTSeq was used to assemble individual 
transcripts from the reads. Longer transcripts produce more sequencing fragments than shorter 
transcripts. Therefore the read count to each transcript’s length must be normalized and 
differential expression calculated using the Bioconductor DESeq2 package 
(http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html). DeSeq2 calculates 
expression levels of transcripts from different conditions and tests the statistical significance 
of observed changes. Differential gene expression analysis was based on a negative binomial 
distribution.  
 
Bioconductor provides tools for the analysis and comprehension of high-throughput genomic 
data. Bioconductor uses the R statistical programming language, and is open source and open 
development  (http://bioconductor.org/packages/release/bioc/html/DESeq.html).  For 
functional grouping of differentially expressed genes lists of the differentially  expressed 
genes, DEGs, (upregulated and downregulated) were then analysed via two internet based 
bioinformatics resources Database for Annotation, Visualization and Integrated Discovery 
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DAVID (https://david.ncifcrf.gov) (Huang da et al., 2009) and REACTOME 
(http://www.reactome.org) (Fabregat et al., 2016). DAVID is a gene annotation tool that 
highlights biological processes and functions from list of DEGs. There are a number of 
annotation categories including protein-protein interactions, protein functional domains, 
disease associations, gene functional summaries, molecular events and functional annotation 
clustering.  REACTOME is a open-source, curated and peer reviewed of human biological 
processes. The central unit of this data model is a Reaction, and subclasses of Reaction model 
these core biological events (Croft et al., 2014). Reactions are grouped into pathways, which 
in turn are assembled into a hierarchy of biological processes. This allows indication of 
whether there were interesting clusters of genes to investigate further as opposed to single 
genes that may be affected by the suppression of the ichthyosis gene of interest. Kyoto 
Encyclopedia of Genes and Genomes KEGG database (accessed through DAVID) was used 
to overlay the list of DEGs onto known signaling pathways. The number of components that 
are highlighted helps determine the extent by which certain pathways were affected. 
GeneMANIA (http://genemania.org) (Warde-Farley et al., 2010) performs biological network 
integration between a gene list and networks generated from available genomic and proteomic 
data. The list of DEGs was input into GeneMANIA to evaluate physical interactions, shared 
protein domains or identify DEGs that participate in the same pathway and also to predict 
functional relationships.  
5.1.1 Aim 
The overall aim of this chapter was to analyse the transcriptome of siRNA transfected 
keratinocytes in monolayer in order to identify differentially expressed genes in keratinocytes 
with knockdown of ichthyosis genes compared to control to evaluate the following:  
1. To directly test the null hypothesis at the level of the transcriptome. If the null hypothesis is 
correct no commonality in gene expression profiles for the in vitro disease models will be 
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observed.  
2. To identify key pathways or biological functions for each ichthyosis. 
For this lists of DEGs following ichthyosis gene knockdown (STS, FLG, TGM1, ICH, 
ALOX12B, ABCA12) were subjected to analysis using DAVID, KEGG and REACTOME.  
 
5.2 Results 
5.2.1 Confirmation of knockdown of siRNA transfected primary 
keratinocytes by DESeq 
For differential expression analysis knockdowns were compared to non-targeting controls for 
all 6 knockdowns (STS, FLG, TGM1, ICH, ALOX12B, ABCA12) using DESeq2 in the 
R/Bioconductor environment.  
There was significant downregulation of all 6 knock-downs: 
Table 5.1: Significant downregulation of the ichthyosis genes STS, FLG, TGM1, ICH, ALOX12B, ABCA12 
Gene Name log2 FoldChange FDR <0.01 
STS -1.807514883 1.50E-23 
FLG -1.242284384 3.07E-08 
ABCA12 -2.067862732 2.23E-146 
TGM1 -2.287142185 2.41E-49 
NIPAL4 -1.723383376 5.64E-48 
ALOX12B -1.090237652 2.07E-08 
	
DESeq2	generated	a	list	of	differentially	expressed	genes	for	each	knockdown	(STS,	FLG,	






5.2.2 Common Genes differentially expressed following 
knockdown of the Ichthyosis genes: 
It is important to investigate whether there were any common signaling pathways or 
biological functions affected following the knockdown of of the ichthyosis genes. 62 genes 
were significantly down-regulated and 26 genes were significantly up-regulated  (FDR < 
0.05).   Gene clusters were found for cell cycle, humoral immune response, keratin 
filament/cytoskeleton and apoptosis (Figures 5.2-5.6). In addition genes related to cytokine 
signaling (FOS, TREM2, CFH, RIPK1, PIP4K2C) and metabolism of lipids and lipoproteins 




Figure 5.2 2D heatmap showing differentially expressed genes in the cell cycle following knock-down of 
the ichthyosis genes.  
DAVID was used to generate a heat map from differentially expressed genes common to all the ichthyosis gene 
knockdowns (STS, FLG, TGM1, ICH, ALOX12B, ABCA12). The heatmap shows corresponding gene terms 







Figure 5.3 Network generated from differentially expressed genes in cell cycle.  
DAVID® used defined gene lists onto well known KEGG® pathways to help interpret the data in a network 

































Figure 5.4 2D heatmap showing differentially expressed genes in apoptosis following knock-down of the 
ichthyosis genes.  
DAVID was used to generate a heat map from differentially expressed genes common to all the ichthyosis 
knockdowns (STS, FLG, TGM1, ICH, ALOX12B, ABCA12). The heatmap shows corresponding gene terms 




























Figure 5.5 2D heatmap showing differentially expressed genes in immune function following knock-down 
of the ichthyosis genes.  
DAVID was used to generate a heat map from differentially expressed genes common to all the ichthyosis 
knockdowns. The heatmap shows corresponding gene terms positively associated (green) and corresponding 









      
Figure 5.6 2D heatmap showing differentially expressed genes in keratin filament/cytoskeleton function 
following knock-down of the ichthyosis genes.  
DAVID was used to generate a heat map from differentially expressed genes common to all the ichthyosis 
knockdowns. The heatmap shows corresponding gene terms positively associated (green) and corresponding 
gene terms not associated (black).        
5.2.2.1 Common Ichthyosis (STS and FLG knockdown) and the Autosomal 
Recessive Congenital Ichthyosis (ABCA12, TGM1, ICH, and ALOX12B): 
	
Venn Diagram for dysregulated genes in the CI and ARCI were made using Venny.  
(http://bioinfogp.cnb.csic.es/tools/venny/index.html). 68 overlapping genes were common to 
the CI and 34 for the ARCI.  Overlapping genes between two or three knockdowns for the 
ARCI were also noted (Figure 5.7). Analysis of dysregulated genes in CI and ARCI using 
GeneMANIA was undertaken. For CI shared protein domains were noted in the epidermal 
differentiation genes. Pathway connections were noted between FOS and NFIB, SPRR3, 
LPAR3, CA2, SAP30, CA2, CCL2, MAPK14 and GSTP. Several physical interactions, 
pathway connections and shared protein domains were noted for CDK2. For ARCI predicted 
interactions were noted between FOS and OPTN. Pathway connections were noted between 
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FOS and CA2. Several physical interactions, pathway connections and predicted interactions 
























Figure 5.7: Venn Diagram of the number of genes that are dysregulated in the CI and ARCI using Venny. 
The number of dysregulated genes are displayed for each ichthyosis knockdown in primary keratinocytes. 68 
overlapping genes were common to the CI and 34 for the ARCI.  For the ARCI, 9 genes were common to 
TGM1/ALOX12B/ABCA12 knockdowns, 22 to TGM1/ICH/ABCA12 knockdowns and 45 to 
TGM1/ALOX12B/ICH. 31 overlapping genes were found for ICH/ABCA12 knockdowns, 8 for TGM1/ABCA12 





Figure 5.8 Analysis of dysregulated genes in CI using GeneMANIA. 
Several gene clusters were noted. Insert: (Left) Shared protein domains were noted in the epidermal 
differentiation genes. (Bottom) Pathway connections (genes involved in the same pathway) were 
noted between FOS and NFIB, SPRR3, LPAR3, CA2, SAP30, CA2, CCL2, MAPK14 and GSTP. 




Figure 5.9 Analysis of dysregulated genes in ARCI using GeneMANIA. 
Predicted interactions were noted between FOS and OPTN. Pathway connections (genes involved in the 
same pathway) were noted between FOS and CA2. (Insert) Several physical interactions, pathway  
connections and predicted interactions were noted for CDK2.  
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5.2.3 Genes differentially expressed following STS knockdown: 
258 genes were significantly down-regulated and 200 genes were significantly up-regulated 
(FDR < 0.01). Several genes involved in female pregnancy, steroid metabolic process, 
neurological processes including behaviour, learning and memory and calcium ion 
homeostasis/binding were noted. STS is known to play a role in these processes but genes 
pertaining to these functions in XLI may be a novel finding. 
 
Altered expression in 27 genes (n  = 14) in patients with XLRI has been reported in a study 
where mRNA expression profiles were determined by oligonucleotide arrays (Hoppe et al., 
2012). None of these genes were altered in our study. This discrepancy may be because 
expression profiling was undertaken on skin containing both epidermis and dermis (obtained 
by taking punch biopsies) rather than micro-dissected epidermis. In addition, tissue was 
obtained from volar forearms of the subjects. This location is only mildly affected by 
ichthyosis in patients with XLRI, and may not be completely representative of their skin 
barrier function in other places (Hoppe et al., 2012).  
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   Figure 5.10 2D heatmap showing differentially expressed genes in neurological function following  
   knock-down of the STS.  
DAVID was used to generate a heat map from differentially expressed genes involved in neurological function 
following STS knockdown. The heatmap shows corresponding gene terms positively associated (green) and 
corresponding gene terms not associated (black).        
 
 
5.2.4 Genes differentially expressed following FLG knockdown: 
There is no published study looking at the transcriptome of IV patients without AD or an IV 
model. Winge et al looked at the transcriptome of 5 AD/IV FLG -/- patients by microarray 
analysis and found that several pathways were significantly altered compared to the healthy 
control group (Winge et al., 2011). Focal adhesion, extracellular matrix receptor interactions, 
regulation of actin cytoskeleton, ABC transport system and calcium signaling pathways 
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showed significantly altered expression (Winge et al., 2011).  
 
In this project, knockdown of FLG lead to the largest number of dysregulated genes compared 
to other knockdowns. 395 genes were significantly down-regulated and 327 genes were 
significantly up-regulated (FDR < 0.01).  Interestingly there are 2 interactions noted with the 
ichthyosis genes of interest in this study-with TGM1 and ALOX12B (Figure 5.9); TGM1 is 
involved in CE formation and filaggrin-dependent keratin aggregation (by a yet incompletely 
understood mechanism) yields keratins that remain as the prevailing proteins inside the CEs 
(Norlen and Al-Amoudi, 2004). In addition to this, genes involved in arachidonic acid 
metabolism (involving ALOX12B) were downregulated. The mechanisms of how FLG 
interacts with TGM1 and ALOX12B needs to be elucidated.  
 
In addition genes involved in acyl-chain remodelling were downregulated. Shorter fatty acid 
chain lengths have been reported in AD (also caused by FLG mutations) which in turn 
produce abnormalities in lipid organization that most likely compromise permeability barrier 
function (Ishikawa et al., 2010, Janssens et al., 2012, Janssens et al., 2011).  
 
Several genes involved in the phenotype of IV involving Ca2+ dependent membrane targeting 
were noted. It is known that FLG may be involved in calcium metabolism in the skin (Bieber, 
2008), and the calcium gradient is important for epidermal differentiation- a loss of this 
gradient increases keratinocyte proliferation and decreases differentiation (Jensen et al.; 
2005).  
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Table 5.3: Dysregulation following knockdown of FLG 
Downregulated genes: 
DAVID  
 Keratinocyte differentiation KRT1,KRT10,KRT14,KRT2,KRT76,KRT7
7,KRT84,ZNF492 
 














 Cornified envelope FLG, LOR, RPTM, TGM1 
 Leukocyte chemotaxis S100A9, CCL2, CORO1A, SAA1 
 Serine hydrolase CFD,DPP4,FAP,KLK1,KLK6,PLAT,PRS
S21,TMPRSS11D 
 
 Lipid metabolic ST3GAL5, ST3GAL6, UGCG, ACER1, 
ITGB8, PSAPL1, P2RX7 











 MAP kinase CD74, EGF, P2RX7, IRAK3 
REACTOME  
 Acyl-chain remodelling PLA2G2F, PLA2G4D 
 Vesicle mediated transport CD36,ARRB1,KIF20B,KIF22, 
RAC2,GJA1, 











KAT2B, LFNG, DLL1, HES5, MAML2 
 Arachidonic acid metabolism ALOX12B, PLA2G2F, PLAY2G4E, 
PTGS1 









 Vesicle mediated transport ANG, FGF2, GRM8, HMOX1, INHBB, 
SYT1, TAC4, TAC1, TRPV6 
 Calcium-dependent 
membrane targeting 
SYT1, SYT2, CADPS2 
 Activation of protein kinase 
activity 
ADCY1, ADRB1, ANGANKHD1-
EIF4EBP3, AMH, CCK, COL4A3, FGF2 
KEGG  
 NOTCH signaling HEY1, MIR34A, NEURL 
 
	
Figure 5.11 Network generated from differentially expressed genes in the NOTCH signaling pathway 
following FLG knockdown.  
KEGG® pathway showing network generated from differentially expressed genes in NOTCH signaling pathway 





Figure 5.12 Network generated from differentially expressed genes in arachidonic acid metabolism 
signaling pathway following FLG knockdown.  
KEGG® pathway showing network generated from differentially expressed genes in arachidonic acid 
metabolism signaling pathway following FLG knockdown.*shows differentially expressed genes. 
 
5.2.5 Genes differentially expressed following TGM1 knockdown: 
163 genes were significantly down-regulated genes and 231 genes were significantly up-
regulated (FDR < 0.05).  As expected several genes involved in CE formation/peptide cross-
linking (a key step in CE formation) were dysregulated. Several of these changes CE proteins 
(LOR, FLG) have been noted in a proteomic study of a TGM1 deficient skin-humanized 
mouse model (Aufenvenne et al., 2012). As noted previously (O'Shaughnessy et al., 2010) 
changes in fatty acid synthesis pathway and in the inflammatory response were also 
dysregulated although the genes involved in this project were different. This is most likely 
due to different disease models-human in this study compared to rat and possibly different 
gene expression platforms used (microarray in the reported study). Additionally RNA-Seq data 
analysis implies that lipid metabolism is regulated by PPAR-alpha following TGM1 
knockdown. Several genes involved in keratinocyte differentiation, epidermal development 
and keratin filament organisation were found to be perturbed. KRT1 expression was 
downregulated in this study and was found to be alterated in LI in another study 
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(O'Shaughnessy et al., 2010). No changes in its pairing partner KRT10 were noted bearing out 
the findings of a proteomics study (Aufenvenne et al., 2012). 
Table 5.4: Dysregulation following knockdown of TGM1 
Downregulation: 
DAVID  
 Cell cycle CHEK1, DBF4B, E2F2, E2F8, HAUS8, 
SPC25, CENPJ, CDT1, CCNF, KIF20B, 







S100A7, CASP14, C1orf68, KRT1, KRT10, 
LCE3A 
 Cornified envelope TGM1, RPTN, LOR, FLG 
 Peptide cross-linking LOR, TGM1, TGM2, TGM4, TGM5, 
MAMDC2 
 Defense   response S100A7, ANKRD1, DEFB4A, HIST1H2BF, 
IL27RA, KRT1, FOS 
REACTOME  
 Cytokine signaling IRAK3, FGF1, SOCS3, MT2A, EGR1, 
TNFRSF18, IL27RA, HLA-DRB1 
 Cell cycle POLE2, HIST1H2BF, CDT1, SPC25, CENPH, 
CENPJ, SMC4, CHEK2, CHEK1, ORC1, 
MND1, LIN9, HAUS8, PRIM1, POLA2, 
KNTC1, LMNB1, E2F2 
 Arachidonic acid 
metabolism 
CYP4B1, PTGS1 
 Metabolism including 
lipids and lipoproteins 
ANKRD1, GBA3, CYP4B1, PTGS1 
 Regulation of lipid 








 Membrane bound 
vesicle 
CSPG5, C12orf39, NPY1R, SHH, SYT2 
 Plasma membrane ADAM23, DIXDC1, GPR1, RAB33A, 
ADCY1, CHRM3, CSPG5, DTNA, HDAC6, 
HAS3, IL1RL1, IL18R1, NPY1R, OLR1, 
KCNMB3, PRKD1, PTPRB, SGCG, SCN9A, 
SHH, SYNE1, SYT2, SDC2 
 Cytoskeleton LDB3, HDAC6, IL1RL1, KIF5A, SGCG, 
SYNE1 
REACTOME  
 Fatty acid CoA 
synthesis 
ELOVL2 
 Cytokine signaling IL1RL1, IL18R1, IFI30 
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5.2.6 Genes differentially expressed following ALOX12B 
knockdown: 
150 genes were significantly down-regulated and 159 genes were significantly up-regulated 
(FDR < 0.01).  ALOX12B encodes the 12R-LOX enzyme which is a iron-containing 
dioxygenase that oxygenates lipids (polyunsaturated fatty acids and their esters). In keeping 
with this several genes annotated to oxidoreductase activity, iron ion binding and lipid 
biosynthetic process/lipid metabolism were noted. RNA-Seq analysis showed several genes 
involved in keratinocyte differentiation/cytoskeleton organization lending support to its 
possible role in keratinocyte differentiation (section 1.5.2.4.3). Genes involved in 
inflammation were also noted thereby implying possible novel functions for ALOX12B, 
whose specific role in skin barrier function is not well understood. Genes involved in 
regulation of lipid metabolism by PPAR-alpha were also noted. 
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Table 5.5 Dysregulation following knockdown of ALOX12B 
Downregulation: 
DAVID  
 Cell cycle BARD1, CHEK1, DBF4B, E2F8, CENPJ, 
CCNF, KPNA2, KIF20B, KIF22, KNTC1, 
LZTS1, LIN9, MND1, PTTG1, PLK2, 
SMC4 
 Extracellular matrix MAMDC2, COL4A2, COL12A1, 
HMCN1, LUM, MMP19 
    Cytoskeleton CHEK1, ACTG2, CENPJ, CNKSR2, 
GDPD2, KRT31, KRT77, KIF20B, 
KIF22, KIF24, KIF26A, KNTC1, 
LMNB1, LZTS1, TNNT3, VIM 
 Intermediate filament KRT31, KRT77, LMNB1, VIM 
 Immune/ 
defense response 
GEM, CCL2, CXCL2, CFH, IL27RA, 
TLR1, TREM2, FOS 
 Lipid localization and 
transport 
ABCG4, SLC1A2, SLCO2A1, SORL1, 
TC 
 Lipid biosynthetic process ST3GAL5, ALOX12B, CYP1A1, PTGS1 
 Oxidoreductase activity, iron 
ion binding and lipid 
biosynthetic processes 
ALOX12B, BBOX1, CYP1A1, DHRS2, 
DIO2, DPYD, LOXL2, MOXD1, PTGS1, 
ST3GAL5 
REACTOME  
 Arachidonic acid pathways CYP1A1, ALOX12B, PTGS1 
 TLR cascades FOS, JUN, TLR1 





 MAPK signalling CHP2, FGF1, JUN, FOS 




 Defense response CCK, INHBB, IL1RL1, KYNU, OLR1, 
TAC1, VNN1 
 Immune response IFI6, OLR1, TNFSF18, IL1RL1, KYNU, 
VNN1; latter three genes involved in 
innate immune response 
   Regulation of 
      secretion 
GDNF, INHBB, TAC1, TRPV6 
 Lysosome IFI30, LAMP3, SLC29A3 
REACTOME  
 Regulation of lipid 
metabolism by Peroxisome 
proliferator-activated 
receptor alpha (PPARalpha)/ 
PPARA activates gene 
expression 
PLIN2, ANGPTL4, PPARGC1A 
 Cytokine signaling IL1RL1, TNFSF18, RET,GDNF, IFI6, 
IFI30, IFI27 
 Signaling by Interleukins IL1RL1, RET, GDNF 
 Metabolism of lipids and 
lipoproteins 
PLIN2, ANGPTL4, PPARGC1A, CPNE7, 
PLA2G4D 
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5.2.7 Genes differentially expressed following ICH knockdown: 
258 genes were significantly down-regulated and 200 genes were significantly up-regulated 
(FDR < 0.01).   Several genes were down-regulated involved in metabolism of lipids and 
lipoproteins and vesicle mediated transport most likely through LB.  ICH is known to encode 
a magnesium transporter membrane associated protein hypothetically involved in epidermal 
lipid processing and in lamellar body formation and transport (Goytain et al., 2008). 
Additionally several genes annotated to keratinocyte differentiation, keratin filament 
regulation of cell differentiation/epithelial development were noted suggesting that ICH is 
involved in keratinocyte differentiation. 
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Table 5.6 Dysregulation following knockdown of ICH 
Downregulated Genes: 
DAVID  
 Keratin filament KRT1, KRT10, KRT2, KRT77 
 Regulation of cell 
differentiation 
CNTN1, DLL1, HES7, JAG1, MAML2 
 Regulation of immune 
response 
THY1, CFH, HSPD1P5, IL12A, IL27RA, 
IRAK3, KRT1 
 Epithelial development TBX18, CA2, DHRS9, JAG1, KRT2, 
TXNIP 
 Vesicle mediated transport ABCA3, CSPG5, C12orf39, GAD1, SHH 
REACTOME  
 Metabolism of lipids and 
lipoproteins 
PPARGC1B, FABP5, CYP4B1, UGCG 
 Cytokine signaling IL12A, IFIT1, ACTG1, CNKSR2, IL7R, 
OAS1, BIRC3, OAS2, OAS3, DDX58, 
IFIT2, IFIT3, MX1, IL33, MX2, IFITM1, 
CSF3, PDGFRA, IL27RA, EGR1, FGF1, 
BST2, EBI3, IL20, IRAK3, UBA7, IFI35, 
IL1RL2, XAF1, USP18 
 Innate immune system IRAK3, CNKSR2, FGF1, ACTG1, 
TXNIP, FOS, PDGFRA, TREM2, BIRC3, 
UBA7, CFH, DDX58 




 Cytokine/cytokine receptor 
interaction 
CCL2, CXCL2, CXCL6, CSF3, IL12A, 
IL20, IL7R, PDGFRA 
 Cell cycle pathways CHEK1, E2F2, CDK6, PTTG1, CHEK2 
Upregulated Genes: 
DAVID  
 Vesicle ABCA3, CSPG5, C12orf39, GAD1, SHH 
 Cytoskeleton LDB3, DNAH1, SGCG, KIF5A 




 Signal transduction and 
metabolism 
CCK, VIP, SHC2, INHBB, ADRB1, 
ADCY1, KIF5A, CHRM3, TAS1R3, 




5.2.8 Genes differentially expressed following ABCA12 
knockdown: 
Knockdown of ABCA12 produced fewer gene expression changes compared to loss of the 
other ichthyosis genes with 136 significantly down-regulated and 87 significantly up-
regulated genes (FDR < 0.01).   In this project, RNA-Seq analysis shows several genes 
annotated to lipids, transportation, secretion and endomembrane systems. This is in keeping 
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with the known function of ABCA12 as a keratinocyte transmembrane lipid transporter 
protein associated with the transport of lipids via lamellar granules. Additionally, several 
genes involved in metabolism of lipids and lipoproteins were dysregulated. Malformation of 
the intercellular lipid layers in HI skin has been noted previously (Aufenvenne et al., 2012, 
Dale et al., 1990, Milner et al., 1992, Akiyama et al., 1998). Defective lipid transport due to 
loss of ABCA12 function leads to the accumulation of intracellular lipids, including 
glucosylceramides and gangliosides, in the epidermal keratinocytes. The accumulation of 
gangliosides seems to result in the apoptosis of Abca12−/− keratinocytes (Akiyama, 2014). In 
this study, several genes involved in cell cycle apoptosis were found to be dysregulated 
following ABCA12 knock down in primary keratinocytes.  
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Table 5.7 Dysregulation following knockdown of ABCA12 
Downregulated Genes: 
DAVID  
 Inflammatory response CCL2, CFH, FN1, IL6, KRT1, FOS 
 Endomembrane system VGF, CLSTN2, CHST6, CORO1A, 
DHRS2, HSD17B2, LMNB1, PTGS1 
 Cytoplasmic bound 
vesicle/secretory granules 
RAB3B, VGF, ARC, ANXA2P1, 
CORO1A, FN1 
 Epithelial development GATA6, CA2, LAMA1, TIMELESS 
 Cytoskeleton CHEK1, ARC, CENPJ, CORO1A, 
HOMER1, KRT1, KIF24, KNTC1, 
LMNB1, LZTS1 
 Cell cycle CHEK1, DBF4B, E2F2, CDT1, 
KNTC1, LZTS1, TIMELESS 
 Apoptosis E2F2, GATA6, XAF1, IER3, IFI6, 
IFNB1, IL6, STAT1, TNFRSF11B, 
TNFRSF18 
REACTOME  
 Cytokine signaling interaction IFIT1, IFNB1, IL7R, OAS1, OAS2, 
STAT1, OAS3, DDX58, IL6, IFIT2, 
TNFRSF18, IFIT3, FN1, PRLR, MX1, 
MX2, SAMHD1, RSAD2, CD70, 
EGR1, OASL, BST2, TNFRSF11B, 
IFI6, ISG15, IFI35, XAF1, USP18 
 Fatty acids CYP4F22 
 Arachidonic acid metabolism CYP4F22, PTGS1 
 Metabolism of lipids and 
lipoproteins and cell cycle 
CYP4F22, PTGS1 
 Interleukin-6 signaling STAT1, IL6 
KEGG  
 Cytokine-cytokine receptor 
interaction 
CD70, CCL2, IFNB1, IL6, IL7R, PRLR, 
STST1, FOS, TNFRSF11B, TNFRSF18 
 TLR signaling pathway STST1, IL6, INFB1, FOS 
Upregulated Genes: 
DAVID  
 Plasma membrane and 
secretion 
C1QTNF4, EGFL6, COL21A1, CRB1, 
IL34, OLR1, PAMR1, TNXB, VIP, 
WNT1 
 Extracellular region ENDOU, C1QTNF4, EGFL6, 
COL21A1, CRB1, IFI30, IL34, OLR1, 
PAMR1, TNXB, VIP, WNT1 
 Transcription and apoptosis NKX3-2, ARHGEF6, ADCY1, NME5, 
OLR1, PREX1, PTGER3, RP1L1, 
TNFRSF10D 
REACTOME  
 Metabolism of lipids and 
lipoproteins 
PLA2G4D, PIK3R3, AKR1C2 
 Arachidonic acid metabolism AKR1C2 
 Transmembrane transport of 
small molecules 
HEPH, ADCY1, SLC24A3 
KEGG  





Figure 5.13 Network generated from differentially expressed genes involved in cytokine-cytokine receptor 
interaction following ABCA12 knockdown.  
KEGG® pathway showing network generated from differentially expressed genes involved in cytokine-cytokine 
receptor interaction following ABCA12 knockdown.*shows differentially expressed genes. 
 
5.3 Discussion 
RNA-Seq is a powerful method to analyse the transcriptome of cells of interest. In this project 
RNA-Seq analysis was employed to investigate differentially expressed genes following 
ichthyosis gene knockdown (STS, FLG, TGM1, ICH, ALOX12B, ABCA12). The lists of 
differentially expressed genes generated following ichthyosis gene knockdown underwent 
gene enrichment and pathway analysis using DAVID and REACTOME.  
 
In this project, analysis of common genes differentially expressed following knockdown of 
the ichthyosis genes was undertaken to identify any common genes or pathways to provide 
more insight into the biology of this group of diseases with similar phenotypes. Furthermore, 
individual ichthyosis knockdowns were analysed separately. 
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5.3.1 Common Ichthyoses (STS and FLG) 
5.3.1.1 Loss of STS expression causes neurological abnormalities in X-
linked Ichthyosis 
Several genes associated with neuronal processes and steroid metabolic processes were 
altered following STS knock-down in primary keratinocytes. It is known that XLI patients 
demonstrate cognitive behavioral abnormalities, such as attention-deficit disorder and social 
communication deficits (Trent et al., 2012, Kent et al., 2008). In addition, inactivation of 
SSase increases aggressive behavior in rodents (Nicolas et al., 2001). These abnormalities 
have been attributed to altered sterol metabolism in the central nervous system (Kent et al., 
2008, Bicikova et al., 2013).  
 
5.3.1.2 STS expression is important in lipid metabolism and cholesterol 
synthesis 
Several dysregulated genes annotated to lipid metabolism were noted. SSase is secreted into 
the intercellular spaces of the SC, along with other lamellar granule-derived lipid hydrolases 
(Elias et al., 2004) where steroid sulfatase catalyzes the desulfation of cholesterol sulfate  
generating cholesterol for the barrier. Several genes altered here are related to ceramides and 
are possibly secondary defects following cholesterol synthesis disruption. 
 
5.3.1.3 Role of AP1 transcription factors in epidermal/keratinocyte 
differentiation following STS suppression 
 It is known that AP1 (JUN/FOS) transcription factors (C-JUN, JUNB, JUND, C-FOS, FOSB, 
FRA-1, AND FRA-2) are key regulators in epidermal differentiation (Eckert et al., 2013). 
RNA-Seq analysis following STS knock-down showed significant dysregulation of genes 
involved in differentiation. As noted in section 1.4.2.6 cholesterol sulfate is thought to be 
operate through an AP-1 binding site in the promoter region of several proteins involved in 
cornified envelope formation thereby regulating their transcription. In this study, both FOS 
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and JUNB were downregulated. Several epithelial abnormalities have been noted following 
perturbations of members of the AP1 transcription family; mice lacking JUNB in 
keratinocytes display pronounced epidermal hyperproliferation, disturbed differentiation and 
delayed wound healing (Florin et al., 2006). In addition, simultaneous deletion of C-JUN and 
JunB in the epidermis produces a psoriasis-like phenotype (Schonthaler et al., 2009).   
 
5.3.1.4 Extracutaneous features/syndromic features following loss of STS 
expression: 
XLI recessive may be non-syndromic (phenotype limited to the skin) or syndromic when 
accompanied by extracutaneous features (Oji et al., 2010).  
	
	
5.3.1.4.1 Prolonged labor in XLI 
Failure of labor either to initiate or to progress due to placental sulfatase deficiency has been 
noted to occur in pregnancies of XLI fetuses.  Following RNA Seq analysis suppression of 
several genes associated with female pregnancy was noted (Bradshaw and Carr, 1986).   
 
5.3.1.5 Role of NOTCH signaling in Epidermal Differentiation following 
loss of FLG expression: 
In this dataset, several genes involved in keratinocyte differentiation, epidermis development, 
intermediate filament were enriched following loss of FLG expression. As discussed in 
chapter 1, filaggrin is thought to aggregate the keratin cytoskeleton, facilitating the collapse 
and flattening of cells in the outermost SC to produce flattened anuclear squames (Manabe et 
al., 1991).  Furthermore, the top signaling pathway implicated in this study for the FLG 
knockdown was the NOTCH signaling pathway. NOTCH signaling is essential for 
keratinocyte differentiation. NOTCH1 is expressed in all epidermal layers, NOTCH2 in the 
basal cell layer and Notch3 in basal cell and spinous cell layers in normal epidermis.  NOTCH 
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signaling functions as a molecular switch that controls the transition of cells between skin 
layers during the epidermal differentiation process (Lin et al., 2012). In addition, previous 
studies have shown involvement of NOTCH signaling in keratinocyte differentiation in 
embryos of mice and rats (Baker et al., 2006, Takahashi et al., 1996) and NOTCH molecules 
are thought to cause aberrant expression of K10 and K14 leading to anomalous differentiation 
of the epidermis in psoriatic lesions (Ota 2014).  In this study IF of 3D FLG knockdown 
organotypic model showed reduced expression of K10 in the knockdown and no change in 
expression of K14 in siFLG and siC (section 4.2.4.1).   
 
5.3.1.6 FLG loss causes abnormalities in ABC transport system  
Several genes related to vesicle-mediated transport were enriched. Abnormalities in lamellar 
body loading and secretion in FLG-deficient IV suggest that FLG deficiency produces a 
cytoskeletal defect sufficient to impair organelle secretion (Man et al., 2008). Thus the 
immune dysfunction noted may be due to abnormalities in the ABC transport system that 
delivers antimicrobial peptides through secretion of LB contents (Braff et al., 2005, Oren et 
al., 2003, Aberg et al., 2008).  
 
5.3.2 Autosomal Recessive Congenital Ichthyosis (TGM1, 
ALOX12B, ICH, ABCA12)  
5.3.2.1 Role of Peroxisome proliferator-activated receptor (PPAR)-alpha in 
ARCI 
 
Peroxisome proliferator-activated receptor (PPAR)-alpha is a fatty acid activated transcription 
factors that belongs to the nuclear hormone receptor family. There are three PPAR isotypes 
(alpha, beta/delta, gamma) with variable ligand specificity and metabolic functions. All three 
PPAR isotypes are expressed in human skin (Westergaard et al., 2001). PPAR-alpha is 
preferentially expressed in the suprabasal epidermis (Icre et al., 2006, Rivier et al., 1998).  It 
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is known that epidermal differentiation and SC formation are stimulated by activation of 
PPAR-alpha (Hanley et al., 1997, Man et al., 2006, Rivier et al., 2000, Batheja et al., 2009). 
There is a strong link between epidermal lipid metabolism and skin barrier function as 
permeability barrier function is largely determined by extracellular lipids in the SC. PPAR-
alpha ligands induce lipid synthesis (Batheja et al., 2009, Rivier et al., 2000)  as well as 
lamellar body formation, secretion and lipid processing, correlating with accelerated skin 
barrier repair (Man et al., 2006). Chakravarthy et al. identified the oxidised phospholipid, 1-
palmitoyl-2-oleoly- sn-glycerol-3-phosphocholine (16:0/18:1-GPC) as a specific PPAR-alpha 
ligand in the liver (Chakravarthy et al., 2009). It is speculated that epidermal lipoxygenases, 
including ALOX12B, generate oxidized phospholipids in cutaneous tissue (Munoz-Garcia et 
al., 2014) and may be endogenous PPAR-alpha agonists in the skin. Both PPAR-alpha and 
ALOXE3, have been found to be downregulated in vitro following barrier disruption.   
 
In addition to their role in barrier formation PPARs play a role in inflammation and PPAR-
alpha expression has been found to be reduced in AD (Plager et al., 2007). It was suggested 
that downregulation of PPAR-alpha could be involved in AD development or maintenance by 
affecting the lipid pathway (Plager et al., 2007). The underlying mechanism is thought to 
involve nuclear factor kappaB signaling (NF-κB)  (Daynes and Jones, 2002, Staumont-Salle 
et al., 2008). Lipoxygenases are thought to play a role in inflammation (Krieg and 
Furstenberger, 2014); however the specific role of ALOX12B in immune 
responses/inflammation is not known. 
 
In this study, RNA-Seq data supports the hypothesis that ALOX12B may be a ligand for 
PPAR-alpha and the changes caused by ALOX12B in epidermal differentiation, barrier 
formation and inflammation may be mediated by PPAR-alpha.  
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RNA-Seq data analysis also showed dysregulation of genes involved in lipid metabolism 
regulated by PPAR-alpha following TGM1 knockdown. PPAR-alpha is an established 
transcriptional regulator of transglutaminase (Hanley et al., 1998). Alterations in lipid 
synthesis and desaturation of fatty acids and acute response inflammatory pathways involving 
the up-regulation of IL1A and NFkappaB/retinoic acid signaling have been reported in an in 
vitro TGM1 knockdown rat model (O'Shaughnessy et al., 2010). Additionally IL1A up-
regulation from patient skin scrapings with LI were reported at the protein level. Normally, in 
response to barrier disruption, trauma and in normal keratinocyte homeostasis, the expression 
of IL1A and IL1RA are tightly controlled and linked (Wood et al., 1994) and NFkappaB 
activation is the downstream effect of IL1A up-regulation. It is known that the PPAR 
transcription factors (Michalik and Wahli, 2007), stimulate synthesis of IL1RA, a direct 
transcriptional target in response to IL-1 increase (Chong et al., 2009).  
 
It has been reported that ABCA12 expression is upregulated by ceramides via PPAR delta-
mediated signaling pathway (Jiang et al., 2009, Feingold and Jiang, 2011) although 
PPARbeta/delta, PPAR-gamma and LXR activators all stimulate ABCA12 expression in 
human keratinocytes in a dose- and time-dependent manner (Jiang et al., 2008). In this 
dataset, no significant changes in ABCA12 and nuclear hormone receptors were noted. This 
could be because the effects of ligand activation on keratinocyte proliferation and 
differentiation may differ between monolayer cultures, 3D equivalents and the in vivo setting. 
 
5.3.2.2 Dysregulation in cornified envelope formation following TGM1 
knockdown 
In this study, several genes related to CE and peptide cross-linking as well as calcium ion 
binding site / calcium ion homeostasis were suppressed. TGM1 participates in the formation 
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of the cornified envelope by catalyzing calcium-dependent cross-linking of several proteins 
such as involucrin, loricrin, and proline-rich proteins (Kalinin et al., 2002) (Robinson et al., 
1997). The CE is missing when TGM1 activity is reduced or nonexistent (Akiyama et al., 
2003, Rice et al., 2005).  In keeping with this and also with a proteomic study of a TGM1 
deficient skin-humanized mouse model downregulation of FLG and dysregulation in LOR 
was noted. Surprisingly no change in involucrin was observed, confirming the findings of the 
proteomics study (Aufenvenne et al., 2012).  
  
5.3.2.3 TGM1 suppression may alter lipid metabolism  
Several genes involved in lipid synthesis and metabolism including lipids and lipoproteins, 
linoleic acid metabolism, fatty acid CoA synthesis and arachidonic acid metabolism, were 
dysregulated following TGM1 knockdown in primary keratinocytes. TGM1 is responsible for 
ceramide (thought to be generated by lipoxygenases) coupling to corneocyte proteins. 
Although the mechanisms are not well understood, all mutations that cause ARCI (except for 
transglutaminase) are thought to affect some of the above lipid pathways resulting in 
metabolite deficiency and substrate accumulation. The changes noted in this dataset may be 
alluding to secondary (compensatory) defects secondary to barrier disruption caused by loss 
of TGM1.  The fact that inactivating mutations in all the ARCI genes produce related skin 
phenotypes supports the idea that they may have common pathomechanisms. Thus, an 
alternative explanation may be that LOX  (by metabolising linoleate) via a novel-signaling 
pathway may be upregulating/downregulating transglutaminase thus forming an efficient self-
regulating system (Munoz-Garcia et al., 2014). 
 
5.3.2.4 ALOX12B affects secretion of LG contents: 
Several genes annotated to glycosyltransferase (ST3GAL5, ST3GAL6, GLT8D2, QPRT) and 
vesicle-mediated transport (ARC, MEGF10, SORL1) were suppressed. From the study of 
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ALOX12B mutant mouse skin transplants, it was suggested that 12R-LOX deficiency might 
affect the processing of LGs (de Juanes et al., 2009). Other studies have reported lipid 
droplets in the cornified cell layers (Harting et al., 2008, Akiyama et al., 2010), and partially 
disturbed LG content secretion into the intercellular space in the epidermis of a patient with 
CIE with ALOX12B mutations suggesting that partially disturbed secretion of LG contents is 
involved in the pathogenesis (Akiyama et al., 2010). This study supports the possibility of 
ALOX12B causing these changes either through an independent signaling pathway or in the 
same signaling pathway as ABCA12 (which is located in LG associated with 
glycosylceramides) (Sakai et al., 2007).  
 
5.3.2.4 Role of TLR signaling pathway in epidermal development by 
altering ABCA12 expression 
RNA-Seq analysis found several genes related to epidermal development and cytoskeleton 
were altered. It has been suggested that ABCA12 deficiency leads to differentiation defects in 
keratinocytes (Akiyama, 2014). The mechanism by which these abnormalities occur is 
unknown; Non-coding double-strand RNA (dsRNA) has been reported to induce TLR3-
dependent increased expression of ABCA12 in human keratinocytes, resulting in increased 
epidermal lipid and lamellar bodies (Borkowski et al., 2013). Additionally, noncoding dsRNA 
can stimulate some events in keratinocyte differentiation that are important for skin barrier 
repair and maintenance via ABCA12 upregulation (Borkowski et al., 2013). In this dataset 
TLR signaling pathway was downregulated and several genes involved in defense response 
were identified possibly explaining the aberrant keratinocyte differentiation.  
In summary, RNA-Seq analysis of keratinocytes with loss of ichthyosis genes has been 
successfully employed as a technique to analyze gene expression changes in these cells. 
Knockdown of FLG caused the highest number of dysregulated genes. Gene clusters were 
found for cell cycle, keratin filament/cytoskeleton, apoptosis, humoral immune response, and 
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metabolism of lipids and lipoproteins common to all knockdowns. In addition, several genes 
involved in TLR signaling pathway and cytokine signaling were impaired (tables 5.2-5.7). 
TLRs, in addition to their role in innate immunity, have been reported to play a role in the 
epithelial barrier (Kuo et al., 2013a, Borkowski et al., 2015, Lin et al., 2011). On further 
analysis (sections 6.2.8 and 6.2.9) TLR2 and TLR3 were downregulated in all the ichthyoses 
and TLR5 was downregulated in both FLG and ICH.  Also, changes were predicted in the 
pro-inflammatory cytokines IL6 and IL8. Thus, the RNA-Seq data was validated at protein 
level (chapter 7) by assessing cytokine profile secretion in unstimulated or stimulated primary 
keratinocytes (following stimulation of TLR2, 3, 5).  
 
5.4 Future work 
RNA-Seq can only provide information at the level of the transcript, therefore it is important 
to confirm gene expression changes at the protein level. This can be achieved by proteomic 
analysis for each ichthyosis gene knockdown. Innate immune systems were further 
investigated in this study (common to all the knockdowns). In the future it will be important 
to investigate other biological functions identified in this study in order to ensure that new 
insights are not neglected.  It might be possible to integrate the RNA-Seq data with proteomic 
data, as altered RNA transcript expression does not always translate into changes at the 






























A heatmap can graphically visualize the matrix data by representing individual values with 
different colours. For visualization, a heat map compacts large amounts of information into a 
small space to bring out coherent patterns in the data (Weinstein, 2008). This can is useful as 
it allows selection of regions of interest for further study. 
 
Coherent patterns (patches) of colour can be generated by hierarchical clustering on both 
horizontal (and vertical axes) to bring like together with like (Weinstein, 2008). Cluster 
relationships are indicated by tree-like structures adjacent to the heat map, and the patches of 
colour may indicate functional relationships among genes and samples (Weinstein, 2008). The 
heat map is one of the most widely used graphs in the biological sciences (Weinstein, 2008).  
 
Recent progress in high-throughput techniques, such as next generation sequencing (NGS) 
has increased the demand for the visualization of data (Deng et al., 2014) to aid in the 
recognition of meaningful association patterns involving complex relations between genetics 
and biological features (Haarman et al., 2015). 
 
In this project, heat maps were generated using the ggplot package in Bioconductor 
(Gentleman et al., 2004, Huber et al., 2015, Wickham, 2009) in collaboration with the Enright 
group at European Bioinformatics Institute, Hinxton (http://www.ebi.ac.uk/research/enright).  
The level of expression of known genes, obtained from NGS, associated with different 
biological processes (identified by literature review by myself ) were represented. Triplicate 
samples for each knockdown and non-targeting control, C, were analysed. Heatmaps are 
plotted using the normalized gene expression data i.e. mean centralized using all 27 samples.  
Each heat map was drawn using this data. Mean centralization was done to visualize deviation 
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of gene expression in a specific sample from the genes’ average across all samples. Thus, 
genes, which are unchanged, were displayed as white. Up-regulated genes were displayed as 
red. Down-regulated genes were displayed as blue. The variability colour pertaining to each in 
vitro model (sample) was indicative of how much a gene was expressed in that particular 
sample. A histogram for each heat map shows fold change on the x-axis (value) and gene 
counts on the y-axis (count).    
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6.2 Results 
6.2.1 Impact of knock-down on other Ichthyosis genes in this 
study 
Heat maps were made to evaluate the impact of knock-down on other ichthyosis genes.  
 
Figure 6.1: Heatmap showing gene expression of STS, FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 
following STS, FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
Reduced expression of the individual genes (blue) following knockdown, compared to C, is seen in STS, FLG, 
TGM1, ALOX12B, ICHTHYIN, and ABCA12 respectively. Upregulation (red) and downregulation (blue) of other 
genes is noted following knockdown. 
 
In each ichthyosis studied there is downregulation compared to control. In the STS 
knockdown there was downregulation of FLG but this was not significant.  FLG knock-down 
showed no changes in STS expression but there was downregulation of ALOX12B (log2FC -
1.26, pval<0.01), TGM1 (log2FC -1.01, pval<0.01) and ICH. In ALOX12B knockdown there 



































































significant downregulation of STS, FLG and ALOX12B was noted in TGM1 knockdown. No 
interactions were noted in the ICH and ABCA12 knockdown models. These findings suggest 
that there are some interactions between the ichthyosis genes.  
 
6.2.2 Interactions between known genes causing ARCI (LI/CIE) 
phenotype 
Several genes (other than those studied in this project) have been implicated in the 
pathogenesis of ARCI (section 1.5.2). Interactions between the ichthyosis knockdowns and 
these genes were evaluated. 
Figure 6.2: Heatmap showing impact of ichthyosis gene knockdown on expression of other known genes 
causing ARCI. 
 
STS silencing lead to downregulation of LIPN (log2FC -1.22, pval<0.01) and CYP4F22 
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(log2FC -2.06, pval<0.01). Several genes were significantly downregulated in FLG 
knockdown including ALOXE3 (log2FC -1.04, pval<0.01), PNPLA1 (log2FC -1.22, 
pval<0.01) and CYP4F22 (log2FC -1.26, pval<0.01). CYP4F22 expression was reduced in 
ABCA12 knockdown (log2FC -1.51, pval<0.01). Thus, interactions were seen between CI and 
ARCI genes and between two ARCI genes-ABCA12 and CYP4F22. 
 
6.2.3 Dysregulation of Epidermal Differentiation Complex (EDC) 
Many proteins essential for epidermal differentiation are encoded by genes clustered on 
human chromosomal region 1q21 (Mischke et al., 1996). The genes constitute the EDC. It is 
known that mutations in the EDC genes are the strongest risk factors for atopic dermatitis 
(FLG genes) and faulty formation of the CE (TGM1 deficiency) causes lamellar ichthyosis 
(Kypriotou et al., 2012). Heat maps were generated to evaluate changes in the EDC genes in 
the ichthyosis knock-downs. 
 
The clustered organization of the EDC genes suggests duplication of ancestors adapting to 
changes in terrestrial conditions during evolution (Backendorf and Hohl, 1992). The EDC is 
divided on the basis of common gene and protein structures, into three clustered gene families 
(Kypriotou et al., 2012):  
(i)   S100A calcium-binding proteins;  
(ii)  Cornified Envelope (CE) precursors-a group of precursor proteins of the CE including 
involucrin, loricrin, the SPRRs and the ‘late cornified envelope’ (LCE) proteins 
(previously LEP, XP5 and SPRRL), and 
(iii) S100 fused genes. The ‘fused gene’ proteins (SFTPs ‘S100 Fused Type Proteins’) FLG, 
filaggrin-2 (FLG2), trichohyalin (TCHH), trichohyalin-like protein (TCHHL1), hornerin 




Figure 6.3: Heatmap showing expression of the Epidermal Differentiation Complex genes following STS, 
FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown.  
 
UCSC Genome Bioinformatics (http://genome.ucsc.edu) was used to generate a list of genes 
listed on human chromosomal region 1q21. Several genes are significantly downregulated in 
the common ichthyoses: In FLG knockdown a subset of S100 genes [(S100A2 (log2FC -1.03, 
pval<0.01), S100A4 (log2FC -1.32, pval<0.01), S100A7 (log2FC -2.28, pval<0.01), S100A8 
(log2FC -1.20, pval<0.01), RPTN (log2FC -2.81, pval<0.01), FLG2 (log2FC -3.17, 
pval<0.01) and LOR (log2FC -2.50, pval<0.01)). There is significant downregulation in 
several other EDC genes in STS knockdown [S100P (log2FC -1.16, pval<0.01), RPTN 
(log2FC -1.69, pval<0.01) and FLG2 (log2FC -2.32, pval<0.01)]. A number of EDC genes 
were also significantly dysregulated in the ARCI; downregulation in TGM1 [(S100A7 
(log2FC -1.29, pval<0.01), FLG2 (log2FC -1.55, pval<0.01)) and ICH [(FLG2 (log2FC -2.18, 
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pval<0.01)) and upregulation in ALOX12B [(HRNR (log2FC -1.09, pval<0.01)) knockdowns. 
Thus, there appears to be significant dysregulation in EDC mRNA expression in the CI and 
ARCI. Interestingly, there was down regulation of all the EDC genes following FLG 
knockdown. 
 
6.2.3.1 Regulation of EDC 
The expression of genes of the EDC is regulated by a pool of transcription factors: Krüppel-
like factor 4 (KLF4), grainyhead-like 3 (GRHL3), and aryl hydrocarbon receptor nuclear 
translocator (ARNT) (Kypriotou et al., 2012). The relationship between the EDC regulatory 
genes and the knockdowns was evaluated. 
 
Figure 6.4: Heatmap showing impact of STS, FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 
knockdown on genes involved in regulating the EDC. 
 
ICH silencing causes significant upregulation of ARNT (log2FC 1.11, pval<0.01). Changes 
were noted in the common ichthyosis genes and ALOX12B knockdowns (non significant); in 

































































regulated. In the FLG knockdown there was downregulation of GRHL3 and ARNT. In 
ALOX12B knockdown KLF4 expression was up-regulated but ARNT was down-regulated.  
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6.2.4 1q21 GENES (not EDC) 















































































Figure 6.5: Heatmap showing gene expression of genes on 1q21 (not included in EDC) following STS, 
FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
 
In STS and FLG knockdowns there was downregulation of TXNIP (log2FC -1.69, pval<0.01 
and log2FC -1.94, pval<0.01 respectively). Other downregulated genes noted in FLG 
knockdowns were PGLYRP3 (log2FC -1.34, pval<0.01), PGLYRP4 (log2FC -1.29, 
pval<0.01), C1orf68 (log2FC -3.69, pval<0.01). ALOX12B silencing lead to C1orf68 (log2FC 
-2.84, pval<0.01) downregulation. This suggests that several genes on chromosome 1q21 
outside the EDC are dysregulated in the CI and ALOX12B knockdown; Almost all the non-
EDC genes on 1q21 were downregulated following FLG knockdown.  
 
6.2.5 Cytokeratin downregulation common to all the ichthyoses  
Changes in keratins have been reported in the ichthyosis [(Toivola et al., 2015, Chamcheu et 













































































2010) and KRT1 downregulation is known in HI (Grone, 2002) and in several other non-
syndromic ichthyosis (Table 1).  
 
Keratins are structural proteins found in all epithelial cells to which they confer stability when 
under mechanical stress. Keratins are grouped into two classes, the acidic type I (K9-K20) 
and the neutral-basic type II (K1-K8) which are expressed in pairs in a tissue and 
differentiation-specific manner (Smith et al., 2003). Keratin 5 (KRT5) and KRT14 are both 
expressed in the basal layers of the epidermis, but are down-regulated and replaced by the 
expression of KRT1 (KRT2 in upper spinous and granular layer; KRT9 in palmoplantar) and 
KRT10 in suprabasal keratinocytes (Schnare et al., 2001). Keratin 15 (KRT15), is a type I 
keratin without a defined type II partner. KRT15 has been shown to be a basal epidermal stem 




Figure 6.6: Heatmap showing gene expression of cytokeratin genes following STS, FLG, TGM1, ALOX12B, 
ICHTHYIN, and ABCA12 knockdown. 
 
KRT1 was significantly downregulated in all the ichthyoses. Its pairing partner KRT10 was 
also downregulated in all the ichthyoses but this was significant in ICH, TGM1, FLG 
[(log2FC -1.39, pval<0.01), (log2FC -1.007, pval<0.01) and (log2FC -1.67, pval<0.01) 
respectively]. The other pairing partner, KRT2 is downregulated in all knockdowns but this 
was significant in STS, FLG and ICH [STS (log2FC -1.23, pval<0.05), FLG (log2FC -1.37, 
pval<0.05) and ICH (log2FC -1.31, pval<0.01)] other than in ABCA12. Basal keratins KRT5 
and 14 were downregulated in all the ichthyoses but KRT14 expression suppression was 

















































































downregulated in all the ichthyoses but was most pronounced in FLG and ABCA12 
knockdowns. Upregulation of K1 has been reported in LI (O'Shaughnessy et al., 2010) and 
KRT1 downregulation is known in HI (Grone, 2002). Thus, K1 downregulation underlies all 
the ichthyosis in this study at transcriptome level and this is significant. 
 
6.2.6 Desmosomal Dysregulation  
Ichthyin has been found to localise to desmoplakin throughout the viable epidermis 
(Dahlqvist et al., 2012). Netherton syndrome (OMIM #256500) characterized by congenital 
ichthyosiform erythroderma, an atopic diathesis, and a characteristic hair-shaft abnormality 
known as trichorrhexis invaginata is caused by serine protease inhibitor lympho-epithelial 
Kazal-type-related inhibitor LEKTI (encoded by SPINK5) (Sarri et al., 2016) and it is thought 
that there is premature cleavage of desmosomal proteins (including desmocollin1 (DSC1), 
desmoglein 1 (DSG1) and corneodesmosin) (Yang et al., 2004, Descargues et al., 2005, 
Descargues et al., 2006). Changes in desmosomal genes were evaluated in the ichthyosis 
knockdowns. 
 
Desmosomes are “mechanical” junctions, involved primarily in cell cohesion (Yamamoto et 
al., 2003a) required for the integrity of epidermis. Desmosomal proteins interact with keratins, 
1(2)/10 in the suprabasal layers of the epidermis and provide cytoskeletal structure (Fox et al., 
2008). Additionally, they contribute to the correct formation and maintenance of the stratum 
corneum barrier.  
 
The structural components of the desmosomes involve three protein families: Desmosomal 
cadherins (desmogleins DSGs and desmocollins DSCs), armadillo proteins (desmoplakin DSP 
and plakoglobin JUP), and the plakophilin family (PKP 1 to PKP 3) (Takeuchi et al., 2000).  
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Desmosomal cadherins located on adjacent cells mediate intercellular connection via 
interactions of their extracellular domains. The intracellular ends of desmosomal cadherins 
are inserted in the molecular network of adaptor proteins, DSP, JUP, PKP 1-3, to which 
keratin filaments bind.  
 
DSG1-4 and DSC1-3 are expressed in the epidermis. According to the level of keratinocyte 
differentiation, DSG2 and 3 from the lower epidermal compartment are progressively 
substituted by DSG1 and 4 in the upper viable epidermal layers. In the same way DSC3 is 
replaced by DSC1. PKP1, 3 are expressed throughout the viable epidermis but expression is 
most prominent in the SG (Takeuchi et al., 2000). PKP2 expression is found in the SB only 
(Yamamoto et al., 2003a).   
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Figure 6.7: Heatmap showing changes in desmosomal genes following STS, FLG, TGM1, ALOX12B, 
ICHTHYIN, and ABCA12 knockdown.   
 
Dysregulation (downregulation predominantly) of several desmosomal genes in the common 
ichthyosis knockdowns was noted throughout the viable epidermis: in STS knock-down there 
was upregulation of desmosomal cadherins DSG1, DSG2, DSC2, DSC3 and downregulation 
of DSG4 expression.  Additionally, PKP2, PKP3 and DSP were upregulated.  In the FLG 
knock-down downregulation of DSC1 (log2FC -1), DSC2 (log2FC -1.04), DSC3 and DSG1, 
DSP, PKP1, PKP3 was seen. In ICH knock-down the SG desmosomal cadherins were altered; 
DSG1, DSC1 were downregulated but DSG4 was upregulated. PKP2 was upregulated in 













































































6.2.7 Antimicrobial peptides (AMP) 
Ichthyosis can be complicated by secondary infection (Grahovac et al., 2009, Fleckman et  al., 
2003). AMP are one of the primary mechanisms used by the skin in the early stages of 
immune defense to prevent infection from bacteria, viruses and fungi. The production of AMP 
such as the S100 proteins, psoriasin (S100A7) (Akiyama, 2010) and calprotectin (S100A8/A9 
complex) (Umemoto et al., 2011) as well as RNase 7 (Harder and Schroder, 2002) occurs 
constitutively in the epidermis. Upon recognising the microbe e.g. by TLRs, keratinocytes 
initiate a defense response by further inducing already present AMP and increasing 
expression of inducible AMPs such as human beta-defensins DEFB4A, DEFB103A, 
DEFB103B and the cathelicidin CAMP (LL-37) (de Koning et al., 2012). The impact of the 




Figure 6.8: Heatmap of changes in gene expression of antimicrobial peptide genes following STS, FLG, 
TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
 
In our dataset, several beta-defensin genes were down regulated. DEFB4A (log2FC -1.06, 
pval<0.01) and DEFB4B (log2FC -1.17, pval<0.05) in TGM1 knockdown. DEFB4A in STS 
knockdown (log2FC -1.01, pval<0.01) and DEFB103B (log2FC -1.907, pval<0.05) in 
ALOX12B knockdown. Upregulation of DEFB1, DEFB4A and DEFB103B was seen in ICH 
and ABCA12 knockdowns but this was not significant. The constitutive AMP, S100A7 
(log2FC -2.28, pval<0.01) and the S100A8/A9 complex (log2FC -1.2, pval<0.01 / log2FC -
1.07, pval<0.01) were downregulated in FLG. S100A7 (log2FC -1.29, pval<0.01) is 
downregulated in TGM1 (EDC heatmap, Fig. 6.5).  
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6.2.8 Toll-like Receptors (TLR) 
Human Toll-like receptors (TLRs, numbered 1–10) are found on a variety of different cell 
types and can recognise various components of microorganisms, subsequently initiating 
signaling pathways important in the generation of cytokines, chemokines, antimicrobial 
peptides, and upregulation of adhesion and costimulatory molecules involved in innate and 
acquired immune responses (Jones et al., 2004). In addition to their antimicrobial effects the 
function of TLRs has recently extended to include epithelial barrier regulation (Kuo et al., 
2013a).  Keratinocytes are reported to express TLRs 1,2,3,5,9 and 10 (Hari et al., 2010); the 
evidence supporting TLR4 expression is conflicting (Hari et al., 2010). In addition, TLRs on 
keratinocytes are functional and respond to their respective ligands to produce cytokines 
implying that keratinocytes can initiate immune responses via activation of TLRs (Chong et 
al., 2004, Yamamoto et al., 2003b); thus TLR2 heterodimererises with TLR1 and recognises 
bacteria-derived lipoproteins, TLR3 recognizes viral double-stranded RNA, TLR4 recognizes 










Figure 6.9: Heatmap of gene expression of toll-like receptors following STS, FLG, TGM1, ALOX12B, 
ICHTHYIN, and ABCA12 knockdown. 
 
 
In our dataset there is downregulation of TLR2 and TLR3 in all the ichthyoses but this is most 
marked in FLG for TLR2 (log2FC -1.412, pval<0.01) and ICH for TLR3 (not significant). 
TLR1 and TLR5 are downregulated in both FLG and ICH.   
 
6.2.9 Cytokines 
Cytokine production influences keratinocyte proliferation and differentiation processes and 
may have pleiotropic effects on the immune system (Nedoszytko et  al., 2014). Cytokines are 
produced by keratinocytes, either constitutively or upon exposure to viral or bacterial stimuli 







































































barrier disruption and may play a role in restoring the cutaneous permeability barrier (Wood 
et  al., 1992) by influencing keratinocyte proliferation and differentiation, atleast in part by 
modulating the gene expression in these cells (Hanel et al., 2013). The impact of the 
ichthyosis knockdowns on cytokines was analysed. 
 
 
Figure 6.10: Heatmap of impact of STS, FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown on 
expression of cytokine genes. 
 
 
In this study, IL12A was downregulated in FLG (log2FC -1.39, pval<0.01) and in ICH 
(log2FC -1.46, pval<0.01). Other trends noted were that the pro-inflammatory cytokine IL6 




































































down-regulated (log2FC -1.25, pval<0.01). The pro-inflammatory cytokine IL8 was 
upregulated in all knock-downs compared to control except in STS where it was down-
regulated.  
 
6.2.10 Kallikreins (KLKs) 
Desquamation (detachment of the superficial corneocytes) requires proteolytic degradation of 
corneodesmosomes which form connections between corneodesmosomes and is mediated by 
a cocktail of proteases including serine proteases. Tissue KLKs are the largest family of 
human secreted serine proteases encoded by 15 genes (Paliouras and Diamandis, 2006). 
Several kallikreins are expressed in the upper stratum granulosum (SG) and stratum corneum 
(SC) of the epidermis, including KLKs 1,3,5-11, 14,15 (Shaw and Diamandis, 2007). 
Kallikrein proteolytic activity in the skin is mostly attributed to the trypsin-like proteases 
KLK5 and KLK14 and the chymotrypsin-like protease KLK7. In XLI desquamation is 
thought to be retarded by KLK5 and KLK7 (section 1.4.2.5) and reduction in KLK5 in HI 






Figure 6.11: Heatmap of gene expression changes in kallikreins after STS, FLG, TGM1, ALOX12B, 
ICHTHYIN, and ABCA12 knockdown. 
 
 
KLK6 was significantly down regulated in the common ichthyoses STS (log2FC -1.61, 
pval<0.01), FLG (log2FC -1.65, pval<0.01) and upregulated in the ARCI. KLK1 was 
significantly downregulated in FLG (log2FC -1.63, pval<0.01) and several ARCI 
knockdowns ALOX12B (log2FC -1.46, pval<0.01); TGM1 (log2FC -1.48, pval<0.01); 
ABCA12 (log2FC -1.86, pval<0.01). KLK 5 and 7 showed upregulation in all the ARCI and 
STS knockdowns and a slight upregulation in KLK14 was seen in ICH and ABCA12 
knockdowns but these changes were not significant.  
 
6.2.11 Lipids 
The permeability barrier resides in the SC which is composed of corneocytes embedded in a 
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matrix of lipid-enriched lamellar sheets. Impairment of the skin permeability barrier leads to 
several cutaneous disorders, including ichthyosis. SC lipids consist free fatty acids (FA), 
ceramides and cholesterol in nearly equimolar ratios (Lampe et al., 1983). The adequate 
balance of these major components is imperative for a proper structure and maintenance of 
SC barrier competence (Janssens et al., 2011). The impact of the ichthyosis knockdowns on 
the known SC lipid genes involved in synthesis, activation (where applicable) and 
transportation were evaluated. 
 
6.2.11.1 FA Transportation/Activation  
Fatty acids (FA) used in the epidermis can be synthesized de novo by keratinocytes or taken 
up from the diet or extracutaneous sites of the body (e.g. linoleic acid and other essential fatty 
acids are unable to be synthesized by keratinocytes) in a process that likely involves protein 
transporters. Several proteins have been proposed to facilitate FA uptake including fatty acid 
translocase (FAT/CD36) (Weinstein, 2008), fatty acid binding protein (FABP) 
(O'Shaughnessy et al., 2010), and members of the fatty acid transport protein/very long-chain 
acyl-CoA synthetase (FATP/ACSVL) family (Cuzick et al., 2013).   
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Figure 6.12: Heatmap showing alteration in expression of genes involved in FA transportation/activation 
after STS, FLG, TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
 
6.2.11.1.1 FAT/CD36  
FAT/CD36 functions as a transmembrane protein that facilitates the translocation of FA 
across the plasma membrane (Maloney et al., 1984). It is not normally expressed in human 
epidermis, but it is detected in skin lesions of patients with ichthyosis vulgaris (IV), psoriasis 
and several other dermatological diseases (Grone, 2002) (Rearick et al., 1987). In this dataset 
there is downregulation of CD36 in the common ichthyoses i.e. STS and FLG (log2FC -1.27, 







































































In contrast to CD36 FABP5 is expressed in the normal epidermis (Epstein et al., 1984).  
FABP5 expression was downregulated in FLG (log2FC -1.07, pval 0.01) and ICH (log2FC -
1.02, pval 0.01).  In contrast its expression is upregulated in psoriasis and eczema (Yanagi et 
al., 2011) (Zuo et al., 2008) possibly highlighting the differences in pathomechanisms of the 
barrier diseases.  
 
6.2.11.1.3 SLC27A /FATP 
The FATP family consists of six integral membrane proteins that are encoded by solute 
carrier family 27 member 1 to 6 genes (SLC27A1 to SLC27A6). SLC27A1, -3, -4, and -6 are 
normally expressed in human epidermis (Akiyama et al., 2005). In addition to FA 
transportation SLC27A/FATP proteins play a central role in activation of fatty acids. 
Activation of FA is a pre-requisite before they can be directed to different metabolic pathways 
(Watkins and Ellis, 2012). 
 
6.2.11.1.3.1 SLC27A4/FATP4 
A recent report of a functional linkage between SLC27A4 and ICH highlighted the possible 
involvement of SLC27A4 in common pathways essential for lipid processing in the epidermis 
(Li et al., 2013). SLC27A4 has also been implicated in a syndromic ARCI, ichthyosis 
prematurity syndrome. It is up-regulated in several ARCI (ICH/ALOX12B/TGM1).  
 
6.2.11.1.3.2 SLC27A Others 
SLC27A1 (or FATP1) is the most closely related protein to SLC27A4.  Thus it may exhibit 
similar substrate specificities. It is downregulated in all knockdowns (albeit slight reduction in 
ICH) and SLC27A6 expression is upregulated in FLG knockdown only.  
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6.2.11.2 Biosynthesis of very long-chain fatty acids (VLC-FA) or ultra long-
chain fatty acids (ULC-FA) 
6.2.11.2.1 Synthesis of FA 
In addition to FA taken up from the diet or extracutaneous sites of the body FA up to 16 
carbons in length can be synthesized de novo by the enzyme complex fatty acid synthase 
(FASN) in keratinocytes (Uchiyama et al., 2000).  
 
 
Figure 6.13: Heatmap of changes in expression of genes involved in synthesis VLC-FA or ULC-FA 









































































6.2.11.2.2 Elongation of FA 
Fatty acids synthesized by FASN or taken up from an extracellular source can be further 
elongated into VLCFA or ULCFA containing 18 or more carbon atoms (Jakobsson et al., 
2006). Each elongation cycle requires four reactions: acyl chain elongation, reduction, 
dehydration and another reduction step. The rate-limiting step is the initiation of elongation 
by a family of seven enzymes, elongation of very long chain fatty acids 1–7, ELOVL1–7 
(Guillou et al., 2010). ELOVLs 1, 3 and 4 have been detected in skin (Jakobsson et al., 2006). 
The ELOVLs exhibit a preference for selected substrates depending on their hydrocarbon 
chain length and degree of unsaturation; ELOVL 1 and ELOVL 4 are crucial to generate 
ULC-FAs with ≥26 carbon atoms; ELOVL 1 accepts activated FA with a chain length of C18 
to C26 (Ohno et al., 2010) and the biosynthesis of FAs longer than 24 carbon atoms depends 
exclusively on ELOVL4 (Guillou et al., 2010) (Jakobsson et al., 2006, Ohno et al., 2010).  
 
There was dysregulation of several ELOVL genes in our dataset. Broadly, there was 
upregulation of several ELOVLs in the knockdowns; ELOVL1 and 7 in all, ELOVL2 in 
ALOX12B and TGM1 knockdowns (log2FC 1.5, pval<0.01; log2FC 1.13, pval<0.05), 
ELOVL3 in STS, ALOX12B and ABCA12 knockdowns (log2FC 1.2, pval<0.05) and ELOVL4 
in all except FLG knockdowns. ELOVL 5, 6 expression was downregulated in ALOX12B 
knockdown but the latter was upregulated in all the other models.   
6.2.11.2.3 Cutaneous FA hydroxylation 
Epidermal fatty acid may be hydroxylated in the α- or ω-position. Hydroxylation in the ω-
position is unique to the epidermis.  
6.2.11.2.4 α-Hydroxylation  
The epidermal enzyme with capacity for α-hydroxylation remains unidentified. Two potential 
candidates are fatty acid 2-hydroxylase (FA2H) and phytanoyl-CoA 2-hydroxylase (PHYH) 
(Rabionet et al., 2014). In this dataset FA2H expression in STS and ABCA12 knockdowns was 
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downregulated. 
6.2.11.2.5 ω-Hydroxylation of FA 
Fatty Acids (and possibly also ceramides containing ULC-FAs) can undergo ω-hydroxylation 
most likely catalyzed by a cytochrome P450 isoform, CYP4F22 (Behne et al., 2000). It is 
known that human mutations in CYP4F22 cause ARCI (Lefevre et al., 2006). CYP4F22 was 
downregulated in the common ichthyoses STS (log2FC -2.067, pval<0.01) and FLG (log2FC -
2.067, pval<0.01) and in ABCA12 (log2FC -1.1516, pval<0.05) knockdown. It was 
upregulated in ALOX12B knockdown.  Thus, perturbations in the CI genes and ABCA12 
(which is not thought to be involved in the 12R-LOX pathway) lend support to the additional 
role of CYP4F22 in ω-hydroxylation in addition to its proposed involvement in the 12R-LOX 
pathway.  
 
6.2.11.3 Ceramide Synthesis 
Ceramides are composed of a FA acid amide linked to a sphingoid base. The heterogeneity of 
the sphingoid bases and the huge variety of FA moieties (variation in carbon chain length, 







Figure 6.14: Heatmap of genes involved in ceramide synthesis following STS, FLG, TGM1, ALOX12B, 
ICHTHYIN, and ABCA12 knockdown. 
 
6.2.11.3.1 Generation of Sphingoid bases  
Serine palmitoyltransferase (SPT) is a key enzyme in generating sphingoid bases (by the 
condensation of palmitoyl-CoA and L-serine) at the ER. It is a heterodimer of subunits, Serine 
Palmitoyltransferase Long-Chain SPTLC 1 either with SPTLC 2 or with SPTLC 3 
(Hornemann et al., 2007). Significant reductions of SPT expression and of ceramide levels 
have been reported in psoriatic lesions compared with non-lesional skin (Hong et al., 2007).  
SPTLC3 was downregulated in FLG and to a lesser extent in ICH knockdowns but 















































































6.2.11.3.2 Generation of ω-acyl-ceramide (and ω-acyl-(glycosyl) ceramide)  
Unique epidermal ceramides are acylceramides. Along with α- or ω-hydroxylated ceramides 
they have an essential function in the formation of lipid lamellae. In addition, acylceramides 
are also important as a precursor of protein-bound ceramide, which functions to connect lipid 
lamellae and corneocytes. After the removal of linoleic acid, the exposed ω-hydroxyl group of 
acylceramide is covalently bound to corneocyte proteins, forming a corneocyte lipid envelope.  
 
Acylceramides have C28–C36 ULCFAs, which are ω-hydroxylated and ω-esterified to FA 
(>95% of the esterified FA consists of linoleic acid) forming hydrophobic ULC-
acylceramides (acylCer).   
 
The linoleate is derived from triacylglycerides (TAG) by an unidentified triacylglyceride 
lipase activated by CGI-58 (gene ABHD5) (Grone, 2002). ABDH5 mutations cause Chanarin-
Dorfman syndrome.  This is a rare autosomal recessive lipid storage disorder characterized by 
ichthyosis, liver disease and lipid vacuolations in neutrophils (also called neutral lipid storage 
disease).  
 
The final step of TAG biosynthesis is catalysed by diacylglycerol acyltransferase 2 (DGAT 
2). This enzyme is decreased in human psoriatic skin (Ilves et al., 2015). Downregulation of 
DGAT2 was seen in FLG knockdown. PNPLA2 (known cofactor of adipose TAG lipase) was 
downregulated with STS knockdown. 
 
6.2.11.3.3 Glucosylation of acylceramides 
Ceramide biosynthesis increases along with keratinocyte differentiation. They are further 
processed to glycosylated ceramides (GlcCers) and sphingomyelins (SM) in the Golgi 
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apparatus. Glucosylation of ceramides is by UDP-Glucose Ceramide Glucosyltransferase 
(UGCG) (Edwards et al., 2003). UGCG expression was downregulated in the common 
ichthyoses STS (log2FC -1.25, pval<0.05) & FLG (log2FC -1.18, pval<0.01). SMs and 
GlcCers are then recruited into lamellar bodies (LBs) for transport and exocytosis into the 
extracellular space. After secretion, they are degraded back to ceramides predominantly at the 
interface between SG and SC as described in Section 6.1.11.4. 
 
Currently it is unclear if ω-OH-ceramides are glucosylated first to ω- OH-GlcCer and then 
acylated to acylGlcCer.  
 
6.2.11.3.4 Extracellular processing of probarrier lipids  
Probarrier lipids synthesized (acylGlcCers, acyl-Cers, ULC-FAs etc.) are recruited into 
lamellar bodies for transport and exocytosis into the extracellular space at the interface of the 
SG and SC. In the extracellular space the linoleic moiety is stepwise oxidized by 12R 
lipoxygenase (12R-LOX) and epidermal lipogenase 3 (eLOX3) (Zheng et al., 2011) followed 
by generation of ceramides by deglucosylation of acylGlcCers (catalyzed by LB-secreted β-
glucocerebrosidase, GBA, and its co-factor Saposin-C, SAP-C) and SM (by Sphingomyelin 
Phosphodiesterase 1, Acid Lysosomal, SMPD1. Ceramides derived from acylGlcCers 
ultimately generate protein-bound ceramides thereby forming CLE (ceremides derived from 
SM do not form the CLE). A slight upregulation of GBA and SMPD1 in the ICH knockdown 
was seen (not significant).  
 
6.2.11.4 Topology and Transport 
Despite the crucial role of LBs in lipid transport and ultimately in epidermal barrier 
homeostasis, our understanding of LB formation and transport is rather superficial. ABCG1, a 
member of the ABCA12 family, is thought to play a role in normal LB formation and secretion 
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(Cheung et al., 2010). Lack of the Golgi pH regulator (Gpr89), an anion channel protein 
essential for normal acidification of the Golgi apparatus, has also been suggested to be 
prerequisite for proper LB formation.  In the SG, newly made ceramides are quickly 
transported to the Golgi apparatus for GlcCer and SM formation. The current literature 
suggests that this transport is carried out by both a vesicular-dependent and a vesicular-
independent route (Sawada et al., 2012). Vesicular flow is believed to be the major mode for 
transport of ceramides to the cis-Golgi cisternae for GlcCer synthesis at the cytosolic site 
(Wang et al., 2004). The non-vesicular transfer of ceramides to the trans-Golgi is mediated by 
the ceramide transport protein, Collagen, Type IV, Alpha 3 (Goodpasture Antigen) Binding 




















Figure 6.15 Heatmap of expression of genes involved in lipid topology and transport following STS, FLG, 
TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
 
In this dataset GPR89A was downregulated in ALOX12B knockdown (log2FC -1.47, 
pval<0.01). ABCG1 expression is increased in all the knockdowns except STS. Conversely, 
GPR89C is upregulated in STS knockdown only (non significant). Expression of COL4A3BP 
was downregulated in ABCA12 knockdown.   
 
6.2.12 Others 
6.2.12.1 AP-1 family of transcription factors:  
In XLI, abnormal desquamation as well as the permeability barrier abnormality is attributed to 
disruption of this cholesterol sulfate cycle. In the epidermis, cholesterol sulfate increases from 





































































and then declines again to 1% as corneocytes move, from inner to outer stratum corneum 
(Long et al., 1985, Rearick et al., 1987).  An ‘epidermal cholesterol sulfate cycle’ in which 
cholesterol is first sulfated in the lower epidermis, and then desulfated back to cholesterol in 
the outer epidermal nucleated layers has been proposed as an explanation (Epstein et al., 
1984). It has been proposed that the increase in cholesterol sulfate that occurs in conjunction 
with keratinocyte differentiation may not just be a marker of differentiation but may in fact be 
a signaling molecule that plays a role in inducing keratinocyte differentiation mediated by the 
AP-1 family of transcription factors or by activating the η isoform of protein kinase C 






Figure 6.16: Heatmap of gene expression of AP-1 family of transcription factors following STS, FLG, 
TGM1, ALOX12B, ICHTHYIN, and ABCA12 knockdown. 
 
Our data show that expression of members of the AP-1 family of transcription factors, FOS, 
was significantly downregulated in all the ichthyoses in this study. Additionally JUNB 
(significant in STS silencing, log2FC-1.27, pval<0.01) and FOSL2 (FRA-2) was in all the 
knockdowns (not significant). There was reduced expression of JUN (log2FC-1.01, 
pval<0.01) in ALOX12B. This suggests that all the ichthyosis genes studied play a role in 
keratinocyte differentiation and this may be mediated by the AP-1 family of transcription 









































































It has been suggested that keratinocyte apoptosis is involved in the pathomechanisms of HI 
(Yanagi et al., 2011). Defective lipid transport due to loss of ABCA12 function leads to the 
accumulation of intracellular lipids and it is thought that may result in the apoptosis of 
Abca12−/− keratinocytes. In addition, AKT signaling pathway has been demonstrated to help 
survival of ABCA12−/− keratinocytes during keratinization (Yanagi et al., 2011). 
Furthermore, PPARδ and RXRα are candidate anti-apoptotic molecules in ABCA12−/− 
keratinocytes (Yanagi et al., 2011). 
 
 
Figure 6.17: Heatmap showing expression of genes involved in keratinocyte apoptosis following STS, FLG, 








































































In this dataset no significant changes were observed. Several trends were noted: RXRA is 
downregulated in all the ichthyosis knockdowns. PPARA and NR1H3 are downregulated in 
FLG and ALOX12B knockdowns. PPARD was upregulated following ALOX12B silencing and 
AKT3 is downregulated in ABCA12 knockdown. 
 
6.3 Discussion 
6.3.1 Common Ichthyoses 
6.3.1.1 STS 
STS silencing lead to FLG down regulation; however this was not significant. A subset of 
patients with XLRI have STS as well as FLG mutations. It is known that FLG mutations 
appear to have a modifying effect on XLRI subjects; those with a mutation in FLG as well as 
mutations in the STS gene appear to have a more severe phenotype and greater barrier defects 
than patients with XLRI with wild-type FLG (Janeway and Medzhitov, 2002). Additionally, 
there was statistically significant down-regulation of LIPN and CYP4F22 genes that are 
implicated in the ARCI; LIPN (log2FC –1.22, pval<0.01) encodes one of six acid lipases 
known to be involved in triglyceride metabolism and mutations in this gene lead to late onset 
ARCI (Hari et al., 2010).  CYP4F22 (log2FC –2.06, pval<0.01) has been suggested to be 
involved in the 12(R)-LOX pathway.  
 
Significant downregulation of the suprabasal keratins KRT1 and KRT2 was seen. Several 
genes in the EDC were significantly downregulated (S100P, FLG2, RPTN). 
 
STS silencing is thought to lead to accumulation of cholesterol sulfate. Cholesterol sulfate is a 
potent transcriptional regulator (van Smeden et al., 2014a). Hanley et al demonstrated that 
cholesterol sulfate increased the expression of Fra-1, Fra-2, and JunD, members of the AP-1 
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family of transcription factors (Danso et al., 2014). Our data show that expression of members 
of the AP-1 family of transcription factors FOS, JUNB, FOSB, Fra-2 (FOSL2) were 
downregulated suggesting that it could play a role in keratinocyte differentiation/proliferation. 
Changes in cell cycle in XLI have been reported previously (Jensen et al., 1989). 
 
Several genes involved in lipid synthesis UGCG, ELOVL3 and CYP4F22 were dysregulated.  
 
The hyperkeratosis in XLI largely reflects delayed desquamation, the early stages of which 
are thought to be due to reduced activity of KLK 5 and 7 (see Section 1.4.2.5). KLK 5 and 7 
were upregulated at the transcriptome level but this was not statistically significant. Post 
translational modifications may explain these findings. In our dataset, significant 
downregulation of KLK6 was noted. There is some suggestion that KLK6 may be a 
desquamatory protease (Borgono et al., 2007). 
 
6.3.1.2 FLG 
Contrary to the observation in STS knockdown, where FLG expression was downregulated, 
there was no alteration in STS expression in the FLG knockdown. Several ARCI genes-
ALOX12B (significant) and ALOXE3 (downstream of ALOX12B in the LOX pathway), TGM1 
(significant) and ICH were downregulated. FLG expression was upregulated in the ALOX12B 
knockdown but remained unchanged in the remaining knockdowns. Additionally, there was 
significant down regulation in CYP4F22, mutation in which is known to cause ARCI (Lefevre 
et al., 2006). 
 
Structural changes were noted in the viable and non-viable epidermis. Several keratins were 
significantly downregulated throughout the viable epidermis-KRT1(2)/10 in the suprabasal 
layer and K14 in the basal layer. Additionally, expression of LOR (component of the CE) in 
the SC was significantly downregulated.  Downregulation in the other SB keratins KRT5/15 
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was also noted. Additionally, desmosomal genes DSC1, DSC2 were significantly 
downregulated thereby reducing cell-cell adhesion. (DSC3 and DSG1, DSP, PKP1, PKP3 
were also downregulated but this was not significant).  
 
The expression of TLR2 was significantly downregulated. Keratinocytes mainly signal 
through TLR2 once activated with Staphlococcus aureus and Candida albicans (Hari et al., 
2010). Expression of the constitutive AMP genes was also significantly downregulated but 
not of beta-defensins and cathelicidin perhaps indicating that an adequate response upon 
stimulation to pathogens is mounted thereby explaining the relatively low rate of infection in 
IV patients compared to the other ichthyoses. 
 
FLG is located in the EDC.  The impact of FLG knockdown on the other EDC genes was 
evaluated.  Several genes in the S100, CE precursors family and fused gene family were 
downregulated. Several other genes on the chromosome 1q21 but not thought to be part of the 
EDC were also downregulated; suggesting that they may play a role in epidermal 
differentiation. Interestingly, there was down regulation of all the EDC genes following FLG 
knockdown (S100A2, S100A4, S100A7, S100A8, RPTN, FLG2 and LOR significant). In 
addition, almost all the non-EDC genes on 1q21 were downregulated following FLG 
knockdown (TXNIP, PGLYRP3, PGLYRP4, C1orf68 significant). Furthermore, there was 
downregulation of two EDC regulatory genes GRHL3 and ARNT. This suggests that FLG may 
play a key role in the EDC. 
 
The permeability barrier defect, in IV, lies in the lipid-enriched extracellular space. The effect 
of FLG mutations on SC lipids is contradictory. In populations of northern European descent 
eczema or atopic dermatitis (AD) occurs primarily due to inherited abnormalities in FLG 
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(Irvine et al., 2011). In IV, caused by FLG mutations but, unlike in AD, there is no 
inflammation. Changes in lipid composition have also been reported in AD patients (van 
Smeden et al., 2014b, Ishikawa et al., 2010, Janssens et al., 2012). These have been attributed 
to reduction in FFA chain length and associated reduction in ceramide chain length suggesting 
a common synthetic pathway (van Smeden et al., 2014b). Therefore knowledge of the role 
that FLG (also known to cause AD) plays in epidermal lipids is of interest not only in IV but 
also in AD. 
 
In this dataset, significant downregulation of FA transporters CD36 and FABP5 (SLC27A1 
downregulated but not significant) was observed. No changes in SLC27A4/FATP4 were noted 
(loss-of-function mutations in FATP4 has been associated with AD) (Khnykin et al., 2012).  
SLC27A6 expression was upregulated. Expression of fatty acid elongases, ELOVL1 and 
ELOVL4 remained unaltered in contrast to reduced levels of ELOVL isoforms that have been 
seen in a murine AD model (Park et al., 2012). In addition, UGCG involved in glucosylation 
of acylceramides and CYP4F22 involved in ω-hydroxylation (Ohno et al., 2015) are 
downregulated. Our data suggests that some enzymes involved in FA transportation and 
ceramide synthesis may contribute to lipid abnormalities due to FLG knockdown in addition 
to altered FFA chain length. Kallikrens, KLK1 and -6 were both downregulated. 
 
6.3.2 Autosomal Recessive Congenital Ichthyoses  
6.3.2.1 ALOX12B 
There was significant downregulation of ALOX12B following FLG silencing.  There was 
upregulation of FLG (not significant) in the ALOX12B knockdown suggesting that these two 
genes may interact with each other: with FLG being downstream of ALOX12B.  Additionally, 
another CE gene TGM1 was slightly upregulated in ALOX12B knockdown (not significant).  
Upregulation of these CE genes is consistent with previous studies where LOX deficiency 
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was reported to affect proteins of the CE (including disturbed processing of pro-FLG to FLG) 
in addition to severely affecting the lipid components causing barrier dysfunction (Krieg and 
Furstenberger, 2014).  
 
There was a slight upregulation of ICH in keeping with the observation that patients with 
mutations in ALOX12B have up-regulation of ichthyin, the putative receptor for the end 
products of the LOX-pathway (Li et al., 2013). There is upregulation (not significant) of 
ALOXE3 (thought to be downstream of ALOX12B) and CYP4F22 (also involved in the LOX 
pathway) genes suggesting an attempt to compensate for the absence of ALOX12B.   
 
In this study, other significantly dysregulated genes in the ALOX12B in vitro model were 
noted: KRT1 was significantly downregulated. HRNR, a component of the EDC, is 
upregulated in ALOX12B knockdown. KLK1 is significantly downregulated. KLK1 is known 
to be expressed in the skin (Fischer and Meyer-Hoffert, 2013) but it’s role as desquamatory 
protease is unknown. The beta-defensin gene DEFB103B was down regulated in ALOX12B 
suggesting that it may play a role in cutaneous infections in the LI/CIE patient group. 
GPR89A  (prerequisite for proper LB formation) was downregulated in ALOX12B knockdown 
(log2FC -1.47, pval<0.01) suggesting a role in lipid transportation. The FA elongase gene 
ELOVL2 was upregulated.  
 
6.3.2.2 ICHTHYIN/NIPAL4 
Changes in the other ichthyosis genes were not seen.  Suprabasal keratins KRT1/2 and 10 
were significantly downregulated in ICH knockdown indicating structural changes in the 
suprabasal viable epidermis.  
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ICH silencing causes significant downregulation of FLG2 (in the EDC) and upregulation of 
the EDC regulatory gene, ARNT. Expression of FA transporter genes was altered; FABP5 was 
reduced. Upregulation of SLC27A4 was noted and although this was not significant it 
confirmed previous reports that downregulation of ICH results in upregulation of SLC27A4 
(Li et al., 2013). Cytokine IL12A was downregulated in the ICH model. 
 
6.3.2.3 TGM1 
FLG knockdown lead to a significant reduction in expression of TGM1 suggesting an 
interaction.  Both the suprabasal keratins KRT1 and 10 were significantly down regulated in 
TGM1 knockdown. Overexpression of keratin 1 has been noted in LI patients (O'Shaughnessy 
et al., 2010). 
 
There was downregulation of EDC genes (S100A7 and FLG2).  
 
The gene ELOVL2 was significantly upregulated. Genes involved in fatty acid biosynthesis 
were also perturbed in a rat epithelial organotypic model although the genes involved in the 
latter were not significantly altered in this study (O'Shaughnessy et al., 2010).  
 
6.3.2.4 ABCA12 
No interactions with the other ichthyosis genes were noted. The suprabasal keratinocyte 
marker KRT1 was significantly downregulated in keeping with previous studies (Grone, 
2002). Its pairing keratin KRT10 was also downregulated (not significant). Downregulation of 
KRT15 was seen (not significant) but no change was seen in the other basal keratins. This 




In this study FLG expression was not significantly altered at the mRNA level suggesting that 
the defective profilaggrin/filaggrin conversion noted in previous studies (Grone, 2002) is due 
to post-transcriptional changes. 
 
The expression of KLK1 was significantly downregulated and mRNA expression of several 
KLKs including KLK5 was upregulated (not significant). This is in keeping with Yanagi et al. 
findings in that upregulated KLK5 mRNA expression was reported although the protein 
expression was reduced (Coutinho et al., 2005).  
 
CYP4F22 thought to be involved in ω-hydroxylation was found to be significantly 
downregulated in ABCA12 knockdown cells. ω-Hydroxyceramides are essential for intact 
barrier function of the SC. A significant reduction in linoleic esters of long-chain ω-
hydroxyceramides and a corresponding increase in their glucosylceramide precursors have 
been noted in the skin of ABCA12-disrupted HI model mice (Zuo et al., 2008). In addition 
ELOVL3 was significantly upregulated suggesting involvement in FA elongation. IL6 
expression was significantly reduced following ABCA12 silencing and this may possibly 
explain the prevalence of skin infections in this patient group. 
 
6.4 Summary 
In summary, in this chapter heatmaps were generated in collaboration with EBI to look at 
known biological processes and genes related to the ichthyosis knockdowns. Significant 
changes noted in this study were as follows: 
 
Some interactions were found in the ichthyosis genes in this study; FLG silencing 
downregulated ALOX12B and TGM1 expression. Interactions were seen between other CI and 
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ARCI genes-other than those studied in this project (STS with LIPN and CYP4F22, FLG with 
ALOXE3, PNPLA1 and CYP4F22) and between the ARCI genes ABCA12 and CYP4F22. 
 
Two genes were significantly altered in all the in vitro ichthyosis models; KRT1 and FOS; 
KRT1 expression was significantly reduced in all the generated models. Its pairing partners 
were significantly disrupted in some but not all the ichthyoses. FOS was significantly 
downregulated in all the ichthyoses in this study. Other trends were noted in other AP-1 
family of transcription factors; down regulation of JUNB (significant following STS 
silencing), FRA-2 (FOSL2) in all the ichthyosis. Cell cycle related changes in the ichthyosis 
have been reported previously (Jensen et. al., 1989, Penneys et al., 1970). 
 
Several EDC genes (clustering of genes on 1q21 that fulfil important functions in epidermal 
differentiation) were significantly downregulated in the CI; all were downregulated in FLG 
knockdown (significant S100A2, S100A4, S100A7, S100A8, RPTN, FLG2 and LOR) and all 
were dysregulated (most downregulated) in STS knockdown (significantly downregulated 
S100P, RPTN and FLG2). A number of EDC genes were also significantly dysregulated in 
some ARCI-TGM1 (downregulation of S100A7, FLG2 and ICH) and ALOX12B knockdowns 
(HRNR upregulation). Although no significant EDC gene dysregulation was observed in ICH, 
significant upregulation Arnt (EDC regulatory gene) (Kypriotou et al., 2012) was observed 
following ICH silencing. Downregulation of all the genes in the EDC in the FLG knockdown 
suggests that it may be the master regulatory gene for the EDC. 
 
Several genes not in the EDC, on chromosomal human region 1q21, were also dysregulated 
with changes noted in almost all genes following FLG knockdowns (significant 
downregulation of TXNIP in STS and FLG knockdowns, other downregulated genes noted in 
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FLG knockdowns were PGLYRP3, PGLYRP4, C1orf68).  ALOX12B silencing lead to 
C1orf68 downregulation. This suggests that several genes on chromosome 1q21 outside the 
EDC are deregulated in the CI and ALOX12B knockdown and these non-EDC genes may also 
be regulated by FLG.  
 
In our dataset TLRs and cytokines (components of the innate immune system but also play a 
role in epithelial barrier function) were found to be altered in all the ichthyoses. Significant 
findings were: downregulation of TLR2 in FLG knockdown. The cytokine IL12A was 
downregulated in FLG and in ICH knockdown models. IL6 expression was reduced following 
ABCA12 silencing. Several beta-defensin genes were down regulated in several knockdowns; 
TGM1 (DEFB4A and DEFB4B), STS (DEFB4A) and ALOX12B (DEFB103B).  The 
constitutive AMP (AMP S100A7 and S100A8/A9 complex) were downregulated in FLG and in 
TGM1 (S100A7). These may be responsible for the impaired antimicrobial barrier in these 
ichthyoses. 
 
Desmosomal genes were predominantly down regulated. KLK6 was down regulated in the CI 
and KLK1 in FLG and several ARCI knockdowns (ALOX12B TGM1 and ABCA12). KLK 5, 7 
implicated in XLI and KLK5 in HI were not significantly altered at transcriptome level 
implying that this may be a post-translational modification.  
 
Several genes involved of biosynthesis of FA and ceramide synthesis were dysregulated. 
Novel findings were downregulation of genes involved in FA transportation was noted-CD36 
in the FLG, FABP5 in FLG and ICH knockdowns and FA elongation ELOVL3 in ABCA12 
knockdowns. Genes involved in ceramide synthesis: CYP4F22 (involved in ω-Hydroxylation 
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of FA) and UGCG (involved in glucosylation of acylceramides) were downregulated in the 












Chapter 7: Validation of RNA-Seq analysis-




7.1.1. Innate Immunity and Toll-like receptors (TLRs)  
The epidermis, the multilayered stratified epithelium of the skin, provides a first line defense 
barrier for the host. The epidermis consists of three main resident cell populations: the 
keratinocytes, Langerhans’ cells and melanocytes. Keratinocytes represent the major cell 
population of the epidermis.  Keratinocytes produce various cytokines, either constitutively or 
upon exposure to viral or bacterial stimuli (Uchi et al., 2000, Grone, 2002) suggesting that 
they play a role in innate immunity of the skin and are a key component of the epithelial 
antimicrobial barrier (Kupper and Fuhlbrigge, 2004).  
 
The cytokines produced by keratinocytes include interleukin (IL)-1, -6, -7, -8, -10, -12, -15, -
18, -20, -IL23,	 -IL33,	 IL34,	 -TGF-beta,	 -VEGF,	GM-CSF,	 tumor necrosis factor-alpha  (TNF) 
and interferons (IFN) -alpha, -beta, and -gamma (Grone, 2002). Such cytokine production by 
keratinocytes has multiple consequences for the migration of inflammatory cells, influences 
keratinocyte proliferation and differentiation processes, affects the production of other 
cytokines by keratinocytes and may have pleiotropic effects on the immune system. 
 
The innate immune system has evolved to recognize a broad spectrum of pathogens as a first 
line of defense. Innate immune cells also instruct adaptive immune responses with 
information required for this most effective and specific second line response, which helps 
eradicate the pathogen (Medzhitov, 2001). Recognition of pathogens by innate immune cells 
is mediated by pattern recognition receptors that recognize conserved pathogen associated 
molecular patterns (PAMPs). One major group of pattern-recognition receptors is formed by 
the Toll-like receptors (TLRs) (Medzhitov, 2001, Akira et al., 2001).  
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In humans, at least ten TLRs have been identified. In the epidermis these receptors are 
expressed on several cells including keratinocytes, melanocytes, and Langerhans cells.  
Keratinocytes are reported to express TLRs -1, -2, -3, -5, -9, and -10 (Hari et al., 2010); the 
evidence supporting TLR 4 expression in keratinocytes is conflicting (Hari et al., 2010). TLRs 
detect a variety of ligands, which include viral double-stranded RNA (TLR 3), and bacterial 
flagellin RNA (TLR 5) (Hemmi et al., 2003, Takeda et al., 2003). TLR2 either forms a 
heterodimer with TLR1 or TLR6 resulting in the distinction between bacterial- and 
mycoplasma-derived lipoproteins (Brightbill et al., 1999).  Keratinocytes, once activated with 
Staphylococcus aureus (S. aureus) or Candida albicans, mainly signal through TLR 2 (Hari et 
al., 2010). Once stimulated TLRs activate the transcription factor NF-kB, leading to the 
production of pro-inflammatory cytokines, chemokines and antimicrobial peptides (Akira and 
Hemmi, 2003).  
 
In addition to their antimicrobial effects the function of TLRs has recently extended to include 
epithelial barrier regulation (Kuo et al., 2013a). It has been demonstrated that TLR2 activation 
by bacterial ligands promotes aspects of the skin barrier; enhances the barrier function of tight 
junctions (Yuki et al., 2011, Kuo et al., 2013) and treatment of human epidermis wounded by 
repeated tape stripping (e.g., model of mechanical injury) with TLR2 agonists enhances skin 
barrier recovery (as measured by transepidermal water loss).  Additionally, TLR2-/- mice 
display a skin barrier repair defect (Kuo et al., 2013, Yuki et al., 2011). Desmosomes and 
tight junctions play an important role in forming a functional skin barrier (Furuse et al., 2002). 
Activation of TLR3 has been shown to induce expression and function of tight junctions and 
expression of skin barrier repair genes ABCA12, GBA, SMPD1 and TGM1 (Borkowski et al., 
2015). Mice lacking TLR3 demonstrate a decreased capacity to restore permeability barrier 
function (Borkowski et al., 2015, Lin et al., 2011). 
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This skin barrier can be divided into three lines of defense: the physical barrier against 
pathogens and mechanical injuries, the chemical/biochemical barrier with antimicrobial 
activity, and a barrier against the unregulated loss of water and solutes (Hanel et al., 2013). In 
the ichthyoses there is abnormal barrier function. The permeability barrier and antimicrobial 
barrier, which keeps out pathogens, are closely related (Fischer	et	al.,	2014). In keeping with 
this, clinically, colonization with pathogens e.g. Staphylococcus aureus (manifesting as 
maceration, irritation and odour) and recurrent skin infections have been noted clinically in 
ichthyosis patients.  
 
7.1.2 Aim: 
RNA-Seq analysis identified that keratinocytes with knockdown of ichthyosis genes had 
altered expression of genes associated with innate immunity and defense responses (Section 
6.7). The aim of this chapter was to assess the following: 
1. Cytokine profile of STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs 
compared to non-targeting control in unstimulated primary keratinocytes. 
2. Cytokine profile of STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs 
compared to non-targeting control following stimulation of TLR -2, -3, -5 in primary 
keratinocytes using PGN, Poly I:C and Salmonella typhimurium respectively.  
 
7.2 Results 
The cytokine profile of IL-8, IL-1β, IL-6, IL-10, TNF, and IL-12p70 was examined in	STS, 
FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs	 compared	 to	 non-targeting	
control,	C	 for stimulated and unstimulated in duplicate samples as described in section 2.4. 
There was no detection of IL-10 and IL-12p70 in all samples and no detection of IL-1B	for 
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unstimulated samples. TNF, IL6 and IL8 were analyzed further.  
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Figure 7.1: Cytokine profile of IL-8, IL-6 and TNF. 
Cytokine profile of IL-8, IL-6 and TNF in STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs 
compared to non-targeting control, C, in unstimulated primary keratinocytes. Constitutive IL8 induction was 
noted in both C and knock-downs. Weak induction of IL6 and minimal induction of TNF was also noted in both 











































Altered	 IL6,	 IL8	 and	 TNF	 profiles	 were	 noted	 in	 STS, FLG, ABCA12, TGM1, ICH and 
ALOX12B knock-downs	compared	to	non-targeting	control,	C.	 in	unstimulated	primary	
keratinocytes	 (Figure	 7.1).	 TNF	 was	 detectable	 at	 very	 low	 levels	 only.	 IL6	 was	
downregulated	 in	 STS, FLG, ABCA12, TGM1 and ALOX12B compared	 to	 C	 but	 was	
upregulated	in	ICH. 	IL8	was	the	most	abundant	cytokine	expressed	constitutively	in	the	
C	and	the	knockdowns.	It	was	downregulated	in	STS, FLG, ABCA12 and TGM1 compared	
to	C	but	was	upregulated	in	ICH and ALOX12B knockdowns.			
 
7.2.2 Cytokine profile in stimulated keratinocytes 
Primary keratinocytes were stimulated with three different TLR ligands: TLR2 ligand PGN, 
TLR3 ligand poly (I:C) and TLR5 ligand S. typhimurium.   
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Figure 7.2: Cytokine profile of IL-6. 
Cytokine profile of IL-6 in STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs compared to non-
targeting control, C, in primary keratinocytes after stimulation with various TLR ligands. Samples were 
stimulated at indicated final concentrations: peptidoglycan (PGN) from S aureus (10 ug/ml), Poly I:C (10 ug/ml) 
and flagellin (Salmonella Typhimurium  1 ug/ml). All three receptors were found to be functional. Results for 
stimulated were normalized to unstimulated for each ichthyosis gene and then compared to control, also 












































ligand	 poly	 (I:C),	 a	 synthetic	 analogue	 of	 double-stranded	 viral	 RNA,	 lead	 to	 the	
strongest	activation	of	primary	keratinocytes	followed	by	TLR2	ligand	(PGN)	and	TLR5	
(S.	typhimurium).	Induction	of	IL6	was	reduced	in	all	knockdowns	compared	to	control	
following	 TLR2	 and	 TLR3	 induction.	 Following	 TLR5	 activation	 there	 was	
downregulation	 of	 IL6	 secretion	 in	 STS,	 ABCA12	 and	 ALOX12B	 knock-downs	 but	
upregulation	was	seen	in	FLG	and	ICH	knock-downs.	
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Figure 7.3: Cytokine profile of TNF 
Cytokine profile of TNF in STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs compared to non-
targeting control, C, in primary keratinocytes after stimulation with various TLR ligands. Samples were 
stimulated at indicated final concentrations: using peptidoglycan (PGN) from S aureus (10 ug/ml), Poly I:C (10 
ug/ml) and flagellin (Salmonella Typhimurium  1 ug/ml). All three receptors were found to be functional. TLR3 









































All three TLRs were functional (Figure 7.3). Induction of TNF was reduced in all 
knockdowns compared to control following TLR2 and TLR3 stimulation. TLR5 activation 
lead to downregulated secretion in TGM1 and ICH knock-downs. Increased secretion was 
seen in STS, FLG, ABCA12 and ALOX12B knock-downs. 
 
7.2.2.3 Induction of cytokine IL8 
All three TLRs were stimulated but several values were not within range i.e. were above the 
maximum range.    
 
7.3 Discussion 
RNA-Seq analysis is a powerful method to investigate the effect of protein knockdown by 
identifying differentially regulated genes. In this study RNA-Seq analysis revealed that genes 
important in innate immunity response were altered as a result of ichthyosis gene knockdown 
in primary keratinocytes. The aim of this chapter was to validate these results and show that 
these changes in gene expression are functionally relevant.  
 
The RNA Seq data showed alterations in cytokine genes as a result of knockdown of 
ichthyosis genes. The RNA-Seq data predicted changes in  pro-inflammatory cytokine IL6 and 
IL8 (section 6.2.9).  These predictions were evaluated by examining the cytokine profile of 
STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs compared to non-targeting 
control in unstimulated primary keratinocytes. IL6 was downregulated in STS, FLG, ABCA12, 
TGM1 and ALOX12B knock-downs compared to C but was upregulated in ICH.  IL8 was 
downregulated in STS, FLG, ABCA12 and TGM1 compared to C but was upregulated in ICH 
and ALOX12B knockdowns.  Thus, these changes confirmed the RNA-Seq findings for IL6 
secretion in ICH and ABCA12 knock-downs but were not consistent for the remaining 
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ichthyoses.  For IL8 STS, ICH and ALOX12B knock-downs were in keeping with the RNA Seq 
data but for the remaining ichthyoses did not show the same expression changes as the RNA-
Seq data.  This discrepancy may be explained by the ligand chosen for TLRs. 
 
Cytokine profile of STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs compared 
to non-targeting control following stimulation of TLR-2, -3, -5 in primary keratinocytes using 
PGN, Poly I:C and Salmonella typhimurium respectively. After stimulation of primary 
keratinocytes with three different TLR ligands-TLR2 by ligand PGN, TLR3 by ligand poly 
(I:C) and TLR5 by ligand S. typhimurium respectively induction of pro-inflammatory 
cytokines IL6 , IL8 and TNF-a was seen in STS, FLG, ABCA12, TGM1, ICH and ALOX12B 
knock-downs. Stimulation of all three receptors was noted suggesting that TLR2, -3, -5 were 
functional in STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs in cultured 
human primary keratinocyes and responded by induction of pro-inflammatory cytokines IL6, 
IL8 and TNF to appropriate stimuli. For IL8 several values were out of range (very highly 
stimulated) and further deductions could not be made. There was reduced induction of 
cytokine secretion in all knock-downs compared to C for IL6 and TNF following TLR2 and -
3.  This may be due to down-regulation of TLR2 and -3 genes as shown by the RNA-Seq data. 
IL6 secretion was observed predominantly following TLR2 and TLR3 stimulation. TNF 
induction was predominantly through TLR3 stimulation. These findings suggest that, 
although reduced compared to C, a more effective cytokine response is produced in the 
ichthyosis knock-downs following viral compared to bacterial stimulation. 
 
IL-6 and IL-6 receptor expression is increased and localized to all nucleated epidermal layers 
after barrier disruption. In a human epidermal keratinization model IL-6 reduces the amount 
of ceramide in the SC but increases the total epidermal ceramide level. The expression of 
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genes encoding key enzymes accountable for the synthesis of ceramides was also inhibited by 
IL-6 treatment (Sawada et al., 2012).  IL6−/− mice exhibit a delay in skin permeability barrier 
repair after tape stripping whereas the application of IL-6 enhances this repair process in a 
concentration dependent manner (Wang et al., 2004).  The role of IL6 in bacterial infection 
has been highlighted following reports that IL6R blockade with Tocilizumab (approved for 
the treatment of rheumatoid arthritis) shows an inverse relationship to bacterial infection  
(Lang	et	al.,	2012).	
 
Filaggrin expression is decreased in AD and is reversely associated with IL-6 (Ilves et al., 
2015) and interruption of IL-6 receptor signaling improves the severity of AD (Wong et al., 
2012). Reduced epidermal TLR2 expression has been observed in AD patients (Kuo et al., 
2013b). This suggests that IL6 secretion may be due factors other than stimulation of TLR2 
(keratinocytes) in AD. It has been reported that a functional amino acid change in the IL-6 
receptor (IL-6R Asp358Ala; rs2228145) was significantly associated with AD (Esparza-
Gordillo et al., 2013). IL6 has been implicated in another skin barrier condition, psoriasis; 
Increased skin and serum IL-6 levels are a feature of psoriasis (Arican et al., 2005). IL-6 is a 
key mediator of IL-23/Th17-driven cutaneous inflammation (Fujishima et al., 2010). Serum 
levels of IL-6 are regarded as a marker of the inflammatory activity in psoriasis as well as an 
indicator of treatment response (Neuner et al., 1991, Grossman et al., 1989, Arican et al., 
2005); a positive correlation between IL-6 serum levels and clinical severity of psoriasis 
before treatment has been described (Balato et al., 2014). Additionally, serum IL-6 levels 
have been reported to decrease after effective treatment with methotrexate or UVB 
phototherapy (Mizutani et al., 1997, Lo et al., 2010).  The role of IL6 in the ichthyoses has not 
been studied before. In this dataset, there is marked reduction in secretion of IL6 following 
stimulation of TLR2 and TLR3 in the knock-downs compared to controls.  
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The transcription factor STAT3 is activated by cytokines of the IL-6 family. After ligand-
induced dimerization of the IL-6 receptor, the associated kinases JAK1 and JAK2 cross-
phosphorylate tyrosine residues of adjacent glycoprotein 130 (gp130) subunits of the 
complex. The SH2 domain of STAT3 binds to newly phosphorylated tyrosines, followed by 
the phosphorylation of Y705 of STAT3 (Heinrich et al., 2003). Two phosphorylated STAT3 
monomers then dimerize and translocate to the nucleus, where they activate the transcription 
of many downstream genes whose products mediate the diverse effects of STAT3 in 
development and disease (Levy and Darnell, 2002). STAT3-dependent gene expression also 
causes upregulation of inhibitory proteins of the SOCS family that interfere with JAK activity 
(Naka et al., 1997, Starr et al., 1997, Ernst et al., 2001). 
 
 
STAT3-deficient mice die during early embryogenesis (Takeda et al., 1997). However, 
analyses of tissue-specific STAT3-deficient mice indicate that STAT3 plays a crucial role in a 
variety of biological functions including cell differentiation, cell growth, suppression and 
induction of apoptosis, and cell motility	(Hirano et al., 2000, Akira, 2000). Phenotypically the 
mutant mice had marked acanthosis with hyperkeratosis and scaling. In addition there was 
aberrant hair follicle expression with pronounced inflammatory infiltration and fibrosis 
throughout the dermis (Akira, 2000). Also, STAT3 regulates the migration of keratinocytes 
(Hirano et al., 2000) and is therefore important for wound healing.  
 
Activation/phosphorylation of transcription factor STAT3 has been reported during 
permeability barrier repair and topical application of IL-6 or Hyper-IL-6, a complex of IL-6 
linked to the soluble IL-6 receptor, enhanced epidermal barrier repair in wild-type mice 
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(Wang et al., 2004). However phosphorylation was markedly reduced, but not completely 
absent, in IL-6-deficient mice compared with wild-type mice suggesting that IL-6 is an 
important (Ernst et al., 2001), though not sole, regulator of STAT3 phosphorylation in the 
skin (Wang et al., 2004) and is involved in permeability barrier repair. Thus it may be 
hypothesised that in the ichthyosis the effects of IL6 in barrier disruption may be mediated by 
STAT3. 
	
Interleukin (IL)-8 is a pro-inflammatory cytokine that has a direct effect on immune cells, 
including polymorphonuclear cells (Jiang et al., 2012). Keratinocytes are a rich source of IL-
8. In this dataset constitutive expression of IL8	was observed to be higher than all other 
cytokines both in the C	and	the	knockdowns.		There	was	reduced	secretion	in	STS, FLG, 




TNF-α is overexpressed in the epidermis of psoriasis skin (Kim et al., 2011) and has a pivotal 
role in the pathogenesis of psoriasis and TNF-a antagonists are highly effective therapeutic 
agents in most patients (Kim et al., 2011). TNF-α was recently shown to modulate filaggrin 
expression via a c-JUN N-terminal kinase dependent pathway (Kim et al., 2011). Psoriasis 
patients treated with a TNF-α antagonist had significant enhancement of epidermal barrier 
protein expression, suggesting that TNF-α acts to inhibit key skin barrier proteins and use of 
specific antagonists may improve barrier protein expression. Thus, specific 
immunomodulatory therapy could be of benefit in other diseases with epidermal barrier 
abnormalities including the ichthyoses. In this dataset secretion of TNFα is noted and is 
higher following TLR3 stimulation than following TLR2 stimulation. There was minimal 
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stimulation of TLR5.  There is reduced secretion in all knockdowns compared to control 
following both TLR2 and TLR3 stimulation. The gene STS encodes SSase.  TNFα 
upregulates SSase enzyme activity (Elias et al., 2014).  TNF stimulates keratinocyte 
differentiation and increases cholesterol sulfotransferase activity (Elias et al., 2014).  TNFα-
mediated induction of human STS occurs by transcriptional activation via a mechanism 
involving PI 3-kinase/Akt pathway in human prostate cancer cells as well as in human 
mammary cancer cells (Suh et al., 2011). In addition, TNFα has been shown to inhibit the 
proliferation of keratinocytes and it is involved in sphingomyelin cycle with a subsequent 




Transcriptome analysis showed downregulation of TLR2 and TLR3 in all the ichthyoses but 
this was most marked in FLG for TLR2 (log2 FC -1.412, p <0.01) and ICH for TLR3 (not 
significant). TLR5 was downregulated in both FLG and ICH. The TLR3 ligand poly (I:C), a 
synthetic analogue of double-stranded viral RNA, led to the strongest activation of primary 
keratinocytes compared to TLR2 and TLR5 ligands. TLR3 stimulation in all knock-downs 
was found to be less than in controls. It has been suggested that TLR3, in addition to its role 
in viral defense, may have other functions in the skin including a role in barrier repair after 
recognition of dsRNA, which keratinocytes detect following epidermal injury (Borkowski et 
al., 2013). In addition it has been demonstrated that TLR3 activation of keratinocytes leads to 
alterations in some of the ichthyosis genes; an increase in transcript abundance of ABCA12, 
and TGM1 in a TLR3-dependent manner (Borkowski et al., 2013). Additionally non-coding 
double-strand RNA was reported to induce TLR3- dependent increased expression of 
ABCA12 in human keratinocytes, resulting in increased epidermal lipid and lamellar bodies 
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(Borkowski et al., 2013). Thus, reduction in TLR3 gene expression in the ichthyosis knock-
downs may play a role in reduced epithelial repair mechanisms.  
	
A reduction of TLR2 expression in AD skin epithelium has been noted (Kuo et al., 2013a). In 
addition, TLR2 has been shown to play a role in the maintenance of tight junction integrity in 
response to barrier insults (Kuo et al., 2013a).  There is a downregulation of TLR2 expression 
in all the knock-downs (significant in FLG) in the transcriptome dataset and reduced secretion 
of IL6 and TNF for all the knock-downs compared to control following TLR2 stimulation 
with staph aureus. Thus, there may be an association between the ichthyosis genes, reduced 
TLR2 expression that may contribute to barrier defects. 
 
7.4 Summary 
In summary, the cytokine profiles of stimulated and unstimulated primary keratinocytes in the 
ichthyoses of interest: STS, FLG, ABCA12, TGM1, ICH and ALOX12B knock-downs 
compared to control were examined.  
 
The cytokine profile is altered in unstimulated primary keratinocytes in the ichthyoses of 
interest compared to control. On comparison of the cytokine secretion to cytokine gene 
expression IL6 secretion in ICH and ABCA12 knock-downs confirmed the RNA-Seq findings 
but were not consistent for the remaining ichthyoses. For IL8 STS, ICH and ALOX12B knock-
downs were in keeping with the RNA Seq data but did not show the same expression changes 
for the remaining ichthyoses.  
 
Cytokine profile following stimulation of TLR -2, -3, -5 in primary keratinocytes is altered in 
the ichthyoses of interest in this study, compared to control. Induction of pro-inflammatory 
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cytokines IL6, IL8 and TNF was observed in response to appropriate stimuli. There was 
reduced induction of cytokine secretion in all knock-downs, compared to control, for IL6 and 
TNF following TLR2 and -3.  Secretion of IL6 was observed predominantly following TLR2 
and TLR3 stimulation. Induction of TNF was predominantly through TLR3 stimulation.  
 
In conclusion, altered expression levels of several TLR receptors as well as dysregulated 
production of pro-inflammatory cytokines (IL-6, IL8) is observed in the ichthyoses of interest. 
 
7.5 Future Work 
It is important to validate TLR 2, 3 and 5 expression pattern of IL6 and TNF cytokine 
expression in organotypic cultures and patient samples by IF staining to ensure the in vitro 
findings are observed in vivo. As changes in IL8 cytokine expression were noted these could 
be evaluated by BD™ CBA Human Inflammatory Cytokines Kit with higher reference ranges 
or by ELISA. Furthermore, plasma IL6, IL8, TNF levels in uninfected, colonized and infected 


















In this study the non-syndromic monogenic ichthyoses were studied to evaluate any genes or 
biological processes common to them and to identify key genes and pathways pertaining to 
each individual ichthyosis. This group of monogenic diseases comprises of ichthyosis vulgaris 
(loss of FLG), X-linked ichthyosis (loss of STS), lamellar ichthyosis/congenital ichthyosiform 
erythroderma (due to mutations in ALOX12B, ICH, ABCA12) and harlequin ichthyosis (due to 
mutations in ABCA12). They all affect the cornified layer and manifest as scaly conditions 
along a spectrum ranging from mild (as in ichthyosis vulgaris) to having a major impact on 
quality of life (as in lamellar ichthyosis/congenital ichthyosiform erythroderma) to severe (as 
in harlequin ichthyosis).  
 
In this study the effect of ichthyosis gene knockdown (STS, FLG, ABCA12, TGM1, ICH and 
ALOX12B) was examined using RNAi technology (siRNA in primary keratinocytes) targeting 
each gene in monolayers and organotypic 3D cultures. RNA-Seq analysis was undertaken and 
compared to control to identify differentially regulated genes following gene knockdown. 
Functional analysis was undertaken to evaluate changes in TLRs and cytokines (altered at 
transcriptome level). 
 
8.2 A novel in vitro 3D model generated for XLI 
No previous 3D in vitro models for XLI have been reported before. In this study a novel 3D 
organotypic culture models for this condition were generated using primary keratinocytes 
using de-epidermalised dermis as scaffold. Loss of expression for the causative gene STS was 
confimed at transcriptome and protein level by qPCR and Western blot respectively. Changes 
in terminal differentiation (TGM1) were noted (figure 4.7).  RNA-Seq analysis revealed 458 
dysregulated genes that are involved in cutaneous and extracutaneous processes suggesting 
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that STS may directly contribute to contiguous gene defects in XLI.  Validation of these results 
by IF or western blotting is important to confirm these findings.  
 
8.3 Filaggrin may play a key role in EDC regulation  
Down regulation of all the EDC genes and almost all the non-EDC genes on 1q21 following 
FLG knockdown was noted. This novel finding suggests that FLG may be a key regulator of 
the EDC.  This was further supported by complete loss of LOR (an EDC gene) in the 3D FLG 
knockdown model. FLG is one of several genes that comprises the EDC, a 2Mb region on 
chromosome 1q21, that encodes proteins that fulfil an important role in terminal 
differentiation in the epidermis (Hoffjan et al., 2007).  EDC protein expression is regulated in 
a gene and tissue-specific manner. Several transcription factors including Klf4, Grhl3 and 
Arnt (Kypriotou et al., 2012) and interaction of Fra-2/AP-1 with Ezh2 and ERK1/2 (Wurm et 
al., 2015) have been reported as regulators of EDC. To validate the hypothesis that FLG is a 
key regulator of the EDC (and non-EDC genes on 1q21) IF on FLG knockdown 3D 
organotypic models and/or Western blotting of the other EDC (and non-EDC genes on 1q21) 
proteins could be undertaken. 
 
8.4 Epidermal differentiation is altered in all the 
ichthyoses knockdowns 
This study shows that both early and late differentiation is altered in the ichthyoses. KRT1 
downregulation, early differentiation marker, was found to underlie all the ichthyosis in this 
study (at transcriptome level) and altered TGM1, a terminal differentiation marker, was noted 
in all the ichthyosis 3D organotypic models. Interestingly RNA-Seq analysis did not show 
significant changes in TGM1 gene expression in all the ichthyosis knockdowns highlighting 
the difference between the transcriptome and the functionally relevant proteome. In addition 
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to downregulation of KRT1, its pairing partner KRT10 was significantly downregulated in 
ICH, TGM1, FLG and the other pairing partner, KRT2 was significantly suppressed in STS, 
FLG and ICH.  These findings are limited to mRNA level and further validation at protein 
level is required by IF staining of organotypic cultures and patient samples to confirm these 
gene expression changes. 
 
This study also provided novel insights for the individual ichthyosis; Loss of FLG confirmed 
changes in terminal differentiation (LOR, TGM1) and implies that a disrupted CE is formed. 
These changes may be explained by gene alterations noted in the NOTCH signaling pathway 
(Lin et al., 2012).  Premature terminal differentiation was noted following ABCA12 
knockdown (with increased expression of filaggrin and TGM1 in the viable epidermis) 
confirming findings seen in HI skin (Thomas et al., 2009); In addition, reduction of K10 
expression was noted implying altered early differentiation in HI possibly due to premature 
terminal differentiation. Noncoding dsRNA (via TLR stimulation) have been reported to 
stimulate some events in keratinocyte differentiation that are important for skin barrier repair 
and maintenance via ABCA12 upregulation (Borkowski et al., 2013). Our data showed 
downregulated TLR signaling which may explain the aberrant keratinocyte differentiation. 
Validation of genes involved in the NOTCH and TLR pathways by qPCR, Western blotting 
and IF would be required to confirm these findings. 
 
8.5 Innate immune system is dysregulated in all the 
ichthyoses 
In this project altered TLRs and cytokines in unstimulated and stimulated cytokines in all the 
ichthyoses were noted. Clinically colonization with pathogens and recurrent skin infections 
have been noted in the ichthyoses (Grahovac et al., 2009, Fleckman et al., 2003); most in HI 
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followed by the ARCI and may be explained by severity of the impaired permeability barrier 
(most in HI followed by the other ARCI) impacting on the antimicrobial barrier. In addition, 
differences in infection prevalence and inflammation are noted between atopic dermatitis and 
ichthyosis vulgaris (higher in the former), both caused by loss of FLG expression. In addition 
to their role in the innate immune system TLRs and cytokines also play a role in epithelial 
barrier function (Wood et. al., 1992, Hanel et al., 2013). Mechanistic insights following 
further study of these components of the innate immune system may explain these 
observations. It may be hypothesised that the effects of IL6 in barrier disruption may be 
mediated by STAT3 in the ichthyoses (section 7.3).  
 
8.6 Dysregulation in stratum corneum lipids in all the 
Ichthyoses 
	
The ichthyoses cause a defect in the epidermal barrier. Epidermal lipids are critical to 
epidermal barrier formation/function in the SC. The SC is composed of corneocytes that are 
filled with water and keratin that is surrounded by a cornified envelope, CE, which consists of 
a densely crosslinked layer of proteins such as filaggrin, loricrin and involucrin. A monolayer 
of non-polar lipids (ω-hydroxylated ceramides and free fatty acids, FFA) referred to as the 
cornified lipid envelope, CLE, is esterified to the cornified envelope, mainly to glutamate 
residues of involucrin (Lazo et al., 1995, Marekov and Steinert, 1998, Swartzendruber et al., 
1987). The CLE is suggested to form a template for the formation of the intercellular lipid 
layers (Sandhoff, 2010, Schuette et al., 1999, Wertz et al., 1989). The cornified envelope, 
together with the CLE allows proper formation of the lipid matrix.  
 
In this project genes annotated to lipid metabolism were dysregulated in all the ichthyosis 
knockdowns and arachadonic acid pathway (in all but ICH knockdown). Metabolism of 
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arachidonic acid by ALOX12B is known (section 1.5.2.4.3). In the FLG knockdown DEGs 
which included ALOX12B in arachidonic acid metabolism were noted implying that there are 
interactions between FLG and ALOX12B (section 5.2.4). ICH it is thought to the putative 
receptor in the same metabolic process as ALOX12B (i.e. metabolism of arachidonic acid) 
(Dahlqvist et al., 2007, Lefevre et al., 2006). It is therefore surprising that genes altered in this 
pathway were not dysregulated in this knockdown. 
 
Dysregulated lipid metabolism in the other ichthyoses may be explained secondary to the 
following; irregular lipid matrix formation resulting from a deficient CE following TGM1 loss 
have been noted (Meguro et al., 2000, Behne et al., 2000, Li et al., 2007, Downing, 1992). In 
support of this several genes involved in peptide cross-linking and CE including FLG were 
dysregulated in the TGM1 knockdown. In addition to its role in the arachidonic acid pathway 
ALOX12B is known to oxidise the ω-esterified linoleic acid moiety which serves as the 
substrate for generation of ω-hydroxylated-(glucosyl) ceramides (section 1.5.2.4.4), a 
prerequisite for CLE formation (Zheng et al., 2011). CLE and bound ceramides are almost 
entirely absent in ARCI caused by mutations in ALOX12B (Krieg et al., 2013, Epp et al., 
2007). In keeping with this genes involved in several lipid processes-lipid localization and 
transport, lipid biosynthetic process, oxidoreductase activity, iron ion binding and lipid 
biosynthetic process were altered. The role of ichthyin in epidermal biology is poorly 
understood; as noted it is the putative receptor in the same metabolic process as ALOX12B 
(Dahlqvist et al., 2007, Lefevre et al., 2006) and it may play a role in the formation, transport 
or fusion of LBs with the plasma membrane (Dahlqvist et al., 2007). Several genes annotated 
to vesicle mediated transport were downregulated. Furthermore, a novel finding was 
involvement of genes in FA/FA biosynthesis.  ABCA12 is involved in lipid transportation via 
LB to the intracellular layers in the SC. Transmembrane transport in this study. Lipid 
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abnormalities due to loss of FLG have been attributed to reduction in FFA chain length and, 
as some FFAs are components of ceramides, in ceramides (van Smeden et al., 2014). RNA-
Seq data confirmed these findings. In addition genes involved in lipid transportation and 
ceramide synthesis were altered. The basis for the permeability barrier abnormality due to loss 
of STS in XLI has been attributed to excess cholesterol sulfate and also in part to the 
decreased cholesterol content of the SC (section 1.4.2.2) and lipid and arachidonic acid 
metabolism have not been reported.  
 
8.7 Conclusions and Final Remarks 
In this study of the non-syndromic monogenic ichthyosis, my original null hypothesis was 
that despite a common phenotype the individual ichthyoses have different underlying 
pathomechanisms and biological pathways. For this in vitro models for the CI (IV/XLI) and 
ARCI (LI/CIE) were developed by transient knockdown of STS, FLG, ABCA12, TGM1, ICH 
and ALOX12B in monolayers and 3D organotypic cultures (including a novel XLI model) by 
using siRNA in primary keratinocytes (neonatal). Knockdown of ichthyosis genes in 
monolayers was confirmed by qPCR and where possible by western blotting. In the generated 
3D models architectural changes and altered terminal differentiation were noted.  RNA-Seq on 
generated 2D models from the same genetic background was successfully undertaken.; 
Altered gene clusters were found for cell cycle, keratin filament/cytoskeleton, innate immune 
response, and metabolism of lipids and lipoproteins. Functional studies showed altered TLR 
and cytokine profile in all the ichthyoses. Altered differentiation was noted in all the 
ichthyosis (early and late differentiation). Furthermore, expression of FOS, a member of the 
AP-1 family of transcription factors, was significantly downregulated. Changes in cell cycle 
have been noted in the ichthyosis previously (Jensen et al., 1989, Penneys et al., 1970). As it 
is clear that in this knockdown model of the ichthyoses, there are common pathways altered in 
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all 6 gene knockdowns, I can partially disprove the null hypothesis. A future hypothesis to 
interrogate might be that the common phenotype of each individual ichthyosis is caused by 
changes in the cell cycle and this may be mediated by the AP-1 family of transcription factors, 
in particular FOS.  However, it is clear that individual ichthyosis genes also have major 
effects which may be relevant to the individual gene, such as the major effect of loss of FLG 
on the EDC or the effect of loss of STS on steroid hormone and ceramide pathway genes 
which is congruent with the null hypothesis.  A large data set, such as the data set generated 
by this thesis could generate many more hypotheses. Further protein analysis 
(proteomics/lipidomics) would be required to firm up possible biomarkers or therapeutic 
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CCK 2.423864811 7.84E-05 
C1QL4 2.317633698 0.005626192 




Gene log2FoldChange p-value 
ABCG4 -1.206351542 0.001727122 
ACTG2 -1.489615109 0.004631323 
ALOX12B -1.090237652 2.07E-08 
ANKRD20A11P -1.759532882 0.005914811 
ANXA8L1 -1.539526985 0.000542176 
ARHGAP19 -1.038402414 2.42E-21 
ATAD2 -1.413821341 2.86E-15 
ATAD5 -1.012589339 0.000768791 
BARD1 -1.033412284 2.16E-08 
BBOX1 -1.775978591 8.59E-09 
CCK 2.625026792 2.41E-05 
SLC5A2 2.554282964 0.000794129 
VIP 2.528158454 0.005192918 
TAL1 2.517034085 0.000545945 
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ADAM23 2.394489117 4.25E-05 
CEND1 2.340324375 0.008276367 
FBXO39 2.319330547 8.37E-06 
CYP2D6 2.273013364 0.000448682 
VNN1 2.222244443 4.36E-13 
INHBB 2.117971461 1.58E-12 
 
 
1.2  RNA quantity and quality for microarray analysis: nanodrop. 
 
Name on tube Conc (ng/ul) Volume (ul) 260/280 
C-1 553.4 10 2.05 
C-2 559.1 10 2.06 
C-3 581.1 10 2.03 
NT-1 428.3 10 2.03 
NT-2 470.9 10 1.95 
NT-3 416.7 10 2.01 
M-1 342.1 10 2.03 
M-2 342.1 10 2.03 
M-3 324 10 2.03 
FLG-1 375.9 10 2.03 
FLG-2 412.7 10 2.02 
FLG-3 383.2 10 2.02 
ABCA-1 270.7 15 2.03 
ABCA-2 249 15 2.02 
ABCA-3 268.3 15 2.02 
TGM-1 446.7 10 2.03 
TGM-2 418.7 10 2.02 
TGM-3 354.2 10 2.01 
ALOX-1 401.5 10 2.03 
ALOX-2 379 10 2.04 
ALOX-3 393.5 10 2.04 
ICH-1 366.4 10 2.02 
ICH-2 384.6 10 2.02 
ICH-3 409.9 10 2.02 
STS-1 356.9 10 2.03 
STS-2 347.5 10 2.02 
STS-3 395.7 10 2.04 
C=control, M=mock, NT-non-targeting 
 
 
 
	 271	
 
 
 
